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Summary  
 
Background: The prevalence of diabetes mellitus and neglected tropical diseases are 
nowadays escalating, especially in endemic resource poor countries and their impact on social 
and economic development are negatively huge. Recent studies indicate that diabetes mellitus 
problem is now truly global epidemic and a number of risk factors are contributed to diabetes.  
Dengue viral infections have been one of the most reemerging diseases worldwide in recent 
years and case fatalities are usually high among dengue infected individuals having any 
underlying co-morbid disease condition. Helminth or parasite infections mainly contribute to 
global burden of diseases and cause adverse events on health. Therefore, it is very important 
to understand the interaction between diabetes mellitus and neglected tropical diseases in 
clinical management for curative, as well as disease epidemiology for preventive purposes.  
Methods: Firstly, we conducted a systematic review and meta-analysis to summarize and 
update the current knowledge of diabetes mellitus and dengue viral infections as well as 
helminth or parasite infections. To follow up the findings between diabetes and parasite 
infections and to explore their association in epidemiological settings, we conducted two field 
studies. A cross-sectional community based study was carried out among adults in 4 
provinces of Lao People’s Democratic Republic. We also investigated a longitudinal study 
among schoolchildren in poor neighborhoods of South Africa to figure out the comorbid 
association and effect of helminth infections on blood sugar concentration determined by 
HbA1c measurements after deworming. 
Results: In this PhD work, we found a positive relationship between diabetes mellitus and 
neglected tropical diseases we studied. Firstly, our systematic review and meta-analysis 
summarized that diabetic patients are more likely to have a severe form of dengue if they 
were infected with a dengue viral infection. In the context of relationship between diabetes 
mellitus and another neglected tropical disease, our findings showed that the prevalence and 
species of helminth infections were different in different country settings. In Laos PDR, food 
born trematodes were more prevalent and the prevalence of diabetes was also higher than 
estimated figures. We observed a positive relationship between diabetes mellitus and teania 
infection in Lao PDR setting. In South Africa, we found soil transmitted helminth infections 
and H. pylori infections were quite common among schoolchildren and the high numbers of 
prediabetic prevalence. A positive relationship between diabetes mellitus and H. pylori 
infections has been revealed in the study. No association has been found between diabetes and 
 vii 
 
other infections. We also disclosed that HbA1c levels are more likely to increase after 
deworming. 
Conclusion: Our research work provides valuable insights of co-morbid association. It can be 
concluded that diabetes mellitus and dengue or taenia or H. Pylori infections have influenced 
each other not in a good way, either dengue infection or teania or H. Pylori infections 
exacerbate diabetes mellitus or vise visa.  The patho-physiological mechanism behind these 
associations should be further explored. As diabetes is a multi-faceted disease, many other 
factors could also top up these interactions. Diabetes, dengue, parasitic infections remain of 
major public health concerns in both Laos PDR and South Africa. Hence, our findings call for 
action to establish a proper public health policy with an integrated approach addressing both 
diseases condition to reduce mortality and/or morbidity and to ameliorate clinical outcomes 
and preventive measures among affected population. Additional studies in other endemic 
countries are also greatly recommended to reflect our current findings to be able to apply for 
the implementation as a global perspective.  
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Chapter 1 
Introduction 
 
1.1 Dual burden of diseases (DBD) 
For decades, communicable diseases (CDs) and chronic non-communicable diseases 
(NCDs) occurred principally in different areas; low- income countries were primarily 
burdened with infectious diseases such as diarrhea, respiratory infections, hepatitis, malaria, 
tuberculosis, NTDs, HIV/AIDS and so on, worsened by poverty. Chronic illnesses such as 
cardiovascular diseases, diabetes mellitus (DM), obesity, cancer, and asthma mostly affected 
the economically well-developed part of the world. Traditionally, in a very young age period, 
CD or infectious diseases such as diarrhea and acute respiratory infections, tuberculosis, 
measles and malaria, and nutritional related problems such as vitamin B1 deficiency called 
Beri Beri, vitamin D deficiency and iron deficiency anemia, are very common. In adulthood, 
accidents and violence-related disabilities and deaths become a major concern while CD such 
as TB, HIV, malaria, NTDs still exist, and in older age groups, NCDs such as DM and 
cardiovascular diseases, followed by cancer and degenerative disorders are generally 
dominating. Due to socio-economic developments, globalization, lifestyle transition and 
longer life expectancy especially in low- and middle- income countries, these resource-poor 
countries are nowadays facing both kinds of problems called a dual burden of diseases 
(DBD); increasing NCD trends are superimposed to continuously high levels of existing, 
emerging and re-emerging CD (Marshall, 2004). This DBD creates a critical challenge to the 
health of people and to health systems. The World Health Organization (WHO) presented the 
proportional distribution of disability-adjusted life years of CDs, NCDs and accidents among 
low income and high income countries in 2002 and estimates for 2030. According to the 
figure, in 2002, CDs accounted 56% of all infections, NCDs for 33% and accidents for 11% 
and in 2030, it will be 41% for CDs, 45% and 14% for NCDs and accidents respectively. The 
figures show that low income countries would simultaneously have to deal with the problems 
of DBD in near future. In high income countries, the proportional distribution of disability 
adjusted life years (DALYs) for NCDs were 85%, 9% for CDs with 6% of accidents in 2002 
and by 2030, it is predicted that they will particularly be suffering more from NCDs 
accountable for 90%, with only 10% for the rest (7% of CDs and 3% of accidents) (Mathers 
and Loncar, 2006).  
An interrelation between chronic diseases and infections has also been evidenced, 
most importantly for diabetes mellitus (DM). DM puts patients at a higher risk for infections 
Chapter 1: Introduction 
2 
 
that are common in low- and middle-income countries, such as for tuberculosis (Joshi et al., 
1999) and possibly other infections including malaria (Ina Danquah et al., 2010). 
Uncontrolled DM furthermore predisposes to candidiasis, otitis externa and rhinocerebral 
mucomycosis, Streptococcus and Klebsiella infections due to suppressed immune response 
and increased susceptibility to the infections (Mueller, 2011). Whether infections such as 
tuberculosis or HIV directly increase the risk of DM is still poorly understood (Remais et al., 
2013, Mueller, 2011). There is a growing evidence for an increased risk of type 2 DM in 
patients with chronic HCV infection (White et al., 2008), however, there are also other studies 
reporting type 2 DM as a predisposing factor for HCV infection (Guo et al., 2013) and we call 
it a two way association (Hammerstad et al., 2015). As recently summarized, a relevant part 
of cardiovascular diseases may be attributable to neglected tropical diseases (NTDs) and other 
infections prevalent in developing world (Moolani et al., 2012).    
Understanding the link between CDs and NCDs is of great policy relevance in terms 
of estimating global burden of disease in a population-specific manner towards preparing 
specific health systems for the challenges ahead. The directions and mechanism underlying 
the interrelations are likely to vary greatly for specific diseases (Knapp, 2013). Current 
evidence for the biology that mediates the link between CDs and NCDs is still limited. 
 
1.2 Diabetes Mellitus 
DM is a chronic metabolic disease which is uniformly characterized by chronic 
hyperglycemia, which is the result, though, of different pathophysiological processes. DM has 
traditionally been subdivided into type 1 (autoimmune destruction of insulin-secreting β 
cells), type 2 DM (insulin resistance and features of metabolic syndrome) and gestational DM 
which develop high blood sugar levels only during pregnancy. Yet, this dichotomous 
classification captures the range of the disease poorly and in fact insufficiency of pancreatic β 
cells in producing adequate amounts of insulin as well as some degree of insulin resistance 
seem involved in all types of DM. DM can also be divided into subgroups characterized by a) 
destruction of β cells, b) defective response to glucose, c) low β cell mass from birth, and d) 
defective processing of insulin (Tuomi et al., 2014).  
DM in children and adolescents or type 1 DM remains the most common form of DM in 
children younger than 15 years of age. Its incidence varies substantially between different 
populations (from 0.51 in China to 40.90 in Finland). The incidence has rapidly risen in recent 
decades globally. As a result of the increase in childhood obesity, type 2 DM has emerged as 
a new type of pediatric DM after age of 10 years, usually after the onset of puberty. Puberty is 
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normally associated with transient insulin resistance, which in healthy adolescents is balanced 
by an increase in insulin secretion. In obesity this increase is insufficient to overcome insulin 
resistance. The prevalence of type 2 DM in Asian adolescents is sometimes even higher than 
in US teenagers, such as in the case of Chinese teenagers. In fact, in both children and adults, 
African-American, Hispanic, Asian-Pacific-Islander and American-Indian persons seem to 
have higher incidence and prevalence of type 2 DM than non-Hispanic whites. But the ethnic 
differences are strongly dependent on lifestyle contexts. The diagnostic classification of 
children and adolescents into type 1 and type 2 DM is not straight forward as auto-antibodies 
and ketoacidosis have also been detected in a considerable percentage of children with type 2 
DM (Tuomi et al., 2014). 
DM in Adults or type 2 DM:  While the age cut-off to differentiate between type 1 and type 2 
DM was originally between 35-40 years, this cut-off is not a valid clinical value these days. 
At around age 20-50 years not only type 1 and type 2 DM but also maturity onset of DM of 
young (MODY) and secondary DM can occur. Obesity and metabolic syndrome have 
generally been used as the basis for diagnosis of type 2 DM but today people who develop 
type 1 DM are often obese, too. In fact, the diagnostic value of obesity and metabolic 
syndrome lies in their absence for diagnostic confirmation of non-type 2 DM. Latent 
autoimmune DM in adults (LADA) has been introduced as a subtype of DM in response to 
the fact that adult onset DM may need immediate initiation of insulin therapy and be 
associated with pancreatic autoantibodies. Whether LADA is a clinical subtype of DM or 
merely reflecting the stage of disease is not clear. Around 5-14% of adult DM patients have 
pancreatic antibodies to glutamic acid decarboxylase (GAD). Positivity for autoantibodies 
may be transient in both, children and adults. LADA is associated with a better cardiovascular 
risk profile (serum triglyceride, HDL cholesterol, obesity and hypertension) than type 2 DM, 
but whether this translates to fewer cardiovascular events has not been sufficiently studied. 
Other hybrid forms of DM exist. For example, African-Americans patients of sub-Saharan 
African descents and particularly obese men have a form of non-autoimmune ketosis-prone 
DM (Tuomi et al., 2014).  
Genetic background: While monogenetic forms of DM exist (MODY)  both type 1 and type 2 
DM are polygenic diseases with over 60 susceptibility loci identified in the context of 
genome-wide association studies. Genetics has provided clear support for the view that 
LADA is between adult-onset type 1 DM and GAD-antibody-negative type 2 DM (Tuomi et 
al., 2014).  
Chapter 1: Introduction 
4 
 
Gene – Environment Interactions: Asian populations seem to be supersensitive to risk factors 
for type 2 DM (Tuomi et al., 2014). Chinese people for example seem to be susceptible to 
even slight increases in body mass index (BMI); the mean BMI value at the moment of DM 
diagnosis in Chinese patients is 25.9 kg/m2. In the American Nurses’ Health Study patients of 
Asian ethnicity had about double the risk of type 2 DM for the same BMI compared to 
Caucasian patients (Pan et al., 2004). Asian persons have more abdominal adipose tissue for 
any given BMI than their non-Hispanic white counterparts. DM in Asian persons is 
characterized by a combination of both, insulin resistance and failing β cells. Lifestyle 
modification can result in substantial reductions in DM risk in these populations, such as in 
India or China (Tuomi et al., 2014). 
1.2.1 Epidemiology  
Globally, as of 2015, an estimated 415 million people have DM worldwide, with 
type 2 DM making up about 90% of the cases  and three fourth of people with DM live in low 
and middle income countries (WHO, 2014). One in 11 adults had DM while one in two adults 
with DM is undiagnosed and one person in every 6 seconds dies from DM causing 5 million 
deaths in 2015. DM overall at least doubles the risk of premature death. By 2040, the number 
of people with DM is expected to rise to 642 million  and one in 10 adults will have DM (IDF, 
2015).If DM is not properly controlled or left untreated without being diagnosed, the people 
living with diabetes may have to deal with short-term or long-term complications. The short-
term complications includes diabetic emergencies such as hypoglycemic diabetic ketoacidosis 
(DKA) or hyperosmolar non-ketotic acidosis (HONK) which requires immediate intensive 
treatment, otherwise, it causes coma or death. The main long-term complications includes 
affecting the eyes and blindness (retinopathy), heart (cardiovascular diseases), kidney failure 
(nephropathy), nerves (neuropathy) that lead to amputation of the limbs, miscarriage and still 
birth in the diabetic pregnant mothers.      
Among 20 leading causes of YLDs at global level in 2011, DM ranked 6th which was 
not changed since 2000, representing 21.8 million. In terms of DALYs, DM ranked 12th in 
2011, topping from 18th in 2000, representing 56.4 million (WHO, 2013). Despite the fact that 
DM reduces life expectancy, it is associated with substantially higher lifetime medical 
expenditures. The person with DM expects approximately 2.3 times higher medical 
expenditures than persons without diabetes and 12% of global health expenditure $673 billion 
is spent on DM in 2015 (IDF, 2015).  
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1.3 Neglected tropical diseases  
NTDs feature a group of different type of infections caused by a variety of pathogens 
which are bacteria, viruses, protozoa and helminths. The WHO considers 17 neglected 
tropical diseases to be tackled namely Buruli ulcer, Chagas disease, dengue and Chikungunya, 
Dracunculiasis (guinea-worm disease), Echinococcosis, endemic treponematoses (Yaws), 
foodborne trematodiases, human African trypanosomiasis (sleeping sickness), Leishmaniasis, 
Leprosy (Hansen disease), Lymphatic filariasis, Onchocerciasis (river blindness), rabies, 
schistosomiasis, Soil-transmitted helminthiases, Taeniasis/Cysticercosis and Trachoma (9 are 
caused by microparasites and 8 are caused by macroparasites), affecting more than 1 billion 
people worldwide mostly in 149 endemic countries . They mainly affect populations living in 
poverty, without adequate sanitation and in close contact with infectious vectors and domestic 
animals and livestock. The figure 1 describes the numbers of NTDs currently presenting in 
endemic countries. 
1.3.1 Epidemiology  
In 2010, it was estimated that NTDs collectively caused 26 million Disability Adjusted 
Life Years (DALYs) worldwide. NTDs devastate human health and can cause death. 
Substantial efforts are underway on a global scale towards understanding the dual disease 
burden related to DM infectious diseases such as tuberculosis and HIV. In contrast little 
research has been conducted on the association between DM and specific neglected tropical 
diseases as defined by the WHO (Table 1) (Hotez et al., 2014), even though several NCDs, 
ranging from cancer to cardiovascular and liver disease result from chronic NTD infections 
(Hotez and Daar, 2008). 
Biological evidence suggests that the association between DM and NTDs may well 
vary by type of infection, as evidenced with the example of helminthic infections versus 
dengue fever. Helminthic infections and dengue fever contribute substantially to the NTD 
associated global burden of disease (Hotez. et al., 2014), so that it is of public health 
relevance to study their association with DM. The examples of helminthic and dengue 
infections prove the complexity of the DM-infection association. In the case of Dengue fever, 
available evidence would suggest that DM mellitus may have an adverse effect on the clinical 
course of the infection. In the case of helminth infections, they may represent the other 
extreme of the spectrum wherein, the helminth mediated immune-modulatory effect can in 
fact dampen inflammation and can potentially confer protection against metabolic diseases 
(Van Riet et al., 2007).  
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Table 1.1 Neglected tropical diseases and estimated global burden (Hotez. et al., 2014) 
Disease DALYs from GBD 2010 
(numbers in parentheses indicate 95% CI) 
NTDs 26.06 (20.30-35.12) 
Intestinal nematode infections 5.19 (2.98-8.81) 
    Hookworm disease 3.23(1.70-5.73) 
    Ascaris 1.32 (0.71-2.35) 
    Trichuriasis 0.64 (0.35-1.06) 
Leishmaniasis 3.32 (2.18-4.90) 
Schistosomiasis 3.31 (1.70-6.26) 
Lymphatic filariasis 2.78 (1.8-4.00) 
Food-borne trematodiases 1.88 (0.70-4.84) 
Rabies 1.46 (0.85-2.66) 
Dengue 0.83 (0.34-1.41) 
African trypanosomiasis 0.56 (0.08-1.77) 
Chagas disease 0.55 (0.27-1.05) 
Cysticercosis 0.50 (0.38-0.66) 
Onchocerciasis 0.49 (0.36-0.66) 
Trachoma 0.33 (0.24-0.44) 
Echinococcosis 0.14 (0.07-0.29) 
Yellow fever <0.001 
Other NTDs* 4.72 (3.53-6.35) 
*Relapsing fever, typhus fever, spotted fever, Q fever, other rickettsiases, other mosquito-borne viral fevers, unspecified 
arthropod-borne viral fever, arenaviral haemorrhagic fever, toxoplasmosis, unspecified protozoal disease, taeniasis, 
diphyllobothriasis and sparganosis, other cestode infections, dracunculiasis, trichinellosis, strongyloidiasis, enterobiasis, and 
other helminthiases. 
1.4 Dengue viral infection 
Dengue is one of the most important arthropod-borne (ARBO) tropical infection 
caused by the dengue virus, family Flaviviridae; genus Flavivirus with its four main serotypes 
(DEN-1, DEN-2, DEN-3 and DEN-4), transmitted by the Aedes aegypti mosquito.  
1.4.1 Epidemiology  
The number of dengue virus infections has increased 30-fold over the last decades. 
Dengue is an endemic disease in the tropics and subtropics and is found in the Caribbean, 
South and Central America, Mexico, Africa, the Pacific Islands, Southeast Asia, the Indian 
sub-continent, Hawaii, and Australia. Approximately 2.5 billion people, or 40% of the world’s 
population, live in areas where there is a risk of dengue transmission (CDC, 2016). The 
number of cases reported increased from 2.2 million in 2010 to 3.2 million in 2015 (WHO, 
2014c). An estimated 500,000 people with severe dengue require hospitalization each year 
and about 2.5% of those affected die (WHO, 2014c). Not only is the number of cases 
increasing as the disease spreads to new areas, but explosive outbreaks are occurring. In 2012, 
an outbreak of dengue occurred on the Madeira Islands of Portugal resulted in over 2,000 
cases. Cases have occurred in Florida of United States of America, Yunnan province of China 
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and Laos in 2013. Worldwide large dengue outbreaks were recorded in the Philippines 
reporting more than 169,000 cases, Malaysia exceeding 111,000 suspected cases of dengue, 
representing a 59.5% and 16% increase in case numbers to the previous year, respectively. 
Brazil alone reported over 1.5 million cases in 2015, approximately 3 times higher than in 
2014 and Delhi, India, also recorded its worst outbreak since 2006 with over 15,000 cases 
(CDC, 2016). 
Dengue has long been viewed as a pediatric disease but the average age of dengue 
cases has been rising and recently adults to be at increased risk for dying from dengue 
infection. The increase in tourism in tropical regions also contributed to the increase in adults 
dengue cases (Tantawichien, 2012). WHO recognizes dengue virus as a major and emergent 
concern due both to its expanding distribution and also to an increased frequency of 
epidemics. 
1.4.2 WHO classification of Dengue viral infection 
In 1975, the dengue viral infection was developed as dengue fever (DF), dengue 
hemorrhagic fever (DHF), and dengue shock syndrome (DSS) case classification of dengue 
by experts based on studies on Thai children in the 1950s and 1960s. DF was defined as 
having the symptoms of dengue fever which begins three to fourteen days after being infected 
with dengue virus with a clinical presentation of high fever, headache, vomiting, muscle and 
joint pains. Dengue fever mostly resolves itself without any treatment; however, it can 
progress to its severe form which is called dengue hemorrhagic fever. DHF was characterized 
by fever lasting from 2-7 days with the evidence of hemorrhagic manifestation or a positive 
tourniquet test and decreased platelet counts (thrombocytopenia:≤100,000 cells per mm3). In 
1997, four grades of DHF were defined as DHF grade I, II, III, and IV), where Grades III and 
IV are clarified as DSS, with hypotensive shock or narrow pulse pressure plus clinical signs 
of shock. The revised WHO 2009 classification consists of dengue without warning Signs, 
dengue with warning Signs, and Severe dengue. Severe dengue is defined as dengue with any 
of the following: (1) severe plasma leakage leading to shock or respiratory distress, (2) severe 
hemorrhage, or (3) any organ failure (Figure 2). 
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Figure 1.1 The revised WHO classification of dengue by 2009 (Hadinegoro, 2012) 
The WHO classification (2009) defines DHF as a clinical entity with plasma leakage 
as the cardinal feature that differentiates it from DF; the 2009 classification lists several 
clinical manifestations as qualifiers for severe dengue. The revised WHO classification for 
severe dengue appears to have higher sensitivity and specificity to identify cases in need of 
heightened care (Narvaez et al., 2011). 
1.4.3 Immunological association between dengue viral infection and DM  
It has been assumed that patients with dengue disrupt microvascular endothelial cell 
function, possibly with the altered metabolic release of proinflammatory cytokines. The initial 
immune reaction of dengue infected cell is to produce a number of interferon and cytokines 
against viral infection through the defensive innate immune system. Although elevated levels 
of proinflammatory cytokines and chemokines occur in patients with DF, a surge in the 
numbers of monocyte chemo attractant protein-1 (MCP-1), vascular endothelial growth factor 
(VEGF), tumor necrosis factor (TNF)-α, IL-6, IL-8, IL-10, chemokine ligand (CCL)-2, CCL-
3, CXCL-8, CXCL-10, and interferon (IFN)-γ have been reported in patients experiencing 
severe dengue disease (Rothman, 2011, Navarro-Sánchez et al., 2005, Chaturvedi et al., 2000, 
Bozza et al., 2008, Leong et al., 2007). They are mainly responsible for increasing endothelial 
permeability or vascular leak, which exacerbate third space fluid shifts characteristic of severe 
dengue (Limonta et al., 2008). Similarly, types 2 DM, a metabolic disorder, creates the 
physiological changes in integrity of the endothelium due to a chronic inflammatory condition 
caused by T- lymphocytes activation leading to release of MCP, TNF-α, INF- γ and VEGF 
(Brausewetter et al., 2001, Makino et al., 2005). All these cascaded cytokines which play a 
fundamental role in triggering intrinsic permeability of endothelial surface of the cell in both 
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diabetic and dengue infected condition increase the severity of dengue infection into severe 
form or death to DENV infected DM patients by third space plasma shift, hemoconcentration, 
hypotension and then, finally shock stage. Therefore, dengue patients with co-morbid DM 
require more medical care with longer duration of hospitalizations than dengue patients 
without diabetes (Mallhi et al., 2015, Pang et al., 2012). In clinical setting, dengue patients 
with diabetes have a tendency having thrombocytopenia (reduced platelet) counts, an 
indicator of the severity of vascular leakage in dengue infection and also a monitoring 
indicator for disease progression (Chen et al., 2015).  
Present evidence suggests that viral factors and additional personnel characteristics as 
well as potentially DM might adversely influence the clinical course of an infection. The 
association between dengue and DM is of relevance in the light of the shift of dengue to older 
ages and the steep increase in the prevalence of DM. However, the evidence was never 
summarized systematically (Figueiredo et al., 2010b). 
 
1.5  Helminth infections  
Helminths also known as worms are living in and feeding on living hosts (humans and 
other animals). Depending on their morphology, helminths are classified into flatworms, 
tapeworms, roundworms and flukes. Most of them reside in the intestines but some in blood 
vessels.   
1.5.1 Epidemiology 
Many helminth infections are contributing to the disease burden of NTD: e.g. soil-
transmitted helminths (STH) with 5.2 million DALYs; schistosomiasis with 3.3 million 
DALYs; lymphatic filariasis (LF) with 2.8 million DALYs; onchocerciasis with 0.5 million 
DALYs. Sub-Saharan Africa, America, China and Asia have the highest burden of NTD 
(Global Burden of Disease Study, 2014). Implications of this figures for the control of NTDs 
were discussed more recently in a review by Hotez and colleagues (Hotez. et al., 2014). Based 
on DALYs as well as years lived with disability, STH, i.e. roundworm (Ascaris 
lumbricoides), the whipworm (Trichuris trichiura) and hookworms (Necator americanus and 
Ancylostoma duodenale), affect the largest proportion of those affected. More than 1.5 billion 
people or 24% of the world's population are infected with one or several species of STH. The 
morbidity caused by these infections contributes to poverty, decreased productivity, and 
inadequate socioeconomic development (WHO, 2014). Over 270 million preschool-aged 
children and over 600 million school-aged children are currently living in areas where these 
parasites are highly prevalent, in some areas affecting the vast majority of the population. 
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Moreover, East, Southeast Asian countries as well as central and south America has high 
prevalence of foodborne trematode infections (flukes) due to ingestion of contaminated food 
or fish which are infected with larvae and at least 40 million people have trematode infection 
(WHO, 2014a).  
 
1.6  Hygiene hypothesis  
It has been hypothesised that differences in the prevalence of infections contribute 
importantly to the geographical variation of the prevalence of autoimmune diseases (Selmi, 
2010). In 1989, the hygiene hypothesis was first formulated by Dr Strachan. He proposed that 
lack of exposure to infections in early childhood may protect against allergic diseases and that 
the increasing cleanliness of household environments would explain in part rises in allergic 
diseases as observed in the second half of the 20th century in Western Europe, North America 
and Australia (Bloomfield et al., 2006). The hygiene hypothesis was later expanded to explain  
more generally increased incidences of immune mediated diseases such as asthma, multiple 
sclerosis, inflammatory bowel diseases and autoimmune DM (Okada et al., 2010).  
 
1.7 Factors that increase the allergies and autoimmune diseases  
1.7.1 Geographical variation  
The prevalence of autoimmune disorders shows substantial geographic variation with 
generally higher prevalence rates in affluent countries. The incidence of type 1 DM in 
Bulgaria or Romania was lower compared to Western Europe (Green et al., 2001), incidence 
of type 1 DM in Finland is six times higher than in adjacent Russia despite similar genetic 
background (Kondrashova et al., 2005). Similarly, the incidence of asthma was higher in the 
residents of former West Germany than East despite their similar genetic background 
(Bloomfield et al., 2006). A higher prevalence of multiple sclerosis is observed in northern 
Europe compared to southern part (Pimentel, 2013).  
1.7.2 Migration 
  Migration accounts one of the factors for the rapid increase in the incidence of allergic 
and autoimmune diseases. Migration studies illustrated the increasing frequency of type 1 DM 
in Pakistani families moving to the United Kingdom (Staines et al., 1997) and Somali children 
who had moved to Finland as high as Finnish children (Tuomi et al., 2014). The risk of 
multiple sclerosis is also increasing in Asian immigrants moving to the United States of 
America (Okada et al., 2010) and in Israel, multiple sclerosis is common among immigrants 
from Europe compared to those from Africa or Asia or Israelis (Kurtzke, 2000).  
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1.7.3 Decreased infectious diseases  
Infectious diseases in early years of life are declining due to better quality of health 
care and services, good public health measures, vaccination against common childhood 
infections and the wide use of antibiotics. For instance, infants who received antibiotics had a 
higher incidence of allergy and other atopic disorders than children who had not received 
antibiotics in their infantile period (Droste et al., 2000). 
1.7.4 Socio-economic related factors 
The epidemiological studies reveal that there is a correlation between the socio-
economic status (SES) and autoimmune disorders; positive correlation between gross national 
product and incidence of asthma, type 1 DM and multiple sclerosis in 12 European countries 
(Bach, 2002), the low incidence of type 1 DM is correlated with low average socio-economic 
indexes such as unemployment, lack of a car, crowded housing conditions, and living in rental 
housing rather than purchased property in a study in Ireland (Patterson et al., 1996), Crohn’s 
disease was also related with SES in the Canadian province of Manitoba (Blanchard et al., 
2001) and privileged SES with higher incidence of atopic dermatitis in Hannover, Germany 
(Werner et al., 2002).  
1.7.5 Environmental factors 
A wide range of factors contribute to decreased early childhood infections in affluent 
regions include improved sanitation such as decontamination of the water supply, 
pasteurization and sterilization of milk and other food products, and cleaned living conditions. 
The PARSIFAL study and GABRIELA study showed that children living and growing up on 
farms with a range of microbial exposures largely explained the protective effect on the 
development of asthma in children than children in the reference groups (Ege  et al., 2011). 
1.7.6 Genetic factors  
The genetic factors also play an important role in the pathophysiological mechanism 
of autoimmune disorders. The rate of atopic dermatitis is much higher among monozygotic 
twins (77%) than among dizygotic twins (15%) due to atopic dermatitis-specific genes 
(Bieber, 2008). The hygiene hypothesis proposed that human genes have adapted to the 
constant exposure of infectious agents results in immune imbalances. Compared to other 
microbial pathogens, genome-wide association studies showed that the effect of 
immunological reactions induced by helminths on IL genes has been stronger than for other 
infections (Fumagalli et al., 2009). 
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1.8  Chronic helminth infections and immunomodulation  
Several lines of evidence suggest that geographic and temporal differences in the 
prevalence of helminth infections may contribute to the changes in autoimmune diseases over 
time and between regions (Van Riet et al., 2007). Despite their broadly different 
characteristics, most helminth infections evoke similar adaptive immune responses in their 
human host. Generally helminth infections induce a shift from Th1 to Th2 phenotype, 
accelerate T regulatory and B regulatory phenotypes, and attenuate the levels of the 
inflammatory cytokines (Figure 1) (Bashi et al., 2015, Van Riet et al., 2007). 
Immunomodulation is hypothesized to protect the helminth from being eradicated by the 
human organism and to protect the human host from organ damage caused by excessive pro-
inflammatory responses. The immunomodulation is not only directed to helminths, but also to 
non-related antigens, which would explain the inverse association of chronic helminth 
infection with allergies, auto-immune diseases, and vaccine response. 
 
 
Figure 1.2: Mechanism behind helminthes immunomodulation in autoimmunity  
(Bashi et al., 2015) 
 
1.8.1 Immunomodulation due to chronic helminth infections 
Soil-transmitted helminthes (STH): Stronger Th2 cytokines were associated with lower 
burden of STH infection (Jackson et al., 2004). The children living in areas helminths 
hyperendemic area have higher level of IL-10 and TGF-ß especially due to intestinal 
nematodes A. lumbricoides and T. trichiura than the children living in mesoendemic areas in 
Cameron and Brazil (Figueiredo et al., 2010a, Turner et al., 2008). The higher production of 
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these cytokines or hyperesponsive effects to helminth probably helps the worms’ survival in 
the human body. Chronic ascariasis and trichuriasis infection was associated with altered gene 
expression profiles with modified Th2 responses (i.e. up-regulation of IL-5 and IL-10), down 
regulation of neutrophil function and up-regulation of eosinophils (Reina Ortiz et al., 2011). 
In mice, chronic STH infection induced down-regulation of a single micro RNA which can 
abundantly be seen in alveoli of normal lungs but not in the lungs fibrosis (Pandit et al., 2010) 
indicating that STH affect not only the immune system but also target organs of the host 
(Reina Ortiz et al., 2011).   
Schistosomiasis: Animal schistosomiasis studies revealed that Th1 cells mainly contribute to 
immunological mechanism, but Th2 responses are associated with resistance to reinfection of 
schistosomiasis (Dunne et al., 1992, Roberts et al., 1993). Pro-inflammatory responses with 
elevated level of TNF and IFN-γ were shown in Kenyan patients (Mwatha et al., 1998) and 
higher IL-13 in Brazilian studies (Alves Oliveira et al., 2006). In addition, Th17 cells are 
believed to be associated with schistosome induced pathology in both animal (Rutitzky et al., 
2008) and humans models (Mbow et al., 2013). Down modulation of effector responses by 
IL-10 and TGF-β, and others also seem to be involved in the prevention of schistosomiasis 
(Baumgart et al., 2006, Herbert et al., 2004, Turner et al., 2011) and the involvement of Treg, 
IL-10 production B cells which could also be present in murine and in human chronic 
schistosomiasis (van der Vlugt et al., 2012). Recently, aaM (alternatively activated 
microphages) as a key player in controlling the immune pathology in schistosomiasis has also 
been highlighted (Barron and Wynn, 2011).  
Lymphatic filariasis: Upregulation of Th1, Th17 cells and antibody responses are observed in 
filariasis infected patients (Babu et al., 2009). The studies have been revealed that immune 
there are increased production of natural Treg as well as IL-10 producing effector cells in the 
individuals infected with W. bancrofti or Mansonella (Metenou et al., 2010). In pathogenesis 
of onchocerciasis, the role of Th2 mediated Treg and IL-13 is significant and was related to 
IL-13 gene mutation which is responsible for allergic hyper-reactivity in the body (Hoerauf et 
al., 2002, Satoguina et al., 2002). 
Yet it is important to keep in mind that helminth related immunomodulation is 
affected by several key elements such as the types of helminths species, intensity of the 
infection and the host's immune system. In most of the cases, helminths will induce tolerance, 
but in some scenarios, they may cause an inflammatory response. Affliction spectrum ranges 
from low pathology/tolerance, along with high parasite burden, to chronic 
disease/inflammation, along with low parasite infection intensity (Bashi et al., 2015).  
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1.8.2 Immunomodulation of chronic helminth infections in NCDs 
Asthma and Allergy: Allergic diseases such as asthma, eczema and rhinitis are mainly type-2 
mediated and helminth infections urge IL-10 or TGF-ß level leading to the development of 
allergic immune response. A study in Gabonese children, who were infected with 
Schistosomiasis, and another study among Vietnamese school children infected with 
hookworm showed that IL-10 production  in response to the helminth antigens, was inversely 
associated with skin prick test (SPT) reactivity to house dust mite allergen (Yazdanbakhsh et 
al., 2002, Flohr et al., 2010). Similar findings have been reported in a study of Ecuadorian 
children with A. lumbricoides infection, (Cooper et al., 2008). There is also evidence that the 
IgE cross-reactivity between helminth Ags and allergens such as with cockroach (Santiago et 
al., 2012) or mite (Acevedo et al., 2009) might influence the outcome of allergy.  
Multiple sclerosis: The MS patients who were infected with helminths demonstrated higher 
production of IL-10 compared to uninfected patients (Correale and Farez, 2007). In another 
immunological study, active colitis was linked to the cytokine-producing CD4 and IL-17 Th 
cells, and the presence of IL-22 Th cells in the colonic mucosa indicated helminth 
colonization and disease remission. The types of released cytokines also depend on the place 
where the infection is occurred e.g. higher levels of IL-4, IL-25, and RELMβ (Broadhurst et 
al., 2010) in helminth-occupied ascending colon; elevated IL-17 and TNF as well as reduced 
expression of RELMβ (Weng et al., 2007) in the rectum. In a murine model, bacterial-colitis 
with Heligmosomoides polygyrus was related to increased aaM (Weng et al., 2007). Another 
chemically induced-colitis model with Hymenolepis diminuta infection showed an expression 
of FIZZ1/RELMα and argininase-1 which attenuated colitis (Hunter et al., 2010). 
Rheumatoid arthritis: The rodent studies have shown that helminth infections or helminth 
extracts can suppress or prevent arthritis (Matisz et al., 2011). A case-control study in India 
showed that no circulating microfilariae or filarial antigens was found in the patients with 
rheumatoid arthritis, in contrast to healthy controls (Panda et al., 2013). 
Cardiovascular disease and atherosclerosis: A couple of risk factors contribute to 
cardiovascular disease including atherosclerosis which is due to the inflammatory process of 
lipids. Studies on the role of anti-inflammatory mechanism illustrated the role of Treg that 
lessened atherosclerosis (Ait-Oufella et al., 2006). One of the lipid lowering agents also has 
anti-inflammatory action. Thus, balancing the proinflammatory and inflammatory actions in 
the body is important in the endothelial function regulation. It is known that helminths 
disturbance the nutritional status of the host and thus turns into the beneficial effects by 
reducing the serum lipid levels (Stanley et al., 2009). Apolipoprotein deficient mice showed a 
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rapid development of atherosclerosis over a short period time (Stanley et al., 2009). Regards 
to the helminths, mice with S. mansoni was found about 50% less in the development of 
atherosclerotic lesions (Doenhoff et al., 2002) and soluble factors released from S. mansoni 
live eggs has an impact the cholesterol lowering effects. Another study in mice injected with 
schistosoma-frozen eggs showed reduced total cholesterol and LDL level compared to non-
injected ones, but no difference in atherosclerotic formation (La Flamme et al., 2007). These 
studies suggest that helminth infections or related products are acting as lipid-lowering agents 
in the development of atherosclerotic formation process. 
 
1.9  Immunomodulation due to chronic helminth infections: Potential role relevance to 
DM   
The auto-destruction of β cells in the pancreas in type 1 DM and related forms (e.g. 
LADA) is mainly Th1 mediated. The Th2 shift associated with chronic helminth infection is 
thus hypothesized to decrease this Th1-related self-destruction of insulin producing cells.  
The effect of helminth infections and helminth antigens on type 1 DM has been 
intensively studied in the type 1 DM non-obese diabetic mouse model. Observed alterations in 
the immune system in response to helminth antigens involved several types of immune cells 
including B cells, tolerogenic dendritic cells, aaM, granulocytes and innate lymphoid cells. 
They all induced Th2, NKT and Treg generation or expansion. The cytokine secretion evoked 
from NKT, Th2 and Tregs feeds back and maintains the tolerogenic and alternatively 
activated phenotypes of antigen presenting cells. As a result, diabetogenic (Th1) cells become 
regulated resulting in only a non-destructive insulitis (Zaccone and Cooke, 2013). In the case 
of infection with L. sigmodontis, transforming growth factor (TGF) β production was a crucial 
factor for DM prevention (Hubner et al., 2011). In another study, N. brasiliensis infection 
leads to accumulation of eosinophils and associated aaM, the predominant macrophage 
phenontypes in adipose tissue from lean mice. As a result, infected obese mice were better 
able to maintain glucose homeostasis (Wu et al., 2011). 
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Figure 1.3 Mechanism of helminth antigen-mediated diabetes (Zaccone and Cooke, 
2013) 
 
Chronic helminth infections could additionally counterbalance sterile metabolic 
inflammation and thus insulin resistance by re-shifting the balance from Th1 to Th2 and Treg 
cells. The insulin resistance, a predominant characteristic of type 2 DM and related forms 
(e.g. LADA) is strongly linked to obesity and specifically to visceral fat mass and therefore to 
obesity-associated metabolic inflammation. This is a sterile inflammation produced in 
response to metabolic rather than infectious stimuli. Obesity related damage-associated 
molecular patterns, such as saturated fatty acids, can activate inflammatory signaling 
pathways in part via toll-like receptors (TLRs) and via NOD-like receptors (NLRs) and 
thereby lead to macrophage inflammation. In addition to receptor-mediated pathways, 
inflammatory signaling can be stimulated by cellular stresses such as reactive oxygen species 
(ROS), ER stress, hypoxia and lipotoxicity, which can all be enhanced in the obese insulin-
resistant state. Metabolic inflammation mediates insulin resistance through the inhibition of 
insulin signaling. Inflammation can also affect insulin action indirectly by modulating various 
metabolic pathways, resulting in the production of “second messengers”, such as fatty acids, 
that promote insulin resistance.  Proinflammatory M2-type adipose tissue macrophages in 
obesity are critical effector cells in the initiation of inflammation and insulin resistance and 
therefore a key etiological mechanism linking the increasing incidence of type 2 DM and 
obesity. Obesity can also cause inflammation in tissue other the adipose tissue such as for 
example in pancreatic islets or liver. In addition to adipose tissue macrophage (ATM) 
alterations, obesity also alters the activity of T cells which are next to ATMs the largest 
immune cell component of adipose tissue. Th1 and Th17 cells are pro-inflammatory whereas 
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Th2 cells and T regulatory (Treg) cells are anti-inflammatory in the context of obesity. The 
number of Th1 cells increases in obesity, whereas the abundance of Th2 and Treg cells, which 
elicit immunosuppressive effects, decreases.  
 
1.9 The effect of helminth infections in prevention and treatment of autoimmune diseases 
including DM 
 Epidemiological studies suggest that the helminth exposure might prevent or treat 
autoimmune mediated diseases or disorders. Anthelminthic therapy is currently being studied 
as a promising treatment for several (non-viral) autoimmune diseases including Crohn's 
disease(Hunter and McKay, 2004), asthma (Falcone and Pritchard, 2005) and ulcerative 
colitis (Saunders et al., 2007). 2500 ova Trichuris suis were administered to active Crohns 
disease patients to determine the possible efficacy and safety of intestinal helminthes as 
treatment option. The study demonstrated that 72% of patients had  improved symptoms with 
no adverse reaction (Hunter and McKay, 2004). In another study, T. suis ova were given to 
patients with active ulcerative colitis and the study found significant improvement of 
symptoms (43% improvement versus 17% for placebo) after 6 weeks (Saunders et al., 2007). 
However, in allergic rhinitis, T. suis ova therapy had no effect even though it induced a 
substantial clinical and immunologic response (Bager et al., 2012). Hookworm (N. 
americanus) is also being investigated for therapeutic use. Two previous studies reported that 
infection with N. larvae was strongly associated with protection against asthma symptoms 
(Scrivener S, 2001 ) and in people with allergic rhinoconjunctivitis (Scrivener S, 2001). 
Inoculation of Crohn’s disease patients with infective N. americanus larvae subcutaneously 
led to a slight improvement in disease symptoms (Croese et al., 2006).While hookworms have 
some pathogenic potential effect (Hotez et al., 2004) they are likely to be safe at low infection 
intensities (Pritchard et al., 1999).  
Observational studies evidenced that intestinal parasites are associated with reduced 
risk and severity of allergy and other autoimmune diseases. A prospective cohort study in 
Argentina showed that multiple sclerosis patients with parasite infections (H.nana, T. 
trichiura, A. lumbricoides, S.stercorais, and E.vermicularis) showed a significantly lower 
number of exacerbations and disease disability scores compared to those without parasite 
infection. Immunological mechanisms involved included an increased production of IL-10 
and TGF-beta, CD25+CD4+ FoxP3+ T cells, and induced regulatory T cells leading to a less 
severe disease course (Correale and Farez, 2007). People living in S. mansoni endemic area 
were found to suffer less from wheezing and use of anti-asthmatic drugs compared to the 
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persons living in  non-endemic area (Araújo et al., 2004). In the context of DM, the influence 
of parasitic infections on the onset of autoimmune DM was studied experimentally in non-
obese diabetic (NOD) murine models of T1DM. NOD mice were infected with S. mansoni (or 
exposed to S. mansoni cercarae or antigen positive) (Cooke, 2009), T spiralis (Saunders et al., 
2007), H.polygyrus (Liu et al., 2010), L. sigmodontis (Hubner et al., 2011) and D. immitis 
(Imai et al., 2001). The helminth exposures were found to prevent the onset of type 1 through 
protection from Th1-mediated β cell destruction in this mouse model (Bashi et al., 2015). 
Children with a frequent intake of anthelminthic drugs against A. lumbricoides and T. 
trichiura exhibited a higher rate of positive skin prick test for house dust mite compared to the 
children not treated or not taking anthelminthic drugs (van den Biggelaar et al., 2004). 
 
1.10 Relevance of the research to Laos People Democratic Republic and South Africa 
Laos PDR, one of low middle income countries, is experiencing the DBD. The 
regional Asia and Pacific prevalence of DM between 20-79 years of adults was 9.3% with 153 
million of DM people in 2015 and it is predicted to increase 215 million in 2040 (IDF, 2015). 
According to WHO Diabetes 2016 Country Profile for Lao PDR, DM prevalence is 5.6% in 
the general adult population. Approximately 2% of the Lao population dies due to DM 
annually, with a 3.6% prevalence rate among 20-79 years aged adults (WDF, 2017). Due to 
increasing DM prevalence, the Laotian government starts to emphasize the DM as an 
important health concern of the country. 
The prevalence of DM in African populations has been increasing rapidly in recent 
decades and 20 million of people are living with DM (20-79 years), 29.7 million with IGT. 
The number of people with DM in the region are predicted to increase up to 41.5 million by 
2035 (an increase of 50%) (IDF, 2015). South Africa is one of the top 5 countries in Africa 
for having high DM prevalence and according to WHO, the prevalence rate of DM in South 
Africa was estimated to be 9.2% and the number of diabetic cases was approximately 2.6 
million (20-70 years of age) in 2014. The prevalence was even higher in a cross-sectional 
survey conducted by Peer et al. among recruited 1,099 participants, (392 men and 707 
women) aged 25–74-year-old, black Africans in Cape Town. The aim of the study was to 
assess the prevalence of the diabetes and to compare the findings with 1990 study. The WHO 
1985 diabetes criteria were used to diagnose the diabetes and the results were compared. The 
prevalence of age adjusted diabetes were 12.2% in 2008/09 compared to 8% in 1990, IGT:  
11.7% in 2008/09 and 7% in 1990. Among diabetes cases, 57.9% were known cases and only 
38.6% of them were treated. The study clearly showed that the prevalence of the diabetes has 
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been increasing over the decades and the numbers are expected to further increase in coming 
years (Peer et al., 2012).  
As dengue fever belongs to the tropical and subtropical world as an important 
infectious disease, dengue infections or DHF mostly occur in urban and suburban areas in the 
Americas, South-East Asia, the Eastern Mediterranean, and western Pacific and in rural areas 
in Africa. Laos PDR is one of dengue endemic countries and dengue ranked on 4th place 
(8.1%) among top leading causes of death in 2012 (WHO, 2015). The country has suffered 
from the worst ever recorded outbreak and nearly 50,000 people have contracted dengue fever 
in 2013. 70% of the cases were children (OCHA, 2013). Dengue outbreaks are usually 
cyclical and occur every 3 to 5 years. In early 2017, 215 dengue cases have been reported and 
dengue serotypes change has recently been recorded in affected provinces (WHO, 2017). In 
Africa, the epidemiology of dengue is not clear even though Aedes spp. mosquitoes are 
extensively scattered and can serve as vectors of dengue virus in Africa. Besides, when the 
population of suspected dengue cases in Africa is compared with those of Asia or the 
Americas, the incidence of dengue cases are highly underreported because most febrile illness 
in Africa is usually assumed to be malaria due to low awareness of the health care providers 
and diagnosis capacity (Msimang et al., 2014). A study was conducted in South Africa aiming 
to describe the epidemiology of laboratory-tested dengue cases from 2008-2013 and the 
results showed the increasing trend of dengue infection over 5 years. The dengue detection 
rate in collected specimens is 6.1% (83 confirmed cases per 1364 dengue tests), 4% (9/249) in 
2011, 6% (19/326) in 2012 and 14 % (21/146) in 2013 and most of the cases were among 
South African travelers returning from the dengue endemic countries (Msimang et al., 2014).  
The intestinal parasitic infections do not usually get much attention by the health care 
decision makers like other bacterial or viral infections as most of the cases are subclinical. In 
Southeast Asia, especially Mekong region, food born trematodes and STHs remain important 
public health concern. An estimated 67.3 million people worldwide are mainly at risk for 
Opisthorchis viverrini, and about ten million infected people live in Thailand and Laos 
(Sithithaworn et al., 2012). A couple of helminth studies have been conducted in Laos in 
recent years and different prevalence of helminth infections have been reported across the 
country. In Campacsack province of Southern Laos, multiparasitism was very common and 
hookworm was the most prevalent STH species was hookworm (76.8%), followed by A. 
lumbricoides (31.7%) and T. trichiura (25.0%). O. viverrini (64.3%) and S. mekongi (24.2%) 
infections were also found in the study area (Sayasone et al., 2011). Moreover, Korea-Laos 
Collaborative Project for Control of foodborne trematode Infections  surveyed among a total 
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of 6,178 residents and revealed the highest prevalence of O. veverrini with minute intestinal 
flukes (55.6%) followed by hookworms (27.8%) and T. trichiura (6.5%) in middle and 
southern area of the country (Savannakhet, Khammouane, Vientiane (Nam Ngum), 
Champasack (Khong Island), and Saravane province). The survey also reported of A. 
lumbricoides (33.8%), hookworms (47.8%), and T. trichiura (32.6%) were observed in 
middle and northern area of the country namely Phongsaly, Luang Prabang, and Vientiane 
(Nam Ngum) areas, respectively (Eom et al., 2014). In Laos, consumption of raw and 
insufficiently cooked fish is a main risk factor for high prevalence of food born trematodes. Other 
risk factors such as drinking contaminated water, improper hand washing and practicing poor 
body and environmental hygienic conditions are also contributing to the infections. 
The studies in South Africa have showed high prevalence of intestinal nematode 
infections in the provinces of the eastern and western Cape (Fincham JE et al., 1996, Evans 
AC et al., 1987, Kvalsvig et al., 1991). It is reported that the children are the most vulnerable 
to the effects of the worm infection and revealed that the prevalence of helminthic infections 
as a baseline assessment were A. lumbricoides 29.5%, T. trichiura 51.9% and S. haematobium 
22.3% among 268 school children, aged 8 to 10 in KwaZulu-Natal province (Jinabhai et al., 
2001). Another study carried out among schoolchildren in northern area of the province 
showed that the prevalence of T. trichiura and A. lumbricoides were 57.2% and 19.4% 
respectively, while the prevalence of hookworms infection 83.2% which was considerably 
higher than in other parts of the province (Saathoff et al., 2004). There are limited data on the 
prevalence of intestinal parasites in the South African adult population. The stool samples 
from 32 randomly selected public hospital laboratories were obtained for parasitological 
examination in KwaZulu-Natal province. The prevalence of parasites in collected 5,733 stool 
samples ranged from 30% to 11.2% depending on the geographical distribution (highest 
infection rate in coastal region and lowest in the inland). A. lumbricoides (10.7%) and 
T.trichiuria (6.7%) were the most common helminth infections, followed by hookworm and 
S. mansoni. The most common protozoan parasites were E. coli and E. nana.  These results 
might be underrepresented as those samples were collected from health facility based area; 
however, it illustrated relatively high prevalence of intestinal parasites in the adult population.   
To date – to the best of our knowledge no epidemiological study in Laos PDR or 
South Africa or in fact elsewhere systematically assessed the DBD of different types of 
helminth infections and DM. Yet, due to the high prevalence of these diseases in Laos PDR 
(South-East Asia region) and South Africa (Africa region) and  more generally, understanding 
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their mutual influence will provide important policy input for health systems planning and for 
caring for comorbid patients. 
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Chapter 2 
Research Goal, Research Hypothesis and Objectives  
 
Goal 
The overall goal of this PhD thesis is to improve the understanding of the biological and 
epidemiological interrelationships of dual burden of diseases in resource poor countries, i.e., 
chronic diseases in combination with infectious diseases. In this aspect, the focus of this work 
is on diabetes mellitus in combination with different neglected tropical diseases, particularly 
dengue viral infections and helminth infections. 
Research hypothesis and research questions 
We hypothesize that: 
1. Diabetes mellitus increases the severity of episodes of dengue viral infections.  
Research questions 
• Is diabetes mellitus a risk factor for a severe course of dengue? Do diabetes 
patients have increased risk for dengue hemorrhagic fever? 
• What is current clinical and epidemiological evidence for diabetes mellitus 
to modulate a dengue viral infection episode? 
• What mechanisms are known that can influence the clinical course of 
dengue viral infection in diabetes patients? 
2. Helminth infections protect from diabetes mellitus.  
Research questions 
• Do helminth infections have a protective effect against diabetes mellitus?  
• How do helminth infections improve the hyperglycemic status? 
• Do helminth species act differently on glycemic level? 
3. Anthelminthic treatment increases the prevalence of diabetes in the population 
Research questions 
• Does deworming increase the glycemic level and therefore, increase 
diabetes prevalence of population?  
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Specific objectives 
1. To summarize the epidemiological evidence on the association between diabetes 
mellitus and dengue viral infection through a systematic literature review and, meta-analyses 
2. To update the current knowledge on the relationship between diabetes mellitus and 
helminth infections through a systematic literature review  
3.  To assess the association between diabetes mellitus and helminth infections among 
adult persons in Lao People's Democratic Republic 
4. To determine the association between diabetes mellitus and chronic intestinal parasite 
in the children in South Africa before and after anti-helminthic treatment  
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Chapter 3 
Methods 
 
3.1 Overview of research methodology 
Due to overlapping geographical presentation between NTDs and NCDs along with 
their current disease trends, we primarily expect to see the effects of NTDs occurring among 
patients with underlying NCDs, and hoping that it would be of a great interest to determine 
whether co-morbidities resulting a significant clinical presentation.  To find out any potential 
epidemiological association between NTDs and DM, we firstly conducted a systematic 
literature review between dengue, one of the most emerging NTDs in recent years in the 
tropical countries, from published articles. Secondly, we considered to conduct a systematic 
review between helminthic infection which contributes a major morbidity among NTDs and 
DM. Then, we have come up with field studies (a cross-sectional study in Laos PDR and a 
longitudinal study with anthelminthic drugs in Port Elizabeth, South Africa) in order to reveal 
the epidemiological association between DM and helminthic infections.  
 
3.2 Research methodology of systematic review and meta-analysis of DBD 
To have a better understanding and to identify the epidemiological gap of DBD 
between dengue and DM, we conducted a systematic literature review using MEDLINE 
database to access any relevant publication describing an association between dengue and DM 
as a part of PhD thesis. We included articles in all languages; articles which reported on 
epidemiology, clinical signs, and laboratory parameters for dengue-infected patients, or on 
severity assessment. There was no restriction in publication dates, place of study, study design 
or age of research participants. As a validity assessment, the PRISMA criteria were used 
(PRISMA, 2014). We extracted the year during which dengue cases were diagnosed (year 
during which the study was conducted), year of the publication, country of the study, study 
design, study definitions of dengue infection and DM, and confounder adjustments. The data 
on the sample size of enrolled persons and number of cases and controls and on the estimates 
(unadjusted and adjusted models) of the association (and their 95% confidence intervals) 
between DM and severe dengue were also extracted. The transition of the patients data from 
clinical or hospital records to this review was based on published non-individual and non-
identifying data. Data were extracted from the published papers independently by two 
reviewers and disagreements were resolved by discussion. We used random-effects models 
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for meta-analyses of the association between DM and a severe clinical presentation of dengue 
(Lau et al., 1997). They take into consideration the variation between the true effects 
estimated by included studies unlike fixed effect models which assume a common true effect 
across studies. We used odds ratios as measure of association across all studies. We used the 
estimates reported by the authors as “primary model” and the I2 metric and Tau2 to describe 
the between study heterogeneity and variance respectively. We conducted sensitivity analyses 
by using a fixed effect model and excluding a study, which was based on non-matched 
random controls and that only reported unadjusted estimates (Karunakaran et al., 2014). We 
performed analyses with Stata version 13 (Stata Corporation, Texas) and considered p<0.05 
as statistically significant.  
We used the same methodology to conduct a systematic review and explore an 
association between helminth infections and DM; however, retrieved data from the published 
articles were not good enough to perform the meta-analysis.   
 
3.3 Research methodology of field studies in Laos PDR and South Africa 
3.3.1 Study design and settings 
We conducted a cross-sectional study (LADUBU study) was conducted among 1,600 
adults aged in both rural and urban area of different 4 provinces. 2 provinces are located in 
middle part of the Laos PDR; Vientiane capital and nearby province of Luang Prabang (LP 
city and Namback district). The other 2 provinces are located in Southern part of the country; 
province of Saravanh (Saravan city and Saravanh district), and Province of Champasack 
(Pakse city and Kong district). In order to investigate the co-morbid association of DM and 
helminth infections, we surveyed the prevalence of different helminth infections and DM in 
rural and urban population within provinces and between provinces and the data collection 
was done in 2016. 
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Figure 3.1: Study area of LADUBU project in Lao PDR 
 
We conducted a longitudinal study, integrated into the ongoing DASH study with the 
add-on of an HbA1c protocol among 900 primary schoolchildren from 8 schools located in 
poor neighborhood of Port Elizabeth, South Africa. We explored the prevalence of different 
parasitic infections at baseline and cross-sectionally and compared blood HbA1c levels 
between the groups affected by helminth and other parasitic infections. The subjects affected 
by helminth infections were offered oral anti-helminthic drugs (Albendazole 400 mg single 
dose for STH infections). Mass or individual anthelminthic treatment regime was applied 
depending on the infectious status of the schools according to WHO recommendation. We 
again measured helminth infection status and HbA1c blood concentrations 6 months after 
anthelminthic treatment. This study was conducted in 2015-2016.  
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Figure 3.1: Study area and location of study schools (Yap et al., 2015) 
 
 
Figure 3.2 Primary schoolchildren in one of study schools in Port Elizabeth,  
South Africa 
 
3.3.2 Assessment methods of the study  
Questionnaires 
In both studies, the standardized questionnaires were used to capture the socio-
economic status of the family, housing or living conditions and life styles by trained local 
volunteers who can speak the local dialect.  
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Clinical examination  
The experienced medical professionals performed the general health assessment of 
participants and gathered the information about recent and current medical problems. Then, 
the body temperature, weight, height, blood pressure, skin fold assessment (in South African 
study), the assessment of anemia by using HemoCue HB 301 system to measure the 
haemoglobin concentration were systematically measured.  
   
Figure 3.3 Clinical examination of in Vientiane, Laos PDR (Ladubu study) 
 
 
Figure 3.4 Research team of Ladubu study 
Assessment of diabetes mellitus  
In both studies, we assessed DM status by evaluating HbA1c values which identify the 
three-month average plasma glucose concentration before the measurement and we used 
point-of-care instrument and the Afinion (Alere Technologies) test, which is based on 
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boronate affinity separation and the use of fluorescence quenching. This method met the 
accepted performance criteria for HbA1c as defined by the U.S. National Glycohemoglobin 
Standardization Program (NGSP) and no interference from other hemoglobin traits results 
(Westra E and RJ., 2014).  All test cartridges for the Afinion tests were from the same lot 
number, given that recent evidence suggest a dependence of test results on the lot number 
(Dupuy AM et al., 2014). Only a small amount of blood (approximately 1.5µL) was 
withdrawn from the finger prick and the results were available in 3 minutes. The advantages 
of this measurement are no requirement of fasting, greater pre-analytical stability and less 
day-to-day perturbations during stress and illness. 
 
 
Figure 3.5: Diabetes assessment with Alere techonology in South Africa project 
 
Assessment of parasites in the collected stool samples 
For the purpose of helminth assessment in LADUBU study, two stool samples from 
each participant were collected and fixed with 10% alcohol. The collected samples were sent 
to the microbiology lab in Kokean University, Thailand. Two thick smears were extracted 
from each stool sample with Kato-Katz method (Katz et al., 1972) and investigated the smear 
under a light microscopic to look for any helminth infections.  
In South African study, to identify the specific STH and other parasites to increase the 
sensitivity of the diagnostic methods to an acceptable level, each stool sample was examined 
with specific diagnostic techniques, namely the Kato-Katz technique (Becker et al., 2013, 
Glinz et al., 2010), on the collected day. Intensity of infection were assessed by counting the 
eggs per Kato-Katz stool smear and multiplied by 24. A crypto‐Giardia Duo-Strip Rapid 
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Diagnostic test (RDT) were used to detect Cryptosporidium species and Giardia intestinalis. 
To assess S. haematobium infection, single urine sample from each child were collected and 
analyzed visually for macro-haematuria and tested with reagent strips to detect the blood in 
urine. In addition, to confirm the presence of S.mansoni infections, the point‐of‐care 
circulating cathodic antigen (POC-CCA) test was performed. Urine infiltration and kato-katz 
samples were randomly re-checked for quality assurance of the diagnostic accuracy of results 
(Knopp et al., 2008). 
 
3.4 Research collaboration and ethical statement 
The Laos project was a cross unit internal collaboration between Swiss TPH (Chronic 
Diseases Epidemiological Unit and Ecosystem Health Sciences Unit and joint research 
collaboration between Swiss Tropical and Public Health Institute (Swiss TPH) and the 
Francophone Institute for Tropical Medicine (IFMT). The ethical approval of study protocol 
was obtained from the Lao Ethical Review Committee with agreement of provincial and 
district health authorities to conduct the study. 
The South African project was also the same research internal collaboration within 
Swiss TPH but an external collaboration between Swiss TPH and, University of Basel 
(department of sport science) and Nelson Mandela Metropolitan University (Health Science 
Faculty, the department of Human Movement Science) in Port Elizabeth, South Africa. Our 
study has been integrated into an ongoing study entitled “Impact of disease burden and 
setting-specific interventions on schoolchildren` cardio-respiratory physical fitness and 
psychosocial health (DASH study)”. The proposed add-on HbA1c test results can additionally 
increase the scientific output of the DASH project. The DASH study had obtained ethical 
approval from Ethikkommission Nordwest und Zentralschweiz (EKNZ) according to Swiss 
TPH regulations, as well as from ethics committees in South Africa (NMMU health Sciences 
Faculty Research committee, NMMU Human Ethics Committee, Eastern Cape Department of 
Education (as the study was conducted at the schools) and the Eastern Cape Department of 
Health). The written informed consent from the research participants (children parents or 
guardians in South African study) was obtained prior the data collection, to capture socio-
economic and demographic information using questionnaires and also biological samples. 
 All participants infected with helminth infections were provided the anthelminthic 
treatment with Alendazole 400 mg according to WHO guideline. The participants who have 
higher HbA1c levels than normal cut-off values were also referred to local hospital or clinic 
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where their DM status could be confirmed and they could receive the treatment when 
necessary. 
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4.1 Abstract  
Background 
The mean age of acute dengue has undergone a shift towards older ages. This fact 
points towards the relevance of assessing the influence of age-related comorbidities, such as 
diabetes on the clinical presentation of dengue episodes. Identification of factors associated 
with a severe presentation is of high relevance, because timely treatment is the most important 
intervention to avert complications and death. This review summarizes and evaluates the 
published evidence on the association between diabetes and the risk of a severe clinical 
presentation of dengue. 
Methodology/Findings 
A systematic literature review was conducted using the MEDLINE database to access 
any relevant association between dengue and diabetes. Five case-control studies (4 hospital-
based, 1 population-based) compared the prevalence of diabetes (self-reported or abstracted 
from medical records) of persons with dengue (acute or past; controls) and patients with 
severe clinical manifestations. All except one study were conducted before 2009 and all 
studies collected information towards WHO 1997 classification system. The reported odds 
ratios were formally summarized by random-effects meta-analyses. A diagnosis of diabetes 
was associated with an increased risk for a severe clinical presentation of dengue (OR 1.75; 
95% CI: 1.08-2.84, p =0.022).  
Conclusions/Significance 
Large prospective studies that systematically and objectively obtain relevant signs and 
symptoms of dengue fever episodes as well as of hyperglycemia in the past, and at the time of 
dengue diagnosis, are needed to properly address the effect of diabetes on the clinical 
presentation of an acute dengue fever episode. The currently available epidemiological 
evidence is very limited and only suggestive. The increasing global prevalence of both, 
dengue and diabetes, justify further studies. At this point, confirmation of dengue infection as 
early as possible in diabetes patients with fever if living in dengue endemic regions seems 
justified. The presence of this co-morbidity may warrant closer observation for glycemic 
control and adapted fluid management to diminish the risk for a severe clinical presentation of 
dengue.  
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4.2 Author Summary  
Both, dengue and diabetes have reached epidemic dimensions and pose a joint threat to a large 
proportion of populations in low- and middle-income countries. Dengue is no longer a disease 
primarily affecting children. Therefore the influence of non-communicable diseases such as 
diabetes, which are increasingly prevalent in adults, on the clinical presentation of a dengue 
episode becomes a public health priority. We conducted a systematic literature review to 
assess the available evidence on the effect of diabetes mellitus (DM) on the clinical 
presentation of dengue. The meta-analysis of published evidence combined with supporting 
biological evidence point to an increased risk for potentially life threatening symptoms of 
dengue among patients with diabetes. The current evidence is limited by statistical power and 
other study limitations and does not allow conclusions about a causal effect of diabetes. Yet, 
based on the currently available evidence, diabetes patients with fever and living in a dengue 
endemic region should seek confirmation of dengue infection as early as possible. Diabetes 
should be considered in the triage of patients for close observation and early intervention, 
which are challenges, particularly during dengue outbreaks. Timeliness of intervention is the 
most important factor averting serious complications and death in patients with acute dengue.  
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4.3 Introduction 
With low- and middle-income countries (LMIC) experiencing a growing chronic non-
communicable disease (NCD) burden and a continuously high communicable disease (CD) 
incidence rate, understanding the co-morbidity between the two disease groups is necessary to 
properly assess, monitor, evaluate, and control their prevalence (1, 2). Cardiovascular diseases 
and their risk factors including diabetes mellitus (DM) are major contributors to the growing 
NCD burden (3). WHO projects that DM will be the 7th leading cause of death in 2030. Today 
there are 347 million people worldwide who have DM (4), around 90% of them type 2 DM 
(5). More than 80% of DM deaths occur in LMIC(5). In high income countries DM has long 
been known for its association with increased susceptibility to infections such as tuberculosis 
(6). Although these associations have been attributed in part to DM associated alterations in 
innate immunity, related evidence is inconsistent and underlying mechanisms remain poorly 
understood. They are likely to vary by type of infection (7). Yet, only few studies investigated 
the complex associations of diabetes with neglected tropical diseases (NTDs).  
Dengue, one of 17 diseases assigned NTD status by WHO, is next to malaria the most 
important arthropo-borne (ARBO) tropical infection caused by the dengue virus. It is 
transmitted by several mosquito species within the genus Aedes, principally A. aegypti (8). 
The number of Dengue virus infections has increased 30fold over the last decades. Today it is 
a major public health problem in tropical and subtropical regions (9). The absence of adequate 
public health awareness, surveillance and control, population growth, globalization and 
urbanization contributed to this increase. An estimated 2.5 billion people are at risk of 
infection in over 100 endemic countries(10). WHO estimates that currently between 50 and 
100 million dengue infections occur annually. An estimated 500’000 dengue patients with 
potentially life threatening symptoms require hospitalization each year and about 2.5% of 
those affected die (11). Dengue ranges from asymptomatic or self-limiting non-severe dengue 
(with or without warning symptoms) to severe dengue, characterized variously by severe 
plasma leakage, severe bleeding or severe organ involvement (12).  The studies reviewed in 
this paper were all except one conducted before 2009 and therefore routine clinical data was 
collected according to the WHO 1997 guidelines. These guidelines group symptomatic 
dengue virus infections into three clinical categories: undifferentiated fever, dengue fever 
(DF), and dengue hemorrhagic fever (DHF). DHF is further subclassified into four severity 
grades, with grades III and IV being defined as dengue shock syndrome (DSS) (13). The 
clinical presentation of a dengue infection is difficult to predict, although the presence of 
warning signs occurring within 3 to 7 days after the first symptoms warrant strict observation 
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and medical intervention. Intervention, including intravenous rehydration as the therapy of 
choice, can reduce case fatality in severe dengue to less than 1 % (14). Dengue has long been 
viewed as a pediatric disease, but the average age of dengue cases has been rising and there is 
a suggestion for adults to be at increased risk for dying from dengue. The increase of tourism 
in tropical regions also contributed to the increase in adult dengue cases (15) .  
There are five dengue virus (DENV) serotypes (DENV-1, DENV-2, DENV-3, DENV-
4 and DENV-5), however, serotype 5 seems not to have a sustained transmission cycle in 
humans (16). Infection confers immunity to the infecting serotype which is life-long, but not 
to the remaining three. Subsequent infections with a different dengue virus serotype increase 
the risk of severe complications (17). Other than that, factors increasing the risk of severe 
clinical manifestations remain poorly characterized (18-20). Present evidence suggests that 
beyond viral factors age, gender, social status, genetic background, sickle cell anemia, uremia, 
bronchial asthma, allergies, hypertension, chronic renal failure and also DM might adversely 
influence the clinical presentation of an infection (18, 19, 21-24).  
In acknowledging the shift of dengue to older ages and the steep increase in the 
prevalence of DM, the objective of this review is to access the current clinical and 
epidemiological evidence for this NCD to contribute to a higher risk of a severe clinical 
presentation in dengue fever patients.  
4.4 Methods 
Search strategy 
We conducted a systematic literature review using MEDLINE database to access any 
relevant publication describing an association between dengue and diabetes up to February 28 
2014. The search terms used were “("dengue"[MeSH Terms] OR "dengue"[All Fields]) AND 
("diabetes mellitus"[MeSH Terms] OR ("diabetes"[All Fields] AND "mellitus"[All Fields]) 
OR "diabetes mellitus"[All Fields] OR "diabetes"[All Fields]”. 
Inclusion criteria 
We included articles in all languages; articles which reported on epidemiology, 
clinical signs, and laboratory parameters for dengue-infected patients, or on severity 
assessment. There was no restriction in publication dates, place of study, study design or age 
of research participants. As a validity assessment, the PRISMA criteria were used (25, 26). 
For meta-analyses, we included studies that compared the prevalence of DM between 
persons affected by different dengue stages (case-control studies), reporting estimates of 
association and their 95% confidence intervals, or enough information to derive this.  
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Data extraction 
We extracted the year during which dengue cases were diagnosed (year during which 
the study was conducted), year of the publication, country of the study, study design, study 
definitions of dengue infection and diabetes, and confounder adjustments. We extracted data 
on the sample size of enrolled persons and number of cases and controls and on the estimates 
(unadjusted and adjusted models) of the association (and their 95% confidence intervals) 
between diabetes and severe dengue. The transition of the patients data from clinical or 
hospital records to this review was based on published non-individual and non-identifying 
data. Data were extracted from the published papers independently by two reviewers and 
disagreements were resolved by discussion. 
Case Definitions 
Dengue 
The studies included in this review mostly included dengue diagnosed before 2009 and  
applied the WHO 1997 dengue classification criteria (13). A 2009 classification was proposed 
by the WHO/TDR group and in 2011 the WHO/SEARO group also suggested modifications 
(14). We list the classification system applied in the respective studies in Table 1, which 
summarizes the available evidence. Control status and case status are predominantly defined 
as DF and as DHF or DSS respectively. Cases of DHF/DSS in the studies reviewed were 
hospitalized cases or deaths confirmed serologically, clinically with hemorrhagic 
manifestations or radiographically with a certain extent of plasma leakage. According to 
WHO 1997 classification, DHF is clinically subdivided into grades I-IV and all 4 grades 
could have some degree of at least subclinical plasma leakage. Grade I is the presence of fever 
with positive tourniquet test, grade II presents with spontaneous bleeding into the skin and 
elsewhere, grade III shows clinical signs of shock or circulatory failure, and grade IV presents 
with severe shock with undetectable blood pressure and pulse. Grade III and IV have also 
been labeled as “dengue shock syndrome” (DSS). The WHO 2009 classification differs from 
the 1997 classification scheme in that dengue cases are classified by the levels of severity with 
or without warning signs. Several clinical features specifically listed in the WHO 2009 
classification were not directly obtained in the reviewed studies, e.g. clinical features such as 
lethargy, restlessness, and severe organ impairment or failure. We refer to DHF/DSS as 
“severe clinical presentation of dengue”. 
In the reviewed publications, laboratory diagnosis methods to confirm dengue virus 
infection as the cause of disease varied across studies and involved detection of virus, viral 
nucleic acid, antigens or antibodies, or a combination of these techniques (12). The detection 
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of virus, nucleic acid or antigen in the blood is confirmatory for an acute dengue infection. 
Antibody response to infection differs by the host immune status. In the setting of a primary 
infection, IgM are the first antibodies to appear, but it takes 10 days for them to be detectable 
in 99% of patients. During a secondary dengue infection, anti-dengue IgG are detectable at 
high levels already in the acute phase, whereas IgM levels remain significantly lower than in 
primary dengue infection. A four-fold or greater increase in IgG antibody levels in paired sera 
(sample collected during the acute stage of illness and sample collected in the convalescent 
stage) indicates acute dengue (12). Identification of virus/viral RNA/viral antigen and 
antibody response are ideally combined for the confirmation of acute dengue. Yet, as 
specimen collection and processing is easier for serology, the laboratory methods applied in 
the studies mostly conducted in LMIC varied broadly. We list the laboratory confirmation 
methods applied in the respective studies in Table 1, together with the available evidence. 
Diabetes Mellitus 
In studies included in this review, the diagnosis of DM was mostly ascertained by self-
reported diagnosis in the context of in-person interviews or DM diagnosis listed in clinical 
records. The DM diagnosis was further verified by requesting the prescription and/or 
medication package during the in-person interview in the only population-based case-control 
study (27). An oral glucose tolerance test was performed in dengue patients in the case series 
published by Hasanat study (28). 
Meta-analysis 
We used random-effects models for meta-analyses of the association between DM and 
a severe clinical presentation of dengue (29). They take into consideration the variation 
between the true effects estimated by included studies unlike fixed effect models which 
assume a common true effect across studies. We used odds ratios as measure of association 
across all studies. We used the estimates reported by the authors as “primary model” and the 
I2 metric and Tau2 to describe the between study heterogeneity and variance respectively.  
We conducted sensitivity analyses by using a fixed effect model and excluding a 
study, which was based on non-matched random controls and that only reported unadjusted 
estimates (30). We performed analyses with Stata version 12 (Stata Corporation, Texas) and 
considered p<0.05 as statistically significant. 
4.5 Results 
Our literature search resulted in 32 hits (Fig. 1). After excluding duplicates and non-
relevant articles based on a full text analysis (single case reports, outbreak investigation 
reports, no specific factors studied, narrative overview of dengue infections in a specific 
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country or globally), ten articles were retained. Among them, five studies were case-control 
studies (30-33)  with one study being population-based (27). The case-control studies 
compared the prevalence of DM in persons with acute or past non severe dengue (controls) to 
that in persons with an acute severe clinical presentation of dengue. Five additional articles 
(case series) characterized DM in mostly dengue patients with severe clinical manifestations, 
including fatal cases (28, 34-37). These studies lack a comparison group with acute or past 
non severe of dengue, and are therefore not included in the meta-analysis. 
Epidemiological evidence from case-control studies on the association between DM and 
a severe clinical presentation of dengue  
Epidemiological studies included in the meta-analysis compared the prevalence of DM 
and other co-morbidities between patients suffering from acute dengue with a severe 
presentation and controls with acute or past dengue without severe clinical manifestations 
(Table 1). In the absence of controls without evidence for a dengue infection history, studies 
thereby compared the prevalence of DM in dengue patients with different degrees for severity 
in clinical presentation, rather than the risk of being infected with dengue virus.  
The only population-based case-control study (27) identified was conducted in two 
Brazilian cities and included both, children and adults. DHF cases were ascertained through 
the national surveillance system. The surveillance records were reviewed by two physicians. 
DHF was defined according to criteria used by Brazilian Healthy System, which were very 
close to WHO 1997 criteria. Controls were selected from the same neighborhood as cases. In 
addition, they were tested positive for anti-dengue IgG and matched to cases by age, sex and a 
report of a past dengue-like fever in the same year as the DHF diagnosis of cases. Additional 
information from both, cases and controls was obtained through in-person interviews. DM 
was based on a self-reported physician-diagnosis. Interviewers also asked for medication 
intake and verified it by seeing the prescription of packaging. DM was statistically 
significantly associated with DHF independent of age, sex skin color, income and educational 
level (aOR 2.75, 95% CI 1.12-6.73). The association of self-reported diabetes with DHF was 
stronger in diabetic patients being treated, especially if treated with insulin or more than 1 
drug (aOR 3.36; 95% CI 0.72-15.61). In addition, white ethnicity (aOR 4.70, 95% CI 2.17-
10.2), high income (aOR 6.84, 95% CI 4.09-11.43), high educational level (aOR 4.67, 95% CI 
4.09-11.43) and a self-report of allergy treated with steroids (aOR 2.94, 95% CI 1.01-8.54) 
were also associated with a more severe clinical presentation of dengue.  
A hospital-based study including persons aged 15 to 65 in Pakistan (31) compared 
hospitalized acute DHF patients (cases) to dengue IgG positive patients, but hospitalized for 
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unrelated conditions (controls). The study was conducted in two major tertiary care hospitals. 
A DHF case was defined as diagnosis by an experienced clinician applying WHO criteria, 
although the version applied was not specified. The categorization into persons with and 
without DHF points to the use of WHO 1997 criteria. Information was obtained through 
structured record review and in-person interview. Age- and sex-matched DHF cases were 
slightly more likely to report a DM diagnosis than control patients. In both groups, the 
reported prevalence of DM was exceptionally high, 41.8% in controls and 43.2% in cases. 
The association of DM with DHF adjusted for age, sex and duration of illness was statistically 
non-significant (aOR 1.26, 95% CI 0.78-2.03, p= 0.34).  
 In Singapore, a hospital-based study was conducted in the nation’s largest clinic. It 
included all admitted patients with acute dengue without age restriction (32). Information on 
case and control status as well as comorbidities was exclusively derived from abstracting 
medical charts. Cases were defined as DHF patients, and controls were DF patients. Probable 
dengue patients had a positive acute dengue serology. Confirmed dengue patients had positive 
dengue polymerase chain reaction assays. Clinical diagnosis for DHF was based on WHO 
1997 criteria. The data was analyzed separately for the two epidemic periods of 2006 
(predominantly DENV-1) and 2007/2008 (predominantly DENV-2; larger sample size). No 
association between DM status and DHF was found in the 2006 dengue outbreak. DM was 
independently associated with DHF in the 2007/8 epidemic (aOR 1.78, 95% CI 1.06-2.97). 
The association was stronger if the diabetic patients additionally had hypertension (aOR 2.16, 
95% CI 1.18-3.96) or asthma (aOR 4.38, 95% CI 0.80-23.85). Mean hospitalization days were 
longer for DM (4.99±3.34days) as compared to non-DM patients (4.04±1.62 days, p =0.001). 
Additional factors associated with DHF were Chinese ethnicity (compared to Malay or Indian 
ethnicity) (aOR 1.90, 95% CI 1.01-3.56 in 2006 epidemic periods and aOR 1.67, 95% CI 
1.24-2.24 in 2007/2008 epidemic periods) as well as middle age in 2007/2008 (aOR 1.41, 
95% CI 1.09-1.81 in 30-39 years and aOR 1.34, 95%CI 1.09-1.81 in 40-49 years of age 
group).  
In 2002 in Taiwan, all patients with confirmed acute DF treated at the Kaoshiung 
Medical University Hospital during a large outbreak occurring in the southern Taiwan were 
categorized into groups of DF and DHF/DSS by strictly adhering to clinical WHO 1997 
criteria and laboratory confirmation under the auspices of the Taiwanese Centre of Disease 
Control (33). Clinical information such as signs and symptoms and the results of blood 
investigation were abstracted from medical records. Cases were mostly adults, only 4.5% 
were below age 15 years. The prevalence of DM was 16.8% in DHF/DSS cases compared to 
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7.6% in DF patients (controls). The adjusted OR reported was 1.86 (95%CI 1.04-3.37), albeit 
covariates were not reported. In addition to the independent association of DHF/DSS with 
DM, statistically significant associations with hypertension and renal insufficiency, uremia, 
past history of dengue infection as well as male gender and older age were also found. 
A hospital-based study in Southern India (30) obtained information on patients 
admitted to the largest multi-specialty hospital in South Kerala for acute dengue between 
2005 and 2008. The case group consisted of 10 in-hospital deaths of patients admitted with a 
clinical diagnosis of probable dengue, which was confirmed by either RT-PCR or IgM 
antibody tests, and review of clinical symptoms through medical record review. Forty non-
matched controls were randomly selected among patients with a confirmed acute dengue, but 
recovering from the illness. The classification of dengue among the controls was not 
specified. Information on co-morbidities and other factors was abstracted from medical 
records. The prevalence of DM in controls was 2.5% compared to 40% in cases. DM was a 
strong predictor of mortality in the bivariate analysis (OR 26.0, 95% CI 2.47-273.67, p 
=0.004). In the same study, hypertension was also a strong predictor of mortality (OR 44.3, 
95% CI 6.2-315.5, p= 0.000). Mortality was much higher in patients over 40 years (OR 9.3, 
95% CI 1.9-44.4, p= 0.002). No adjusted odds ratios, which would facilitate the interpretation 
of independency in the reported associations, were reported. 
Meta-analysis of epidemiological evidence from case-control studies 
 We included the results of five above mentioned studies in a meta-analysis. One of 
these studies reported two separate estimates from two independent cross-sectional 
assessments; hence, we considered them as separate studies. The meta-analysis showed that 
the presence of a severe clinical presentation of dengue was positively associated with the 
presence of DM.  
A diagnosis of DM was associated with an increased risk for severe clinical 
manifestations of dengue by 75% (95% CI: 1.08-2.84, p =0.022) compared to non-DM 
patients (Fig. 2). This OR remained robust across sensitivity analyses involving fixed effect 
analysis. We observed some heterogeneity across the studies, consistent with the broadly 
differing study settings. The small number of studies included in the meta-analysis did not 
provide statistical power for formal statistical assessment of heterogeneity (Fig. 2). 
Clinical case series on characteristics of DHF patients 
We additionally identified five case series reporting dengue-related hospitalizations 
and the prevalence of DM in these cases. They are listed in Table 1 as reference of the 
prevalence of DM in dengue patients with a severe clinical presentation. The studies have 
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been conducted mostly in Asian dengue endemic regions such as Malaysia (36); Bangladesh 
(28); Singapore (34, 35). In the absence of a control group, these studies are of limited value 
for better understanding of the role of DM on the clinical presentation of dengue. In several 
instances the case definition was restricted to just being dengue seropositive. This does not 
allow differentiating between DM influencing the clinical manifestations of dengue infection 
versus dengue infection influencing the clinical presentation of DM. Of interest, in that 
respect is the study by Hasanat et al (28). Hospitalized DF patients underwent oral glucose 
tolerance testing (OGTT) between 3 and 10 days after the start of illness. A subset of these 
patients agreed to a second OGTT before discharge. The authors demonstrated a high rate of 
glucose intolerance in the early phase of disease, which returned though to normal in 55% of 
the patients.  
4.6 Discussion 
 The few published studies specifically addressing the role of DM as a risk factor for a 
severe clinical presentation of dengue provide suggestive evidence for an adverse effect. This 
result merits further investigation in the context of study designs that overcome the 
weaknesses of currently available publications as addressed below.  
Assigning causality to the modifying effect of diabetes on the clinical presentation of 
dengue is premature. First, the case-control studies conducted to date and summarized above 
are mostly retrospective in nature. The clinical and laboratory diagnostic criteria applied in 
different studies vary broadly, as does the definition for the control group. Second, the WHO 
1997 dengue classification used in the studies reviewed, has itself a number of limitations. For 
example, the development of this classification was based on disease patterns of children in 
Thailand, potentially limiting its generalizability to other geographical regions and to older 
age groups. Furthermore, clinical assessments such as the  Tourniquet test do not differentiate 
between DF, DHF and other febrile illness (38, 39). It also fails to detect severe dengue 
manifestations in many patients (40). Third, information on DM was either self-reported or 
record-based and did not systematically allow differentiating between DM diagnosed before 
versus concurrent with the dengue episode. Given the high degree of under diagnosis of DM, 
especially in LMIC, misclassification of DM status in the studies is likely substantial. The 
problem of under diagnosis is not easy to overcome, as DM measured at the time of acute 
dengue is not necessarily reflecting the underlying DM status, but rather stress-related 
hyperglycemia, which disappears after recovery from dengue (28). Longitudinal studies of 
dengue patients are needed that allow studying both, the longitudinal course of hyperglycemia 
and the evolvement of clinical presentation of the dengue infection. In addition, whether better 
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control of DM in early stages of dengue will prevent severe forms of dengue needs to be 
assessed in the context of intervention studies. The basis should be dengue surveillance 
programs which registers all dengue episodes and which includes routine collection of blood 
specimens for HbA1c and other hyperglycemia parameters and of information regarding 
diagnosis and treatment of DM. A fifth limitation of studies conducted to date is the fact that 
most of them were hospital-based case-control studies with a high potential for selection bias. 
But the results from the only population-based case-control study also point to DM increasing 
the risk for a severe clinical presentation of dengue (27). Finally, study limitations also 
include the fact that the modifying effect of DM on different dengue serotypes could not be 
differentiated; that the age range of study subjects was not always reported; and that many 
studies included children and adolescents in whom DM is rare.The observed heterogeneity 
between the results of the individual studies is a limitation in the meta-analysis and reflects 
differences in the diagnostic and classification criteria for dengue and DM, differences in the 
controls selected, as well as differences in study design such as sample size, population and 
study setting or confounders considered in the analysis. Our systematic and broad search 
strategy, (not limiting to publication dates, place of study, study design or age of research 
participants) and the novelty of this topic are the strengths of our review and should stimulate 
further research into the topic, also in the light of supporting results from experimental 
studies. 
Biological evidence exists to support the hypothesis for a high DHF: DF ratio in 
diabetes. One example for a line of reasoning is that the cytokine overload related to a Th1 to 
Th2 shift and a severe manifestation of dengue superimposed by the cytokine overload of a 
diabetic state may be particularly detrimental to the endothelium and for subsequent vascular 
leakage (41-43).  The third space fluid shift such as pleural/pericardial effusion or ascites is an 
important clinical manifestation in dengue with severe clinical symptoms, which is a 
consequence of endothelial dysfunction and results in hemoconcentration, hypotension and 
shock (34).  DM shares with a severe clinical presentation of dengue alterations in the innate 
immune response, a pro-inflammatory state and endothelial dysfunction. Lee and colleagues 
infected mononuclear cells from diabetic (n=33) and healthy individuals (n=29) with dengue 
virus. Cells from diabetics produced higher levels of IL-4 and of both, IL-4 and IL-10 as well 
as granulocyte-macrophage colony-stimulating factor (GM-CSF) on the first and third day 
post-infection, respectively. No differences in viral load were found (44). In a post-mortem 
study of DHF/DSS related deaths, the intestinal serosa of 1 DM case with ascites, but not of 
non-DM cases showed apoptosis of microvascular endothelial cells (42). Microvascular 
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endothelial cells cultured with sera from acute dengue infection patients containing high TNF-
 levels exhibited activation and apoptosis, a pathophysiological alteration likely related to 
vascular leakage (41). 
Currently available epidemiological studies on the DM/DHF, DSS association do not 
provide sufficient clinical details to specifically address this “cytokine overload” hypothesis. 
For example, the Brazilian study explicitly stated that it did not look into ascites or pleural 
effusion, as these were very rarely recorded (27). The other studies did not mention plasma 
leakage such as pleural effusion or ascites except for the Taiwan study, where 51% of 164 
DHF cases showed evidence of pleural effusion in X- ray and 31% of DHF cases had ascites 
in ultrasound (33). Future studies thus need to specifically address the issue of plasma leakage 
in the overlap between severe dengue and DM. Clinical reporting of the presence of pleural 
effusion and ascites as signs of severe plasma leakage is essential, as hemoconcentration and 
shock symptoms in the absence of plasma leakage can also arise from poorly controlled DM. 
The direct hypovolemic effect of hyperglycemia and the associated elevated hematocrit may 
even lead to misclassification of diabetics as DHF in the absence of objective evidence of 
plasma leakage. While recognition of hemoconcentration irrespecitive of its reason is of 
primary clinical importance for the provision of appropriate fluid therapy, currently available 
studies on the DM and DHF/DSS association do not provide sufficient clinical details to 
differentiate between effects of DM vs. DHF/DSS.   
The potential role of altered innate immunity in mediating the association between 
DM and a severe clinical presentation of dengue obtains indirect support by observations that 
the latter may also have a higher prevalence of asthma and allergies. Patients with asthma and 
allergy also exhibit altered Th1 and Th2 responses (27, 31). But in DM, factors beyond the 
altered cytokine profile may additionally put people at risk. Diabetic patients express high 
rates of hypertension and impaired renal function which are both themselves associated with 
endothelial dysfunction (45, 46). Hypertension was also observed to be more common in 
patients with dengue (27, 30-32, 35), but often exhibited no independent effect in regression 
models adjusting for diabetes (31, 32). Pang and colleagues (2012) reported a higher risk for a 
severe clinical presentation of dengue in hypertensive when compared to non-hypertensive 
diabetic patients (32).  
4.7 Conclusion 
Understanding factors increasing the likelihood of dengue patients with severe clinical 
symptoms would help the physician to decide in a timely fashion on the need for close 
observation, adequate treatment, or hospitalization. The available evidence points to DM as a 
Chapter 4: Is diabetes a risk factor for a severe clinical presentation of dengue?   
Review and Meta-analysis 
 
56 
 
potentially important co-factor. Additional prospective studies among DM and non-DM 
patients are needed to assess the impact of pre-existing DM as well as of hyperglycemia at the 
time of dengue diagnosis on the risk of a severe clinical presentation of dengue and of related 
deaths. Even in the absence of causal inference, it seems justified that fever episodes in 
patients with DM and living in a dengue endemic region are confirmed for dengue as soon as 
possible and that they remain under close surveillance if an acute dengue infection is 
confirmed. Future studies need to also address whether better control of glycemia level in 
dengue patients with DM can improve the outcome of the patient and decrease the risk of a 
severe clinical presentation. As the fluid management in diabetic patients with a severe 
clinical presentation of dengue poses a particular challenge, this issue should be taken into 
consideration by these studies. Diabetic patients in dengue endemic regions should 
consistently receive recommendations to protect against dengue infection by taking preventive 
measures against indoor mosquito breeding and against mosquito bites.  
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Fig. 1: PRISMA Flow diagram of diabetes and dengue 
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Fig. 2: Meta-analysis of case-control studies on the association between diabetes mellitus 
and a severe clinical presentation of dengue 
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Table 1. Summary of case-control studies and case series  
First author 
and 
publication 
date 
Country & 
Year of 
study 
Study design Characteristics of Study population Results(Odds ratios (OR) and 95% 
confidence intervals) 
Epidemiological case-control studies 
Figueiredo et 
al.(2010)  
Brazil, 
2002-2003 
(Salvador), 
2003-2005 
(Fortaleza) 
Population-based 
case-control study 
Cases:170 acute DHF    
-registered in the national surveillance systems 
-residents of 2 cities 
-no age restriction 
-diagnostic criteria: 
surveillance record review by 2 physicians;  
Brazilian Health Service (very similar to WHO 1997) criteria; 
fever & positive serology for anti-dengue IgM and/or viral isolation and characterization; 
at least two signs or symptoms of dengue fever (headache or retroorbital pain, myalgia, 
arthralgia, prostration, exanthema); 
all of the following signs: hemorrhagic manifestations, hemoconcentration with an 
increased haematocrit level; thrombocytopenia; 
no consideration of ascites or pleural effusion (rarely recorded) 
Controls: 1175  
-neighborhood controls  
-sero-positive (anti-dengue IgG)  
-self-report of dengue like illness in same year as matched case  
-no history of DHF 
-matched for age and sex (within 5 years) 
Information on dengue history, confounders, effect modifiers & comorbidities: in-
person interviews  with cases and controls 
DM: self-report of physician diagnosis and verification of prescription /packaging of 
medication 
 
 
 
 
 
 
 
 
 
Predominantly DENV-3,Association DM – 
acute DHF vs. asymptomatic (IgG) (+)ve 
controls Adjusted OR (age, sex,income, 
neighborhood, skin colour, education) 
DM yes vs. no.: aOR 2.75 (1.12-6.73) 
DM according to the number of medications: 
no medication vs. no DM :aOR 1.83 (0.18-
18.67)                           
1 medicine vs. no DM: aOR 2.72 (0.86-8.60)     
Insulin/ >1 medicine vs. no DM:aOR 3.36 
(0.72-15.61) 
DM prevalence: controls:2.6%,cases:5.3% 
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Mahmood et 
al (2013)  
Pakistan 
(2011) 
Hospital-based case-
control study 
Cases: 132 acute DHF Association DM – acute DHF vs. 
asymptomatic IgG positive controls: Adjusted 
OR (sex, age, duration of illness) 
DM yes vs. no: aOR 1.26 (0.78-2.03), p=0.34 
DM according to its duration: 
5-10 vs. <5 yrs aOR 2.76(0.77-9.84),p=0.11       
>10  vs. <5 yrs:aOR 1.86 (0.55-6.26),p=0.31 
DM prevalence: controls: 42% ,cases:43% 
-admitted to two major tertiary care hospitals of Lahore 
-age 15-65 
-diagnostic criteria: 
diagnosed as DHF by a  trained clinician; 
WHO criteria (version not specified) 
Controls: 249 patients without acute dengue 
-random sample of patients from same health facilities admitted for reasons other than 
dengue; 
-positive for anti-dengue IgG; 
-matched for age and sex (within 5 years); 
-Information on dengue history, confounders, effect modifiers & co-moribities: in-person 
interviews  with cases and controls; checklist for clinical record review 
DM: self-report or clinical record 
Pang et al 
(2010) 
Singapore 
(2006-2008) 
Hospital-based case-
control study 
2006 epidemic: Cases:149 acute DHF, Controls:326 acute DF 2006 epidemic: predominantly DENV-1 
27.6% of patients PCR (+)ve 
72.4% of patients sero-positive & PCR(-)ve  
Association DM- acute DHF vs. acuteDF: 
Adjusted OR (age, ethnicity) 
DM yes vs. no: aOR 0.34 (0.06-1.89) 
DM prevalence: controls:  2.2% ,cases: 1.3%   
2007/8 epidemic: predominantly DENV-2 
32.6% of patients PCR positive 
67.4% of patients sero-positive & PCR (-)ve 
Association DM- acute DHF vs. acute DF: 
aOR (age, ethnicity, gender, hypertension) 
DM  yes vs. no: aOR 1.78 (1.06-2.97)                
DM with hypertension: aOR 2.16  (1.18-3.96)    
DM with hyperlipidemia:aOR 1.62 (0.90-
2.92)                            
DM with asthma: aOR  4.38 (0.80-23.85)           
DM prevalence: controls:3.5% ,cases:6.4% 
2007/2008 epidemic: Cases:590 acute DHF, Controls:1141 acute DF 
-admitted to the largest hospital of Singapore for dengue 
-adult 
-diagnostic criteria: 
probable DF: positive acute dengue serology (Dengue Duo IgM & IgG Rapid Strip Test) 
and clinical criteria of DF by WHO1997; 
confirmed DF: positive dengue PCR and clinical criteria of DF by WHO 1997 
-DHF: presence of all four criteria of fever, hemorrhagic  manifestiations, 
thrombocytopenia, plasma leakage 
Information on dengue history, confounders, effect modifiers & comoribities: 
clinical record review 
DM: clinical records 
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Lee et al.  
(2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Karunakaran 
et al (2014) 
 
Taiwan 
(2002) 
Hospital-based case-
control study 
Cases:232 acute DHF (12 DSS) 
Controls:412 acute DF 
-all confirmed acute DF treated at Kaohshiung Medical University Hospital in 2002 
-no age restriction 
-diagnostic criteria for confirmed acute DF: 
WHO 1997 criteria, meeting any of: 
positive dengue virus by PCR; 
4-fold increase of dengue virus-specific IgM or IgG in paired serum samples; 
positive for dengue virus-specific IgM or IgG in a single serum sample; 
additional diagnostic criteria for confirmed acute DHF: 
Thrombocytopenia; 
Evidence for hemorrhage and plasma leakage; 
additional diagnostic criteria DSS: 
hypotension, narrow pulse pressure, clinical signs of shock 
Information on dengue history, confounders, effect modifiers & comoribities: 
clinical record review 
DM: clinical records 
Association DM- acute DHF/DSS vs. acute 
DF: Adjusted OR( factors not reported) 
DM  yes vs. no: aOR 1.86 (1.04-3.37) 
DM prevalence: cases :16.8% ,controls:7.6% 
Plasma leakage prevalence: Pleural effusion: 
51% of DHF cases  
Ascites: 31% of DHF cases 
 
 
 
 
 
 
 
 
 
 
 
 India 
(2005-2008) 
Hospital-based case-
control study 
Cases:     10 acute dengue patients, fatal Association DM -  mortality among 
confirmed acute dengue patients 
DM yes vs. No: Crude OR 26.0 (2.5-273.7) 
DM prevalence: controls:2.5%, cases:40% 
Controls: 40 acute dengue patients, non-fatal 
-confirmed dengue patients admitted to in South Kerala hospital between 2005-2008 
diagnostic criteria: 
-confirmation by PCR or IgM antibody 
Information on dengue history, symptoms, confounders, effect modifiers & 
comorbities: semi-structured interview ;assessment of warning signs according to WHO 
2009 case definition 
DM mellitus: self-report 
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Case series 
Lye et al. 
(2009) 
Singapore 
(2004) 
Hospital-based  Cases: 1971 acute DF, DHF, and DSS cases DM prevalence: Age <60:2% ,Age ≥ 60: 17% 
-all patients admitted to the Tan Tock Seng Hospital in Singapore in 2004   
- fulfilling WHO 1997 criteria for acute dengue   
- positive dengue  diagnostic tests:  
- probable dengue:(+)ve acute dengue serology (Dengue Duo IgM & IgG Rapid Strip Test)  
- confirmed dengue:   
- positive PCR   
- no age restriction  
Information on dengue history, symptoms, confounders, effect modifiers & 
comoribities:  clinical records 
 
DM: clinical records  
Wieten et al. 
(2012) 
Netherlands 
(2006-2011) 
Tropical and travel-
medicine based case 
series 
Cases: 132 acute dengue cases  DM prevalence: 8% 
-dengue patients serologically tested at Amsterdam Medical Center between 2006-2011  
-diagnostic criteria:  
serological confirmation:positive anti dengue  IgM or at least fourfold increase  in dengue 
specific IgG if possible based on  one sample from the initial phase and one from the 
convalescent phase or else according to WHO 2009 criteria for a single sample; 
 
 
 
clinical picture of probable dengue (WHO 1997 and 2009 criteria) or  
DHF (WHO 1997) or dengue with warning signs (WHO 2009); 
 
 
Information on dengue history, symptoms, confounders, effect modifiers & 
comoribities: clinical records 
 
DM: clinical records  
Sam et al  
(2013)     
Malaysia 
(2006-2007) 
Hospital-based  Cases: 10 acute DF/DHF/DSS patients, fatal DM prevalence: 30% (pre-existing) 
-fatal cases at the University Malaya Medical Center 2006-2007 Plasma leakage prevalence: 78% of all cases  
-diagnostic criteria: (67% among diabetic patients) 
laboratory confirmation: acute phase dengue-specific IgM and IgG; RT-PCR;  
disease severity classification WHO 1997 ;  
age range: 11-59;  
Information on dengue history, symptoms, confounders, effect modifiers & 
comoribities: clinical records 
 
DM: clinical records  
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Lahiri et al  
(2008)    
Singapore 
(2004-2005) 
Hospital-based  Cases: 9 acute dengue cases, fatal  DM prevalence: 78% 
-fatal cases of a total of 1235 admissions with acute dengue in 2004-2005 Plasma leakage prevalence: 28% of  DM 
patients 
-all 9 patients had positive laboratory test for dengue (7 by IgM, 3 by PCR)  
-all 9 patients had evidence for capillary leakage and hemorrhagic manifestations  
-7 of  9 patients strictly met DHF WHO 1997 criteria  
- age range: 37-71  
Information on dengue history, symptoms, confounders, effect modifiers & 
comoribities: 
 
clinical records   
DM: clinical records  
Hasanat et  
al.(2010) 
Bangladesh 
(2009) 
Hospital-based  
(prospective) 
Cases: 133 acute dengue cases  Status on 1st  OGTT (n=133): Normal:25% , 
Glucose intolerant:54% ,DM:21% 
-patients admitted to Samoritha Hospital in Dakha for dengue Status on 2nd   OGTT (n=40):  
- laboratory confirmation by anti-dengue antibody test 1 week of onset of illness Normal:83% 
-further diagnostic criteria not provided Glucose intolerant:17% 
Information on dengue history, symptoms, confounders, effect modifiers & 
comorbities: interviews 
Repeatedly normal:25%, 
DM: Oral glucose tolerance testing in consenting cases: 1st test between day 3 and 10 of 
admission and 2nd test before discharge 
Repeatedly abnormal:18% 
 Reverting to normal:55% 
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5.1 Abstract 
Background: The hygiene hypothesis states that the lack of exposure natural infections in 
early childhood increases the chance for the development of chronic allergic and autoimmune 
diseases. The dual burden diseases (DBD) of infectious (helminthic) diseases and chronic 
diseases such as diabetes mellitus is high in low- and middle income countries (LMIC). This 
review aims to summarize the epidemiological and immunological evidence on an association 
of helminthic infections and diabetes mellitus.  
Methods: A systematic literature review was conducted using the MEDLINE database.  
Results: Eleven cross-sectional studies and one population based cohort study were identified 
The prevalence of helminth infections among diabetes and non-diabetic patients or the 
prevalence of diabetes mellitus among helminth infected and non-infected groups were 
compared. The results from revealed that helminthic infections and diabetes mellitus are 
inversely associated.  
Conclusion The elucidation of the immune mechanism and epidemiological findings by 
helminth infections against diabetes mellitus could not only lead to the identification of 
potential helminth related products but also in indicating a specific cell or molecule for anti- 
inflammatory induction in diabetes mellitus. Yet, successful mass-deworming programs that 
decrease the incidence of helminthic infections might have an impact on the incidence of 
autoimmune mediated disorders including diabetes mellitus in the future. It is of importance 
to closely follow-up this issue as helminth control activities precede in many LMIC.  
 
Keywords: helminth infections, diabetes mellitus, epidemiology, systematic review 
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5.2 Introduction 
Understanding the complexity of the dual burden of diseases (DBD) between 
infectious and chronic diseases is a highly relevant issue in low- and middle-income countries 
(LMIC) as they are particularly frequent in these settings. As of 2015, an estimated 415 
million people were affected by diabetes mellitus (DM) worldwide; Type 2 DM making up 
about 90% of the cases  representing 8.3% of the adults global population. In that year, DM 
resulted in an estimated 1.5 to 5.1 million deaths worldwide corresponding to the 8th leading 
cause of death globally. The number of people with DM is expected to rise to 592 million by 
2035 (WHOa, 2014). Even though the incidence of type 1 DM varies substantially between 
different populations, it is globally rapidly rising.  
Helminthic infections are still a major contributor to the global burden of infectious 
diseases. Today, more than 1.5 billion people or 24% of the world's population are infected 
with one or several species of soil-transmitted helminths (STHs). 200 million people are 
infected worldwide with schistosomiasis and an estimated 120 million cases of lymphatic 
filariasis (LF) are counted (Global burden of study, 2014). Moreover, according to the World 
Health Organisation (WHO), countries of East and Southeast Asian, central and south 
America have high prevalence rates of foodborne trematode infections; An estimated 40 
million people have trematode infections (WHO, 2014b) that are accumulating in patients 
over lifetime and are particularly prevalent in older age groups.  
In 1989, the hygiene hypothesis was first formulated by Dr Strachan (Okada et al., 
2010). It states that in early childhood infections may protect against allergic diseases at a 
later age and that the increasing cleanliness of household environments would explain in part 
the rises in allergic diseases and immune mediated diseases. Over the last decades, 
autoimmune disorders including DM, have been increasing in geographical distribution (west-
east or north-south gradient) (Kondrashova et al., 2005). Reasons mentioned were migration 
(Jayaweera, 2011), decreasing the infectious diseases (Droste et al., 2000), the low socio-
economic related factors (Okada et al., 2010), gene related issues (Tuomi et al., 2014) and 
environmental factors such as air pollution (Eze et al., 2015) or toxin (Sharp, 2009).  
Generally helminthic infections induce a shift from Th1 to Th2 phenotype, accelerate 
T regulatory and B regulatory phenotypes, and attenuate the levels of the pro-inflammatory 
cytokines (Bashi et al., 2015, Van Riet et al., 2007). The cellular response to Ascaris 
lumbricoides infection is characterised by a polarized Th2 response with the prominent 
production of both IL-4 and IL-5, indicated in an Ecuadorian case-control study (Cooper et 
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al., 2000). The Trichuris trichiura infection suggests a mixed cytokine response producing IL-
10 (97%), TNF-α (93%), and IFN-γ (32%) while IL-4 (7%), IL-9 (5%), and IL-13 (17%) in 
Cameroon study (Faulkner et al., 2002). Like other intestinal helminths, hookworm infection 
is also specified by antibody responses dominated by IgG1, IgG4, and IgE, under the control 
of Th2 cytokines, predominately IL-4, IL-5, and IL-13, with IL-4 and eosinophil production, 
while Th1 cytokines such as gamma interferon inhibit its production(Loukas and Prociv, 
2001). In Kenyan schistosomiasis studies, pro-inflammatory responses with elevated level of 
TNF and IFN-γ were shown in the patients (Mwatha et al., 1998), and additional higher IL-13 
in Brazilian study (Alves Oliveira et al., 2006). Recently, alternatively activated macrophages 
(AAM) as a key player in controlling the immune pathology in schistosomiasis has also been 
highlighted (Barron and Wynn, 2011). The upregulation of Th1, Th17 cells and antibody 
responses are observed in filariasis infected patients (Babu et al., 2009). In pathogenesis of 
onchocerciasis, Th2 mediated Treg and IL-13 have a significant character and is related to IL-
13 gene mutation which is responsible for allergic hyper-reactivity in the body (Hoerauf et al., 
2002, Satoguina et al., 2002). 
In the context of type 1 DM, the influence of helminth infections on the onset of 
autoimmune DM was studied experimentally in non-obese diabetic (NOD) murine models. 
NOD mice were infected with Schistosoma mansoni antigen (Cooke, 2009), Trichinella 
spiralis (Saunders et al., 2007), Heligmosomoides polygyrus (Liu et al., 2010), Litomosoides 
sigmodontis (Hubner et al., 2011) and Dirofilaria immitis (Imai et al., 2001). The exposures to 
helminths were found to prevent the onset of type 1 through protection from Th1-mediated β 
cell destruction (Bashi et al., 2015). Observed alterations in the immune system in response to 
helminthic antigens involved several types of immune cells including B cells, tolerogenic 
dendritic cells (DCs), AAM and innate lymphoid cells (ILCs). They all induced Th2, natural 
killer T cells (NKT) and Treg generation or expansion. The cytokine secretion evoked from 
NKT, Th2 and Tregs feeds back and maintains the tolerogenic and alternatively activated 
phenotypes of antigen presenting cells. As a result, diabetogenic (Th1) cells become regulated 
resulting in only a non-destructive insulitis (Zaccone and Cooke, 2013).  
Obesity, type 2 DM and cardiovascular diseases share a metabolic profile 
characterized by insulin resistance (IR) and chronic sub-acute inflammation (Donath and 
Shoelson, 2011). The insulin resistance, a predominant characteristic of type 2 DM and 
related forms (e.g. Latent Autoimmune Diabetes of Adults LADA) is strongly linked to 
obesity and specifically to visceral fat mass and therefore to obesity-associated metabolic 
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inflammation rather than to stimuli of infections. The inflammatory signalling can also be 
stimulated by cellular stress such as reactive oxygen species, endoplasmic reticulum stress, 
hypoxia and lipotoxicity, free fatty acids which can all be enhanced in the obese induced 
insulin-resistant state. Then, chronic helminthic infections, as an inducer of type 2 immune 
responses induce IL-4, IL-5, IL-13 and eosinophilia production which further boosting the 
alternatively activated macrophages (aaM) development together with regulatory T and B 
cells and the production of anti-inflammatory cytokines like IL-10 and TGFβ, leading to 
insulin sensitivity (Allen and Maizels, 2011, Hubner et al., 2013), which was shown in diet 
induced obesity mice studies by S. mansoni infections (Hussaarts et al., 2015). The helminth 
mediated protective mechanism against type 2 DM is that the helminth induced type 2 
immune responses increase IL-4 production by eosinophil and aaM polarization in the 
adipocytes, further suppresses the activation of classically activated macrophages leading to 
anti-inflammatory immune responses, thus improving insulin sensitivity and inhibiting β-islet 
cell destruction (Donath et al., 2008) and the study conducted on Flores Island in Indonesia, 
showed that individuals infected with STH had a lower insulin resistance (Wiria et al., 2012). 
Many studies provide some evidence that helminth induced immunomodulation mechanism 
shield the onset of type 1 DM. However, the mechanism of interaction of helminths on type 2 
DM is still unclear and need to be further investigated. It is also important to keep in mind 
that the extent of helminth related immunomodulation varies with helminths species, intensity 
of the infection and the direct metabolic reaction of host's immune system.  
The objective of this review was to evaluate the epidemiological evidence related to an 
association between helminthic infections and the development of DM and the interaction of 
two diseases. 
5.3 Methods 
Search strategy 
A systematic literature review using MEDLINE database was performed to identify 
articles in which an association between helminthic infections and DM was examined. The 
following search terms (MeSH terms) were: Trematodes infection (dicrocoeliasis, 
echinostomiasis, fascioliasis, fascioloidiasis, opisthorchiasis, paragonimiasis, schistosomiasis, 
schistosomiasis haematobium, schistosomiasis japonicum, schistosomiasis mansoni); 
Cestodes infections (diphyllobothriasis, sparganosis, echinococcosis, hymenolepiasis, 
taeniasis, cysticercosis); Nematodes infections (larva migrans, ascariasis, trichuriasis, 
oxyuriasis, strongyloidiasis); "helminth", “helminthiasis", "parasitology" in combination with 
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"diabetes mellitus", "diabetes, type 1", "diabetes mellitus, type 2", "insulin resistance", 
"IDDM", "NIDDM" alone and in combination. 
Inclusion and exclusion criteria 
We included all articles without restriction on language, publication date (up to 31 
August 2016), study settings, design or age of study participants and also articles describing 
the epidemiology, clinical signs, and laboratory parameters of either helminth infected or 
diabetic patients, and the assessment of complications. The studies conducted in animals 
settings were excluded in the review. The PRISMA criteria (PRISMA and Moher, 2009) were 
used for validity assessment of the published articles. 
Data extraction 
The following information was extracted from the publications: Year of the study, 
year of publication, place (country) of study, study design, study populations and their 
characteristics, study definitions and diagnostic criteria for DM and helminth infections and 
adjusted confounder. Moreover, we extracted data on the prevalence of DM among helminth 
infected persons and verse versa and the reported estimates of the association such as adjusted 
and unadjusted odd ratios (OR) with 95% confidence intervals (CI). The transition process for 
this review is confidential and anonymous. The two reviewers independently extracted the 
data from the published manuscripts and disagreements were sorted out by discussion. 
5.4 Results 
Our literature search revealed 52,958 articles (Fig. 1) of whom 34,691 articles were 
animal studies and were excluded. Among the remaining 18,267 articles, 18,255 articles were 
not relevant (clinical single case reports, non-comorbid studies, and overview of helminthic 
infections in a specific countries or particular geographical settings, and cellular or molecular 
study of helminthic infections) and were not considered for the review. Finally twelve articles 
which reported the relationship between helminthic infections and either type 1 or type 2 DM, 
were retained (Table 1).  
Eleven studies had a cross-sectional and one study had a cohort design. They were 
conducted among the communities in countries endemic for different helminth species. In the 
articles, the prevalence of helminthic infections was reported among diabetic, pre-DM and 
non-diabetic subgroups and the association assessed. The epidemiological studies in this 
review also described the prevalence of DM in helminth infected versus non-infected groups 
and means of measures to describe its association. In Table 1 the key features of the identified 
studies are summarized. Below a short description of each study is provided.  
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Aravindhan and colleagues conducted two studies in India in which they observed a 
lower prevalence of lymphatic filariasis (LF) in patients with type 1 and type 2 DM compared 
to persons with a normal glucose tolerance (NGT). The study participants were recruited from 
the Chennai Urban Rural Epidemiology Study (CURES). The first study identified type 1 DM 
patients (n=200), selected healthy NGT persons from the CURES and compared their 
seropositivity of LF (Aravindhan et al., 2010b). Type 1 DM was diagnosed by C-peptide 
assay < 0.3 pg/mL and GAD–specific autoantibody levels ≥10 IU/mL. Bancroftian LF was 
detected in the serum samples analyzed by using the Wuchereria bancrofti Og4C3 antigen-
capture ELISA. The antibody titer to LF was determined by the serum antibody (IgG and 
IgG4) levels against Brugia malayi antigen. The prevalence of LF was 0% in type 1 DM 
persons and 2.6% among NGT persons (p = 0.03). The blood parameter also supported these 
findings that Brughia malayi antigen specific IgG4 which is a standard marker of present 
infection, was lower among type 1 DM patients. However, another indicator for Wuchereria 
bancrofti exposure, the levels of antigen specific IgG, did not show any difference between 
the groups. In this study, the authors argued that socioeconomic factors were unlikely to be a 
confounding factor among type 1 DM and NGT persons after stratification.  
In the second study, Aravindhan and colleagues observed a significantly lower 
prevalence of LF among type 2 DM subjects (5.7% in both newly diagnosed and 4.3% in 
those under treatment) compared to pre-diabetic subjects 9.1% and non-diabetic subjects 
10.4% (Aravindhan et al., 2010a). There was also a lower significance level of filarial antigen 
loads as well as serum cytokine levels of the pro-inflammatory cytokines (especially IL-6 and 
GM-CSF and TNF-α) in LF positive diabetic subjects compared to those who were LF 
negative. The levels of anti-inflammatory cytokines such as IL-10, IL-13 and TGF-β were not 
significantly different among the study groups. The study concluded that the LF modulated 
inflammatory reaction supressed the pro-inflammatory responses in the body and provided a 
protective mechanism against type 2 DM.  
Concerning Enterobius vermicularis infection, a large, population-based cohort study 
(Bager et al., 2012) was conducted to determine the association between childhood E. 
vermicularis infection and incidence of chronic inflammatory diseases such as asthma, 
juvenile arthritis, ulcerative colitis, or Crohn’s disease, including type 1 DM in the children 
who were born in Denmark between 1995 and 2008 and registered in the Civil Registration 
System. The results revealed that childhood enterobiasis did not reduce the risk of having type 
1 DM. An incidence rate ratio of 1.05 (95% CI: 0.79 –1.12). Similar results were obtained for 
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the other chronic diseases. The research participants were identified from in-patient or 
outpatient hospital diagnosis record of chronic inflammatory disease from National Patient 
Registry and history of medication with mebendazole. The authors mentioned some possible 
logic with regards to the findings that general practitioners overprescribed of anthelminthic 
drugs for other helminthic infections which could diminish the effect of E. vermicularis on 
chronic diseases On the other hand, the results could also be due to the nature of enterobiasis 
infection which is only persistent for a short time period and not repeated. Hence insufficient 
to modulate the immune system such as other helminths infections as Ascaris or Trichuris 
infections may do.  
In a study in Egypt with a cross-sectional design the prevalence of the Islet cell 
antibody (ICA) seropositivity was two times higher among diabetic children (50%) than the 
children with schistosomiasis infection (25%). In addition, normal glucose tolerance or lower 
IR to intravenous glucose load was also found in the children with schistosomiasis compared 
to the other two groups. Gender, being a sibling, previous medical illness, and the blood 
results for liver and kidney functions did not show significant difference between the groups. 
The findings suggested that the autoimmune reaction of the children with schistosomiasis 
infection could lessen islet cell dysfunction, resulting decreased risk of developing glucose 
intolerance and DM in future (Soliman et al., 1996).  
Similarly, in rural China, Chen and colleagues (Chen et al., 2012) performed a cross-
sectional study which reported the association of the previous schistosome infection (PSI) and 
the presence of DM and metabolic syndrome among individuals aged 60 years and older. The 
researchers found a strong protective effect of PSI on current DM status (aOR 0.51, 95% CI 
0.34–0.77). Five different statistical models were used to explore the association. In four 
models, the associated was adjusted for a series of other factors such as age, sex, body mass 
index (BMI), physical activity, family history of DM and educational levels but also on 
metabolic markers such as plasma fasting blood glucose (FBG) and postprandial blood 
glucose (PBG), haemoglobin, haematocrit, and eosinophils, serum insulin, liver function tests, 
lipid profile, HbA1c levels. The different models gave consistent and statistically significant 
results. The ORs ranged from 0.44-0.52. PSI was reported by the study participants and 
confirmed by using hospital records. DM was defined according to WHO 1999 criteria. 
Furthermore, the study found a protective effect of PSI against metabolic syndrome (aOR 
0.40, 95% CI 0.27–0.58) by using the same five models. However, there were some 
potentially important confounding factors such as the age of study participants, the 
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consumption of alcohol, smoking status and self-reported physical activities were not able to 
be considered in the study. 
In Brazil, Mendonca and colleagues carried out a cross-sectional study (Mendonça et 
al., 2006) to determine the frequency of positive Strongyloides stercoralis serology in DM 
patients compared to healthy controls. They found that S. stercoralis seropositivity in the DM 
group (23%) was significantly higher (OR 3.9, 95% CI 1.6-15.9) then in the control group 
(7.1%). In this study, the diagnosis of strongyloidiasis was made by the detection of larvae in 
the stool as well as serodiagnostic test (ELISA) using the filariform larvae antigen. The study 
provided a positive association between S. stercoralis serology and DM and concluded that 
the S. stercoralis infection superimposes and put the DM patients at fatality risk, especially 
those with poor sugar control.  
Another cross-sectional survey conducted among aboriginal adults living in a remote 
community in northern Australia (Hays et al., 2015) was done to assess the relationship 
between infection with S. stercoralis and the likelihood of having type 2 DM. The diagnosis 
of DM was defined by HbA1c testing or being under DM treatment in the past. The 
serological diagnosis for S. stercoralis was performed by using ELISA. The study showed 
that 36% of participants showed prior infection with S. stercoralis and 51% of them had type 
2 DM. Those with previous S. stercoralis infection were 61% less likely to have a diagnosis 
of type 2 DM than those uninfected (OR 0.39, 0.23–0.67, P = 0.001). 51% in ≥ 0.2 value level 
OR 0.49, 95% CI 0.30-0.83, p = 0.007 and 57% in ≥ 0.4 cut-off value (OR 0.43, 95% CI 0.25-
0.75, p = 0.003) after adjusted for age, triglycerides, systolic blood pressure and BMI using a 
propensity score. These findings indicated that a S. stercoralis infection seemed to reduce the 
risk for a type 2 DM in adults although in the study community the prevalence was very high 
in all individuals, including the DM patients.  
To assess the predisposition of parasitic infections among DM population, Nazligul 
and colleagues conducted a cross-sectional study in southeastern Anatolia, Turkey (Nazligul 
et al., 2001). Collected fresh stool samples were investigated macroscopically and 
microscopically by native, lugol, and flotation methods. The study showed that non-DM 
participants had a higher prevalence of intestinal parasite infection compared to DM patients 
(55.9% vs. 47%). The prevalence rates of intestinal parasitic infections in DM patients were 
high for A. lumbricoides (57.5%) followed by T. trichiura (14.2%), Entamoeaba histolytica 
(13.3%), Giardia intestinalis (11.7%), and Taenia saginata or Hymenolepis nana (3.3%). 
Ascariasis was the most common parasitic infections in both groups. No statistically 
Chapter 5: Interaction between helminthic infections and diabetic mellitus: 
 Systematic review 
 
77 
 
significant differences were reported between the prevalence of the parasites and age groups 
as well as gender.  
To explore the prevalence of acquiring helminth infections and its associated risk 
factors in the DM patients, a cross-sectional study was done in Nigeria by Akibo and 
colleagues (Akinbo et al., 2013). With an overall prevalence of 18.7% of intestinal parasitic 
infections, however, none of non DM participants were infected. The study also showed DM 
status was significantly associated with intestinal parasitic infections (OR 14.19; 95% CI: 
0.842-239.22; p=0.022). The most frequent parasites were A. lumbricoides, hookworm, 
followed by E. histolytica among DM patients. The prevalence of infections was only 
significantly influenced by age groups and types of toilet used but not by the other variables. 
The types and duration of DM status don’t reveal any significant effect on the prevalence of 
infections.  
Bafghi and colleagues carried out a descriptive cross-sectional study among Iranian 
DM and non-DM participants to determine the frequency distribution of intestinal parasitic 
infections in diabetic patients (Fattahi Bafghi et al., 2015). The study indicated the intestinal 
parasites rate in diabetic patients was slightly higher compared to control group (24.4% versus 
23.2%). The most common parasites found in both groups were protozoa (G. intestinalis, 
Entamoeba coli, Cryptosporidium sp., Blastocystis hominis) and A. lumbricoides. In this 
article, the diagnostic methods of the parasitological examination were not clearly stated. Due 
to higher prevalence of protozoa infection, the author argued that even though the protozoa 
detection is not usually included in the routine stool examination, the standard diagnostic 
methods of protozoan detection should be considered especially for immunocompromised 
patients like DM.   
A similar cross-sectional study exploring the intestinal parasite prevalence rate of DM 
patients was performed in Sohag University hospital, Egypt (Elnadi et al., 2015). The stool 
smears were prepared with different standard methods of concentration for microscopy 
examination and blood HbA1c assessment was done to detect the DM status of research 
participants. The prevalence of intestinal parasites was 25% in diabetic group and 7% in 
healthy controls. There was a high prevalence rate in age group of less than 10 years old 
children, marked lower rate in 10-30 age groups and with a gradually increasing rate with 
ages, a highest prevalence rate was seen in 50 - 59 years old age group. The protozoa 
infections (G. intestinalis, E. histolytica and E. coli) with cestode infections (H. nana) were 
mostly diagnosed. Compared to type 1 and type 2 DM, 52% in type 1 compared to 16% with 
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type 2 were reported with a significant association (X2:11.1, p<0.001) between types of DM 
and intestinal parasites prevalence with type 1.The study also described that uncontrolled DM 
status was a risk factor for having higher prevalence rate of parasites and significant 
relationship in both type 1(p<0.007) and type 2 (p<0.01). 
Similarly, with a total cases of 150 diabetic patients and healthy control group of 85 
non-diabetic individuals were recruited to conduct a hospital based cross sectional study in 
Limbe and Buea Municipalities of Cameroon (Tangi  FB, 2016). The study also aimed to 
examine the prevalence and type of intestinal parasites among DM patients. The study showed 
the overall prevalence of intestinal parasites among diabetics was lower than the control group 
(10% vs 23.5%) with a protective association between intestinal parasitic infections and 
diabetic status (OR: 0.36; 95% CI: 0.17-0.75; p=0.005). The detected parasites were mostly E. 
histolytica along with B. hominis, A. lumbricoides, hookworm and C. parvum.  
The Table 2 summarizes the outcomes of the studies on DM in relation to different 
types of helminthic infections and the referred animal models. The concepts of conducting the 
epidemiological studies included in this review are based on animal models when NOD mice 
were infected with either S. mansoni or injection of soluble egg antigen (SEA) or soluble 
worm antigen (SWA) from this helminth species where the protection mechanism through 
immunomodulation against the DM especially type 1 has been clearly shown.  
5.5 Discussion 
This systematic review summarizes the current knowledge and epidemiological 
evidence, immunological and metabolic interaction of DM associated with different types of 
helminths. Most studies in this review confirm a negative association between helminthic 
infestations and DM. or they demonstrate that helminthic exposure contributes to a protective 
effect to the population from having DM either type 1 or type 2 (Aravindhan et al., 2010a, 
Aravindhan et al., 2010b, Soliman et al., 1996, Chen et al., 2012, Hays et al., 2015, Tangi  FB, 
2016, Nazligul et al., 2001). However, some other studies indicate that helminth infection may 
increase the severity of DM (Mendonça et al., 2006, Fattahi Bafghi et al., 2015, Akinbo et al., 
2013, Elnadi et al., 2015). The Danish study did not support the fact that common childhood 
enterobiasis infection protected against chronic inflammatory diseases (Bager et al., 2012). 
The strengths of this systematic review are firstly, it highlights the importance of 
complex helminthic interactions and immune modulations in chronic diseases like DM. 
Second, most of the studies were community based which a large number of research 
participants were recruited to avoid bias and the confounder adjustments such as age and sex 
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were carefully considered in the studies. Third, clear case definitions with laboratory and 
biochemical investigations of DM and helminthic infections and measures of association were 
well described in the studies. However, there are also limitations. This review is very confined 
to the published articles; the results of studies couldn’t identify the direct causal link between 
helminthic exposures and DM due to cross-sectional study design; poorly controlled of some 
unmeasured confounding factors in a few studies. Nevertheless, this review draws an attention 
on the complex immune mechanism between two diseases and any possible solutions or 
potential therapeutic agents to be considered.  
As helminths are also known for reducing energy overload of the body by taking up 
the nutrition and anti-inflammatory response, they protect the individuals from having 
atherosclerosis formation in the body. A study in Indonesia evidence that helminthic 
infections are negatively associated with the risk factors for atherosclerosis and cardiovascular 
disease, mediated by an effect on carotid media thickness, lipid levels, BMI and waist-hip 
circumference (Wiria et al., 2013). This finding is supported by another study that the 
individuals infected with chronic Opisthorchis felineus had lower levels of serum cholesterol 
and attenuated the atherosclerosis development (Magen et al., 2013). One step moving 
forward, that is pure, non-pathogenic helminth derived molecules or immunomodulators is 
another choice to avoid the pathological consequences of helminths. There are a number of 
therapeutic studies in which the different types of immunomodulators were used in different 
diseases in mouse models (Schnoeller et al., 2008, Bashi et al., 2015) but they have not yet 
been used in human beings because the interaction of immune system between mice and 
human are quite different and complicated. 
In past few years, a large amount of studies or clinical trials have been conducted to 
find out the possible drugs or alternative solution for treatment of DM. The studies have 
shown that chronic tissues inflammation is a critical factor in immune mediated diseases and 
anti-inflammatory drugs/therapy improves systematic insulin sensitivity in type 2 DM patients 
by reducing 0.37% of HbA1c level after 48 weeks (Goldfine et al., 2013) and in another 
study, treating the rheumatoid arthritis patients with anti TNF-α upgrades the insulin 
sensitivity (Esser et al., 2015). However, due to complicated inflammatory signals in insulin 
sensitivity, new diabetic therapies emphasizing on the specific inflammatory cytokines or 
receptors are still needed to have an effective clinical significance in type 2 DM patients. A 
substitute like probiotics has also been proved in many evidence based immune related 
research. The probiotic supplementation (Lactobacillus strains) in pregnancy and early life 
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relieve atopic sensitivity in infants (Elazab et al., 2013) and using probiotics in the first 6 
months of life decreases type 1 DM-associated autoantibodies in the children who have 
genetically high risk and only 2% prevalence at 24 months of age in the PRODIA study 
(Ljungberg et al., 2006) but the detailed immune mechanism of the probiotics is still 
debateable. Furthermore, there is evidence that the gut microbiota also shows a significant 
part in the regulation of glucose and lipid metabolism. Many studies in both animal and 
human models suggested that changes in the composition and metabolic function of the obese 
microbiota in obese individuals compared to lean controls extract more energy from the diet 
and interacts with host epithelial cells, leading to increased storage of fats and hepatic 
triglycerides leading to increased liver lipogenesis, hepatic insulin resistance and 
hyperinsulinaemia (Turnbaugh et al., 2006, Hartstra et al., 2015). As the microbiome and the 
helminths have the same characteristics in terms of interplaying with the nutrition and 
modulating the host immune system (Glendinning et al., 2014), micorbiome could also be an 
alternative option for the therapy of obesity and metabolic diseases including type 2 DM. 
Additional research with a proper understanding of environmental influences on the 
microbiota and the consequences of functional changes within microbiota on metabo-
inflammatory diseases and the impact on its host health are crucial.  
There is another interesting facet, namely the “fetal origins” hypothesis stating that a 
mother's metabolism during pregnancy which is influenced by maternal nutrition, infection 
status and underlying social factors such as maternal smoking determine the baby's size and 
increase risk of DM in childhood and early adult life (Harder et al., 2001). Many 
epidemiological studies have demonstrated the relationship between low birth weight and the 
later development of insulin resistance, type 2 DM, hypertension, hyperlipidaemia and 
cardiovascular diseases in both men and women across Europe, Asia, Africa and the USA 
(Newsome et al., 2003). This hypothesis could be applied assuming that if a pregnant mother 
has inadequate nutrition due to chronic helminthic infections, the offspring could have a lower 
weight at birth and a higher chance of getting insulin resistance or type 2 DM in adult life and 
this aspect of study is worthwhile to explore any possible association between maternal 
infectious status and its impact on health outcome of newborn for evidence based purpose.  
Nowadays, large-scale deworming programs are being introduced into tropical 
helminth endemic countries aiming to reduce the helminth related morbidity mainly for STH 
and to have a global elimination of a certain helminthic infection such as LF and 
schistosomiasis. This initiation of mass anthelminthic therapy is universally acceptable and 
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cost-effectiveness in controlling the helminth infections, however, on the other hand, it might 
produce an unwanted effect on immune-metabolism of the human beings. There is a cluster-
randomized placebo controlled trial in Indonesia examining the association of the helminthic 
infections with the insulin sensitivity and the protection mechanism of helminths are possibly 
diminished by anthelminthic treatment (Tahapary et al., 2015). The finding of this study is 
very relevant and important to the all helminth endemic countries which are currently under 
mass deworming programs.  
In summary, there are controversial scientific associations between helminth infections 
and DM status and different prevalence rates of parasitic infections among DM population. 
Additional epidemiological research are still required to identify the knowledge gap in 
learning which extent of helminthic infections could result how much effect on glucose or 
insulin metabolism in detail and also their advantages for therapeutic purposes. Community 
based, well designed with longer follows up or longitudinal studies with assessment of the 
fluctuations of specific cytokine and inflammatory mediator caused by a particular helminthic 
type in different country settings would be absolutely vital to identify the causal relationship 
between the helminthic infections and insulin sensitivity in type 2 DM.  
5.6 Conclusion 
This systematic review discovers the comprehensive updates of immunological and 
epidemiological interactions between helminths and DM covering from basic immuno-
cellular level to extensive metabolic pathways and the evidence of potential helminthic 
derived therapies is also thoroughly discussed. Aside from the divided findings of relationship 
between helminth infections and DM condition among the articles, in a case if helminthic 
infections regulate mechanisms of immune system in a good way, the administration of 
helminth derived immunomodulators or substitutes could still be a critical challenge in the 
treatment of DM due to the undesirable and pathogenic virulence effect of the helminths. On 
the other hand, the health care policy makers in the helminth endemic countries should be 
well prepared for the possible uprising of DM at a later time due to the consequences of 
deworming.  
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Figure 1: PRISMA flow diagram of helminths and diabetes mellitus 
 
Records identified through database 
(Medline)  
(n = 52,958) 
Sc
re
en
in
g 
In
cl
u
de
d 
El
ig
ib
ili
ty
 
Id
en
tif
ic
a
tio
n
 
Duplications and animal studies 
(n =34,691) 
Screened records  
(n = 18,267) 
Excluded Records with reasons 
(n=18,255) 
Studies with no associated 
factor: 8,171, Clinical case 
report: 3,653, Helminths 
immunology: 5,226, Overview/ 
report of helminths in a 
particular country situation: 
1,205 
Full-text articles assessed 
for eligibility  
(n = 12) 
Epidemiological studies (n= 12) 
(Studies related with type 1DM: 3, 
studies related with type 2 DM: 4, 
Studies with parasites and DM: 5 
Search terms: MeSH terms of 
helminths, parasitology, 
trematode, nematode and 
cestode infections, diabetes 
mellitus, type1 DM, type 
2DM, NIDDM, IDDM, insulin 
resistance  
Chapter 5: Interaction between helminthic infections and diabetic mellitus: 
 Systematic review 
 
89 
 
Table 1. Summary of the epidemiological studies of helminths and diabetes mellitus 
Year of 
publicatio
n and first 
Author 
Study design 
and setting Characteristics of the study population 
Measures of association: 
Odds ratio (OR) with 95% confidence 
intervals (CI) and p value) 
 
Hays et al 
(2015)  
 
 
Cross-
sectional study 
in Australia 
259 Aboriginal adults living in a remote community in northern 
Australia  
Data extraction: age, sex, date of testing, S. stercoralis ELISA titre, 
haemoglobin, total eosinophil count, percentage eosinophilia, height, 
weight, calculated BMI, diabetic status and HbA1 C Triglyceride level, 
HDL and total cholesterol. 
Diabetes: HbA1c ≥ 6.5% or greater, or RBS ≥ 11.1 mmol/l, or FBS ≥ 
7.0 mmol/l, or patients with past medical history of receiving diabetes 
treatment 
S. stercoralis serology testing: by ELIZA (The reference values: 0.3 
units of absorbance) 
92(36%): S. stercoralis infection  
131 (51%): T2DM. 
aOR = 0.39, 0.23–0.67, P = 0.001 (Those with 
previous S. stercoralis infection were 61% less 
likely to have T2DM than those uninfected, 
adjusted for age, triglycerides, blood pressure 
and BMI using propensity score ) 
Chen et al. 
(2012) 
 
Cross-
sectional 
population 
based study in 
Jiading 
County, 
Shanghai, 
China 
 
9939 individuals, both genders, ≥40 years and above 
 
Data collection 
Socio-demographics, medical history, and lifestyle factors, Weight, 
height, waist circumference, blood pressure, intensity, duration, and 
frequency of physical activity using International Physical Activity 
Questionnaire, separate metabolic equivalent hours per week  
Blood samples at 0 and 2 hours after 75-g oral glucose tolerance test 
using the glucose oxidase method, FBG,PBG 
Haematological parameters including haemoglobin,haematocrit, 
and eosinophils.  
Serum insulin, ALT, GGT, albumin, lipid profile, serum insulin 
concentration HbA1c level 
 
Previous Schistosoma Infection: self-reported medical history and 
validated by cross-referencing with the registry data generated during 
screening program in 1989 
 
Prevalence of PSI: 
0.05%in 40-49, 1.10% in 50-59, 8.89%in 60-69, 
17.85% in 70 years and above 
 
Prevalence of diabetes: 
18.04% the entire population and 24.25% in 
individuals aged 60 years and older (more than 
53% newly diagnosed diabetes) 
 
Prevalence of DM and metabolic syndrome in 
PSI group (14.9% vs 25.4%, P < .0001) 
compared with the non-PSI group (14.0% vs 
35.0%, P < 0.0001). 
 
Adjustment for insulin resistance: adjusted OR 
0.51, 95% CI 0.34–0.77, P = 0.0012 for diabetes;  
adjusted OR 0.40, 95% CI 0.27–0.58, P < .0001 
for metabolic syndrome 
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DM diagnosis (WHO 1999 criteria): 
(1) FBG ≥7.0 mmol/L or (2) PBG ≥11.1 mmol/L or (3) self-reported 
diagnosis of diabetes by physicians and use of antidiabetic medications.  
 
Metabolic syndrome: National Cholesterol Education Program Adult 
Treatment Panel III criteria; any 3 or more of the following conditions: 
(1) BP 130/85 mmHg or greater or taking antihypertensive drugs; (2) 
WC 102 cm or greater in men and 88 cm or greater in women; (3) TG 
1.69 mmol/L or greater; (4) HDL-C less than 1.03 mmol/L in men and 
less than 1.29 mmol/L in women; (5) FBG 6.1 mmol/L or greater or 
taking hypoglycemic medications. 
Insulin resistance: homeostasis model assessment of insulin resistance 
(HOMA-IR) higher than 2.50. 
 
Aravindhan 
et al (2010) 
Cross-
sectional in 
Southern India  
Study subjects from ongoing CURES epidemiological study, every 10th 
individual in Phase 1 participated (26,001 individuals from urban 
component of CURES). 
Details of the study participants using questionnaires and form 4 groups 
by randomly selected. 
Group 1- 943 NGT 
Group 2- 154 IGT 
Group 3- 158 NDDM 
Group 4- 161 KDM 
Anthropometric measurements (height, weight, and waist circumference, 
BMI, fasting plasma glucose, lipid profile and HbA1C by using 
standardized techniques. 
DM diagnosis: HbA1c level measurement 
Detection of Bancroftian LF antigen levels by Wuchereria bancrofti 
Og4C3 antigen-capture enzyme linked immunosorbent assay 
Determination of anti-filarial antibody titre (IgG and IgG4) against 
Brugia malayi antigen (BmA) by ELISA 
 
Determination of serum cytokine levels by using a Bioplex multiplex 
cytokine assay system 
Prevalence of LF: 
10.4% in the NGT, 9.1% in IGT, 5.7% in ND-
DM and 4.3% in KDM. The differences in the 
prevalence rate between NGT and KDM (p= 
0.0463) and NGT and ND-DM (p = 0.0095) were 
significant. 
Geometric mean of CFA levels: 
NGT-1,594 (127–32,768), IGT-1,520 (209–
16,345), NDDM-929 (129–32,768) and KDM-
351 (163–1,126) with the differences in the 
antigen levels between the KDM and the NGT 
(p= 0.04) and the KDM and the IGT (p = 0.04)  
The mean IgG levels: lower in the KDM 
compared to NGT (p=0.0023). 
In comparison to controls (DM-LF-), 
the diabetes only (DM+LF-) group had high 
levels of IL-6 and GM-CSF; (p=0.01) 
In DM+LF+subjects, there was a significant 
reduction in the levels of IL-6 (p=0.05)and GM-
CSF(p=0.05) compared to the diabetic only 
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group (DM+LF-).  
IFN-γ levels were significantly elevated in 
diabetic only group compared to controls. 
TGF-β was significantly higher in both the 
diabetic groups compared to controls (p=0.01).  
No significant difference in IL-10 levels among 
the three groups. 
Mendonc
aet al 
(2006)  
Cross-
sectional study 
in Brazil 
120 ambulatory patients (28-77 years; 78 type 2 diabetic and 42 healthy 
controls) from a strongyloidiasis hyperendemic area. Patients and 
controls with similar background and current socio-economic conditions 
 
DM diagnosis: Glycated haemoglobin (HbA1c) level 
 
S. stercoralis detection: Three faecal samples on consecutive days.  
Parasitological diagnoses were carried out using Baermann and 
Hoffmann method. 
Serology tests by IFAT, ELISA and WB 
 
The frequency of positive S. stercoralis serology 
in diabetes vs controls was 23% vs 7.1% (P < 
0.05). OR: 3.9 (CI, 1.6–15.9, P < 0.05). 
 
 
Aravindhan 
et al (2010)  
Cross 
sectional study 
in Southern 
India 
Total 762 (200 type 1 DM; 562 NGT) 
 
Type-1 DM diagnosis: the presence of lean body weight with 
hyperglycemia, ketonuria,and absence of insulin release by C-peptide 
assay <0.3 pg/mL and GAD–specific autoantibody levels ≥10 IU/mL) 
 
Controls: serum C-peptide values ˃0.3 pg/mL and were GAD 
autoantibody negative (from the Prevention Awareness Counseling and 
Evaluation project) 
 
Medical history, a physical examination, Anthropometric measurements, 
fasting plasma glucose, serum lipids, and glycated hemoglobin (HbA1C) 
estimations were obtained. 
 
Detection of Bancroftian LF: The filarial antigen levels and prevalence 
were analyzed by the Wuchereria bancrofti Og4C3 antigen-capture by 
The prevalence of LF was significantly different 
(p = 0.026) between NGT persons (2.6%) and 
those with T1DM (0%). 
 
Filaria-specific IgG4: lower in the T1DM group 
(2%) than in the NGT group (14%) ( p<0.001) 
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ELISA 
Determination of antibody titer to LF: IgG and IgG4 levels against 
Brugia malayi antigen was determined by ELISA as described. IgG titers 
>14 and IgG4 titers >100 were considered positive. 
 
Bager et al 
(2012)  
Danish cohort 
study  
A Danish cohort of 924,749 children born from January 1, 1995 through 
December 31, 2008 using the Civil Registration System, 
(n=924,749; age 0–14 years); 132,383 of these children (14%) filled a 
prescription for Mebendazole, 102,482 of the children (11%) had a 
household peer who was registered with a filled Mebendazole 
prescription, and the remaining 689,884 children (75%) comprised the 
reference group.  
 
Enterobius vermicularis infection: Any child with Mebendazole 
prescription 
 
Diagnosis of asthma, type 1 DM, juvenile arthritis, ulcerative colitis, 
or Crohn’s disease: from the National Patient Registry.  
 
The incidence rate ratios : 
Type 1 DM: 1.05 (95% CI: 0.79 –1.12),  
Juvenile arthritis: 1.13 (95% CI: 0.94 –1.37),  
Ulcerative colitis : 0.77 (95% CI: 0.41–1.46)  
Crohn’s disease: 1.44 (95% CI: 0.82–2.53) 
Asthma: 1.07 (95% CI: 1.00 –1.13), 
Soliman et 
al (1996)  
 
Cross- 
sectional study 
in Egypt 
(University of 
Alexandria 
Children's 
Hospital) 
94 (14 children with IDDM, 30 of the non-diabetic siblings of patients 
with IDDM, 40 children with chronic Mansoni schistosomiasis, and 10 
normal children) 
 
History-taking (age, nutrition, consanguinity of the parents, previous 
viral infections (measles, mumps, and rubella), and duration of IDDM or 
schistosomiasis), anthropometric data, height and weight, the stage of 
sexual maturation recorded according to Tanner's sex maturity rating 
system. 
Schistosoma infection: Viable schistosoma eggs in their freshly 
prepared faecal and/or urine samples. 
DM diagnosis: venous blood sample from all the children to measure 
ICA, blood urea and serum insulin-like growth factor-I, creatinine, 
alanine transferase, alkaline phosphatase, and bilirubin concentrations, 
OGTT and 2HPP, estimation of insulin concentrations by radio-
Prevalence of Islet Cell Antibody:  25 % in 
children with schistosomiasis, 13 % in diabetics' 
siblings, and 50 % in children with IDDM. 
 
OGTT:  normal in all the studied children.  
 
Five minutes after intravenous infection of 
glucose load: lower insulin increments in 
children with schistosomiasis compared to the 
other two groups. 
 
IGF-I concentrations: lower in children with 
schistosomiasis vs children in the other two 
groups. 
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immunometric assay after intravenous injection of glucose 
 
Bafghi et al 
(2015) 
Cross-
sectional study 
in Yazd, Iran 
250 diabetic patients and 250 healthy individuals with cluster random 
sampling in Yazd diabetes research centers from December 2012 to 
December 2013 
Parasitic infection detection: Stool samples under microscope  
DM diagnosis: known cases from diabetic research centers 
 
Higher intestinal parasites rate in diabetic 
patients (61:24.4%) than healthy control 
group (58:23.2%) 
 
Tangi et al 
(2016) 
Cross-
sectional 
hospital based 
study in 
Cameroon 
A total of 235 participants in the study 
 
DM diagnosis 
Cases: 150 diabetic patients who live in the study area and visit diabetic 
units in hospitals.   
Controls: Non-diabetic individuals in the study area (confirmed with 
random blood sugar level) 
 
Parasitological examination: Stool samples were analyzed by direct 
microscopy followed by modified ziehlnelsen method was used to detect 
intestinal protozoa. Stoll’s technique was used for the quantification of 
helminth eggs 
 
  
 
 
The overall prevalence of intestinal parasites 
among diabetic patients : 10% (Entamoeba 
histolytica 10(6.7%), 
Blastocysti shominis 4(2.7%), A. lumbricoides 
1(0.67%), Hookworm 1(0.67%) and 
Cryptosporidium parvum 1(0.67%)).  
An overall prevalence of intestinal parasites 
among controls: 23.5% (Entamoeba histolytica: 
18(21.2%), A. lumbricoides 2(2.4%), and  
Blastocystishominis 1(1.2%).  
A significant protective association with the 
prevalence of intestinal parasites (OR: 0.36, 
CI=0.17-0.75; p=0.0051) 
 
 
 
Akinbo et 
al (2013) 
Cross-
sectional study 
in Nigeria 
A total of 180 individuals were included in this study. 
DM diagnosis 
Cases: 150 (41 males and 109 females) DM patients attending clinics 
Controls: 30 (7 males and 23 females) non-DM individuals  
 
Parasitological examination: freshly collected stool samples were 
analyzed under microscope after preparing stool slides with standard 
methods. 
Blood examination: CD4 count with flow cytometry, Hb concentration 
An overall prevalence of of intestinal parasitic 
infections among DM patients: 18.7%  
DM status was significantly associated with the 
prevalence of intestinal parasitic infections 
(OR:14.192; 95% CI :0.842-39.22; 
p=0.022). 
Females have higher infection rates (78% vs. 
21.4%) 
Age group (51-60 yrs) and persons who use pit 
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with autoanalyzer to assess the status of anemia  latrines have highest prevalence rate of infection. 
Anemia is also associated with DM patients who 
had infection (OR:3.310; 95% CI:1.311- 
8.361;p=0.016) 
Elnadi et al 
(2015) 
Cross-
sectional 
hospital based 
study in Egypt 
A total of 200 participants aged 1-70 years (100 from hospital DM 
outpatient clinic, 100 cross matched controls) 
 
Parasitological examination 
All  fecal  samples  were  preserved  with  10% formalin and   
macroscopically  and  microscopically inspected  after preparing by 
simple  sedimentation,  simple floatation,  formalin-ethyl  ether  
sedimentation, Kato   thick   smear  with modified    Ziehl-Neelsen stein 
 
DM diagnosis: HbA1c assessment of blood (considered as normal range 
of 4% -5.9%) 
Infection prevalence rate 
Cases (25%) vs controls (7%) 
G. lamblia (22% vs. 5%) 
E. histolytica (7% vs. 3%) 
H. nana (5% vs. 3%) 
E. coli (8% vs. 3%) 
E. hartmanni (3%), D. 
D. Fragilis  (1%), 
Only in DM group: C. parvum (5%) and 
microsporidia (3%)  
Type 1 vs. type 2 
52% vs. 16% (X2: 11.1, p<0.001) 
 
Uncontrolled vs. controlled (type 1) 
40% vs. 26.4% (X2:7.2,p<0.007) 
 
Uncontrolled vs. controlled (type 2) 
32% vs. 8% (X2:5.46,p<0.01) 
Nazligul et 
al (2001) 
Cross-
sectional study 
in Sanliurfa 
province, 
Turkey 
A total of 1224 participants (200 (type 1:16, type 2:184) DM patients 
and 1024 non-DM subjects)) aged 15-79 years 
 
DM diagnosis: 26  with insulin therapy, 106 with oral antidia- 
betic agents, 21 with diet alone, and 47with no therapy 
 
Parasitological examination 
The stool samples were examined macroscopically, followed by mi- 
croscopic examination by native, lugol, and flotation methods. 
 
Infection prevalence rate 
Cases (47%) vs controls (55.9%) 
 
In DM groups, 
A. lumbricoides: 57.5%,,  
T.trichura: 14.2%  
E. histolytica: 13.3% 
G. intestinalis: 11.7% 
T. saginata or H.nana: 3.3%  
NGT: normal glucose tolerant; IGT: impaired glucose tolerant; NDDM: newly diagnosed type-2 DM subjects; KDM: known type-2 DM subjects 
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Table 2: The relationship of helminths and DM with animal models in research 
Helminth species Outcome on DM References 
Animal 
model References 
Wuchereria 
bancrofti 
Brugia malayi 
(lymphatic 
filariasis) 
Protective effect 
on type 1 DM 
Aravindhan 
et al (2010) 
Non-obese 
diabetic mice 
infected with 
S. mansoni 
soluble egg 
antigen 
Hubner et al 
(2009) 
Wuchereria 
bancrofti 
Brugia malayi 
(lymphatic 
filariasis) 
Protective effect 
on type 2 DM 
Aravindhan 
et al (2010) 
Non-obese 
diabetic mice 
infected with 
S. mansoni 
soluble egg 
antigen 
Hubner et al 
(2009) 
Enterobius 
vermicularis 
(enterobiasis) 
No association 
or not reduced 
risk for type 1 
DM 
Bager et al 
(2012) 
Non-obese 
diabetic mice 
infected with 
S. mansoni 
soluble egg 
antigen 
Liu et al 
(2009) 
Schistosoma  
(schistosomiasis) 
Protective effect 
on type 2 DM 
Chen et al. 
(2012) 
 
Non-obese 
diabetic mice 
infected with 
S. mansoni 
soluble egg 
antigen 
Zaccone et al 
(2003) 
Schistosoma 
mansoni 
(schistosomiasis) 
Lower islet cell 
antibody level 
and lower 
insulin 
impairment in 
type 1 DM 
Soliman et al 
(1996) 
NA NA 
Strongyloides 
stercoralis 
(strongyloidiasis) 
Positive 
association with 
type 2 DM 
Mendonca et 
al (2006) 
NA NA 
Strongyloides 
stercoralis 
(strongyloidiasis) 
Reduced 
risk for type 2 
DM 
Hays et al 
(2015)  
 
Non-obese 
diabetic mice 
infected with 
S. mansoni 
soluble egg 
antigen 
Cooke et al 
(1999) 
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6.1 Abstract 
Background:  As a result of epidemiological transition, the health systems of low- and 
middle-income countries are increasingly faced with a dual disease burden of infectious 
diseases and emerging non-communicable diseases. Little is known about the mutual 
influence of these two disease groups. The aim of this study was to investigate the co-
occurrence of helminth infections and diabetes mellitus in adults in Lao People’s Democratic 
Republic (Lao PDR).  
Methods:  We conducted a cross-sectional study among 1600 randomly selected adults aged 
35 and older from four different socio-economical and ecological provinces. Information on 
socio-demographics, risk factors and health conditions was obtained from personal interviews. 
Clinical assessments including anthropometry (height, weight, waist and hip circumference) 
and blood pressure measurements were also conducted. Diabetes was classified based on self-
reported diagnoses and a point-of-care glycated haemoglobin (HbA1c) test from finger prick 
blood samples. Stool samples for helminth diagnosis were examined with formalin-ether 
concentration technique for intestinal parasitic infections. The independent associations of 
helminth infections with diabetic status and HbA1c were assessed using multiple regression 
analyses. 
Results: The prevalence of pre-diabetes and diabetes was 37.3% and 22.8%, respectively. 
Fifty-six percent of diabetic cases were undiagnosed and 85% of diagnosed diabetic cases had 
poor glycemic control. Participants from rural areas and from southern parts of the country 
had higher infection rates, with Opisthorchis viverrini, being the most common helminth 
infection (30.5%). We found a positive association between Taenia spp. infections and 
HbA1c (β = 0.117; 95% CI: 0.042–0.200) and diabetes mellitus risk (OR = 2.98; 95% CI: 
1.10–8.05). No other helminth species was associated with glycated hemoglobin. 
Conclusions:  Hyperglycaemia and diabetic rates in Lao PDR are alarmingly high, but 
consistent with other high rates in the region. Given the high rates of under-diagnosis and 
poorly-controlled glycaemia in diabetes mellitus patients, routine diabetes screening and 
treatment is essential for the local healthcare system. Large longitudinal cohorts integrating 
biomarkers are warranted in the search of causal diabetes mellitus risk factors in the region. 
Common intestinal helminth infections, including O. viverrini, are unlikely to explain the high 
diabetes mellitus rates observed. 
Keywords: Dual burden of disease, Opisthorchis viverrini, Taenia, Diabetes mellitus, Cross-
sectional, Epidemiology, Adults, Lao PDR 
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6.2 Background 
Most low- and middle- income countries (LMICs) are faced with challenges arising 
from demographic aging and lifestyle changes along with economic development, resulting in 
an increasing prevalence of non-communicable diseases (NCDs). An estimated 415 million 
people are currently living with diabetes mellitus (DM) worldwide, and the number is 
estimated to increase to 642 million in 2040 (1). Similarly, the infectious disease (ID) burden 
in these countries also remains high. Approximately, 24% of the world’s population (more 
than 1.5 billion people) is infected with one or more species of helminth infections (2). The 
population of the Lao People’s Democratic Republic (Lao PDR) is affected by even higher 
rates of helminth infections, as a result of high rates of soil-transmitted helminths (STH) such 
as hookworm (87%), Trichuris trichiura (33%), Ascaris lumbricoides (3%) and Strongyloides 
stercoralis (45%)(3-6). Foodborne trematode infections are endemic in all provinces in Lao 
PDR, however rates are particularly high in the southern provinces and frequently reach 50% 
and above (7). In a study in the province of Saravane, the prevalence of Taenia spp. at the 
village level reached a prevalence of 12% (8). According to the World Health Organisation 
(WHO) Lao PDR country profile, 2016, the prevalence of DM in the total population is 
estimated at 5.6%, and is expected to increase considerably in the near future (9). 
Recent epidemiological discoveries have pointed to a potential role of helminth 
infections in the aetiology of diabetes. Many helminths have evolved to live in human 
organisms for long periods of time. The strategy against being expelled involves a cross-talk 
with human innate and adaptive immune responses, which may be mediated in part by 
alterations in the gut microbiome. The inverse relationship between helminth infections and 
risk of metabolic disorders has been named “metabolic hygiene hypothesis”, after the 
framework of the hygiene hypothesis for the association between early childhood infections 
and allergies. Furthermore, inflammation is an established etiological factor for insulin 
resistance, a precursor phenotype on the pathway to DM (10); however, the metabolic hygiene 
hypothesis has not been commonly tested. The objective of this study was therefore, to 
evaluate the epidemiological association of specific helminthic infections with glycaemia and 
DM in adults from the Lao PDR.  
6.3 Methods 
Study setting and sample size 
A total of 1600 adults aged 35 years and older were recruited in four areas of Lao 
PDR, each consisting of urban as well as rural sites from the provinces of Vientiane (the 
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Vientiane capital and Pakgneum district), Luang Prabang (LP city and Namback district), 
Saravane (Saravane city and Saravane district), and Champasack (Pakse city and Kong 
district), between March and April, 2016. Study subjects were randomly recruited among 
inhabitants if they had been living in the selected study areas for the last five years. We 
assumed a 20% parasitic infection rate in the study area. With 186 enrolled individuals the 
infection rate could be assessed with a 95% confidence interval (CI). We compensated for an 
expected non-optimal compliance by adding 10% to the sample calculated size. Therefore, 
200 persons were enrolled in each of the 4 study areas. Data collection took place in March‒
April 2016. All 1600 participants answered a questionnaire, had a clinical examination and 
blood taken through finger prick. They also provided two stool samples each. The data 
collectors were first year master students from the Francophone Institute for Tropical 
Medicine (IFMT), Vientiane, Lao PDR (today named International Program for Health in the 
Tropics, now integrated in the Lao Tropical and Public Institute [Lao TPHI] in Vientiane) 
who had undergone a rigorous training for each segment of data collection. 
Questionnaire and clinical information 
Each participant was assigned a specific six-digit identification number, reflecting the 
study site, the village and the household number. A semi-structured questionnaire was 
developed to collect information on socio-demographic factors, risk factors for chronic 
diseases, previous and current health problems, as well as knowledge and perception of 
diseases of interest for the study. The questionnaire was translated from English to the local 
language for the interviews.   
The clinical examination included a general assessment of the participant’s health 
status, including the measurement of arterial blood pressure, height, weight, waist and hip 
circumference, as well as haemoglobin and glycated haemoglobin (HbA1c) in capillary blood.  
Blood pressure was measured three times over an interval of five minutes between 
each reading using the Omron M6 AC (Hoofdoorp, Netherlands) upper arm digital blood 
pressure monitor. Participants were seated for 15 minutes before the blood pressure 
assessment and the mid-arm circumference was also measured  with the use of an appropriate 
semi-rigid preformed arm cuff. The mean systolic and diastolic blood pressure readings were 
noted.  
Height was measured using a SECA 206 roll-up measuring tape with wall attachment. 
(SECA GmbH & Co. KG, Hamburg, Germany)  The height was recorded in centimetres with 
one decimal. 
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Weight was measured using the non-automatic personal scale, SECA 877 (SECA 
GmbH & Co. KG, Hamburg, Germany). Participants were asked to take off shoes, coat and 
heavy clothes before being weighed. The weight was recorded with one decimal. 
Waist and hip circumference was measured using the SECA 203 measuring tape 
(SECA GmbH & Co. KG, Hamburg, Germany). The waist circumference measured was the 
area between the ribs and iliac crest, and the hip circumference was the maximum 
circumference between the iliac crest and the crotch. Measurements were recorded in 
centimetres with one decimal.  
Haemoglobin level was measured using the point-of-care anaemia screening, 
HemoCue Hb 301 System (HemoCue AB, Ängelholm, Sweden). Results were reported to the 
nearest 0.1 g/L.  
Glycated haemoglobin (HbA1c)/DM status assessment: HbA1c values reflect plasma 
glucose concentration over an eight to 12 weeks period before the measurement. It is a 
convenient screening test for diabetes as there is no fasting requirement. HbA1c concentration 
in blood obtained by a finger-prick test was measured using the point-of-care instrument 
Afinion AS 100 analyser and cartridges (Alere Inc. Waltham, Massachusetts, USA). The cut-
offs of the American Diabetes Association (11) were applied: normal: <5.7; pre-DM: 5.7‒6.4; 
and DM: ≥6.5. Subjects which self-reported a diagnosis and treatment of DM were classified 
as DM, irrespective of their HbA1c blood concentration. DM categories were further 
subdivided into diagnosed and treated DM; diagnosed DM, but untreated DM and 
undiagnosed DM. Newly diagnosed DM cases with HbA1c levels ≥6.5% were referred to a 
health clinic or hospital for confirmation of DM. 
Parasitological examination 
Two faecal samples were collected consecutively for two days for each participant and 
fixed in 10% formalin. The fixed samples were sent to the microbiology laboratory at Khon 
Kaen University, Khon Kaen, Thailand, in which, the formalin ether concentration technique 
(FECT) was used for helminth diagnosis.  
Data management and analysis 
Data was double-entered and subjected to validation checks using EpiData 3.1 
(EpiData Association, Odense, Denmark). A complete case analysis (individuals with stool 
samples, HbA1c results, and complete covariate information) was conducted to investigate the 
association of explanatory variables (helminths; covariates) with the outcome variable 
(HbA1c; DM) using STATA 14.1 (StataCorp; College Station, TX, USA). Descriptive 
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statistics of the  participants characteristics were reported as frequencies and percentages for 
categorical variables and means and standard deviations (SD) for continuous variables. The 
sex-stratified DM categories according to the measured HbA1c concentrations were cross-
tabulated with self-reported DM diagnosis and treatment. The helminth infection prevalence 
was stratified by study sites as well as the type of study area (rural vs urban). The distribution 
of covariates and helminth infections was presented separately for non-DM (non self-reported 
DM; normal HbA1c), pre-DM (non self-reported DM; pre-DM HbA1c), and DM groups (self-
reported DM diagnosis or diabetic HbA1c). The socio-economic status (SES) of participants 
was estimated using a household-based asset approach. SES scores were constructed using 
principle component analysis (PCA). Participants were categorized into three groups; poorest, 
second poorest and least poorest (12). Chi-square (χ2) tests and analysis of variance tests were 
conducted to investigate the unadjusted association between covariates and DM categories. 
Linear (outcome HbA1c measurements) and logistic (outcome DM status) regression models 
with random intercepts of study sites were performed to explore the independent relationship 
between helminth infections and HbA1c measurements and diabetes, respectively. 
Participants self-reporting a physician diagnosis of DM and medical DM treatment (N = 54) 
were excluded from these regression analyses. The regression models were adjusted for a set 
of preselected potential confounders (study sites, age, sex, educational level, SES status, 
alcohol consumption, smoking status, haemoglobin levels, body mass index [BMI] and 
physical inactivity). A two-sided P value <0.05 was considered as a statistically significant 
level.  
6.4 Results 
Among the 1604 participants, 1528 (95.3%) were considered in the analysis. The 
observed prevalence of pre-diabetes and diabetes was 37.3% and 22.8%, respectively (Fig 1). 
Table 1 summarizes the total and sex-stratified distribution of DM and pre-DM according to 
HbA1c levels, both, for the entire study sample and stratified by self-reported DM diagnosis 
and treatment. Among the total sample, 614 participants had HbA1c values in the normal 
range, in which, five self-reported DM; 585 in the pre-DM range, in which, 15 self-reported 
DM; and 329 in the DM range, in which, 135 self-reported DM. The distribution of DM 
categories did not differ considerably between males and females. Fifty-six percent (n = 194) 
participants from a total of 349 participants with DM were unaware of their disease (Fig 1). 
Among  the 155 participants self-reporting a DM diagnosis, only 39% (n = 61) reported some  
kind of treatment, while only 35% (n = 54) reported intake of physician-prescribed anti-
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diabetic treatment. In more than 85% of patients with self-reported DM, irrespective of 
undergoing treatment or not, HbA1c concentrations measured were still in the diabetic range. 
Table 1: Diabetes status according to HbA1c measurements, stratified by sex, self-
reported diabetes diagnosis and treatment status 
DM category according to HbA1c 
level1 
Total 
N (%) 
Male 
N (%) 
Female 
N (%) 
All study participants (N = 1528) 
Normal 614 (40.2) 183 (40.9) 431 (39.9) 
Pre-DM 585 (38.3) 165 (36.8) 420 (38.9) 
DM 329 (21.5) 100 (22.3) 229 (21.2) 
Mean (Standard Deviation)  6.4 (1.9)  6.4 (1.9) 6.4 (1.9) 
Self-reported DM cases (N = 155) 
Normal 5 (3.2) 3 (6.1) 2 (1.9) 
Pre-DM 15 (9.7) 3 (6.1) 12 (11.3) 
DM 135 (87.1) 43 (87.7) 92 (86.8) 
Self-reported  DM cases with any treatment (N = 61) 
Pre-DM 8 (13.1) 0 (0) 8 (17.0) 
DM 53 (86.9) 14 (100)  39 (83.0) 
Self-reported DM cases with a physician diagnosis and currently taking DM drugs 
(N = 54) 
Pre-DM 7 (13.2) 0 (0) 7 (17.1) 
DM 46 (86.8) 12 (100) 34 (82.9) 
1
 According to cut-offs of the American Diabetes Association [11]: Normal: <5.7; Pre-DM: 5.7‒6.4; DM: ≥6.5 
DM: Diabetes mellitus; HbA1c: Glycated haemoglobin 
Table 2 shows the prevalence of helminth infections stratified by rural and urban areas 
as well as by the four study provinces. Helminth infections were more frequent in rural areas 
compared to urban areas and in the two southern provinces compared to the two Northern 
provinces. The two southern provinces in Lao PDR and along the Mekong River (Saravane 
and Champasack) had overall infection rates of 49% and 44.9%, respectively, mostly due to 
O. viverrini (43% and 40%, respectively). In fact, O. viverrini was the most frequent 
trematode followed by minute intestinal flukes and Paragonimus spp. with prevalence rates of 
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30.5%, 6.3% and 0.3 %, respectively. The overall nematodes infection rates were 7.7% 
including hookworm (4.8%), S. stercoralis (2.6%), T. trichiura (0.5%) and A. lumbricoides 
(0.3%), respectively. We also found an infection rate of 2.2% for Taenia spp. 
Table 2: Prevalence (N, prevalence) of helminth infections in the study area 
1
 in each province participants from urban and rural sites were recruited 
Table 3 compares the characteristic of participants and helminth infection rates across 
DM status categories, defined by the combination of self-reported DM and HbA1c 
concentration. The mean age of participants was 54.9 years (SD: 12.0 years, range: 35‒95 
years), 70% were women, 50% lived in rural settings, 94% belonged to the Lao ethnic group, 
16% were illiterate and 31% belonged to the poorest category. With regard to lifestyle factors, 
32% reported to be ever smokers, 48% to be ever alcohol drinkers and 19% to be physically 
inactive. The mean waist circumference was 82.8 cm in men and 80.7 cm in women 
(recommended cut-off points for Asians: 90 cm in men and 80 cm in women)(13). The mean 
Hb concentration was 131.3 mg/dl in men and 119.1 mg/dl in women (WHO cut-off points 
for non-anaemic Hb values are ≥130 g/L (male); ≥110 g/L (female)). As expected, 
Helminth infections 
 
Total 
 
 
 
(N = 1528) 
Rural  
 
 
 
(n = 766) 
Urban  
 
 
 
(n = 762) 
Northern 
Province 
 
Vientiane1 
(n = 378) 
 
Northern 
Province 
 
(n = 363) 
Southern   
Province 
 
Saravane1 
(n = 396) 
Southern 
Province  
 
Champasack1 
(n = 391) 
Any infection 539 (35.3) 
332  
(43.3) 
207  
(27.2) 
113  
(29.9) 
58 
(16.0) 
193 
(48.7) 
175 
(44.8) 
Any trematode infection 473 
(31.0) 
286  
(37.3) 
187  
(24.5) 
108  
(28.6) 
34 
(9.4) 
174 
(43.9) 
157 
(40.2) 
Opisthorchis viverrini 466 (30.5) 
282  
(36.8) 
184  
(24.1) 
106  
(28.0) 
33 
(9.1) 
171 
(43.2) 
156 
(39.9) 
Minute intestinal flukes 96 (6.3) 
71 
(9.3) 
25  
(3.3) 
8 
(2.1) 
0 
(0) 
45 
(11.4) 
43 
(11.0) 
Paragonimus spp. 4 
(0.3) 
2 
(0.3) 
2 
(0.3) 
1 
(0.3) 
1 
(0.3) 
1 
(0.3) 
1 
(0.3) 
Any nematode infection 117 (7.7) 
87  
(11.4) 
30 
(3.9) 
5 
(1.3) 
26 
(7.2) 
52 
(13.1) 
34 
(8.7) 
Hookworm 73 (4.8) 
55 
(7.2) 
18 
(2.4) 
2 
(0.5) 
10 
(2.8) 
44 
(11.1) 
17 
(4.4) 
Strongyloides 
stercoralis 
40 
(2.6) 
28 
(3.7) 
12 
(1.6) 
2 
(0.5) 
12 
(3.3) 
9 
(2.3) 
17 
(4.3) 
Ascaris lumbricoides 4 (0.3) 
4 
(0.5) 
0 
(0.0) 
1 
(0.3) 
3 
(0.8) 
0 
(0) 
0 
(0) 
Trichuris trichiura 7 (0.5) 
5 
(0.7) 
2 
(0.3) 
0 
(0.0) 
4 
(1.1) 
2 
(0.5) 
1 
(0.3) 
Cestodes (Taenia spp.) 34 (2.2) 
25 
(3.3) 
9 
(1.2) 
12 
(3.2) 
3 
(0.8) 
13 
(3.3) 
6 
(1.5) 
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participants with DM were more likely to be older, to be of higher socio-economic status and 
to score higher on the anthropometric parameters including BMI, waist circumference, hip 
circumference and waist-hip ratio. Participants without diabetes exhibited the highest overall 
infection, with trematode and O. viverrini among this unadjusted comparison, whereas there 
was a tendency for Taenia spp. to be more common in subjects with DM.  
Table 3: Participants characteristics according to DM categories (N = 1528) 
Covariates 
Total 
(N, %) 
Categories of DM (N, %)1 *P-
value 
 
No DM 
(n = 609) 
Pre-DM 
(n = 570) 
DM 
(n =349) 
Age <0.001 
35‒49 years 535(35.0) 303(49.7) 163(28.6) 69(19.8)  
50‒60 years 534(34.9) 177(29.1) 199(34.9) 158(45.3)  
61‒95 years 459(30.1) 129(21.2) 208(36.5) 122(34.9)  
Mean, SD    54.9(12.0) 
Female (%) 1080(70.7) 429(70.4) 408(71.6) 243(69.6) 0.83 
Rural (%) 766(50.1) 322(52.9) 276(48.4)  168(48.1) 0.12 
Ethnicity (Lao) 1438(94.1) 564(92.6) 540(94.7) 334(95.7) 0.59 
Education  0.05 
Illiterate  247(16.2) 80(13.1) 105(18.4) 62(17.8)  
Primary level 719(47.0) 286(47.0) 270(47.4) 163(46.7)  
Secondary level 562(36.8) 243(39.9) 195(34.2) 124(35.5)  
Socio-economic status  0.002 
Poorest 505(33.1) 219(36.0) 199(34.9) 87(24.9)  
Second least poorest 514(33.6) 208(34.1) 186(32.6) 120(34.4)  
Least poorest 509(33.3) 182(29.9) 185(32.5) 142(40.7)  
Ever smokers  491(32.1) 196(32.2) 177(31.1) 118(33.8) 0.64 
Ever alcohol drinkers 733(48.0) 354(58.1) 244(42.8) 135(38.7) <0.001 
No physical activity  288(18.8) 112(18.4) 122(21.4) 54(15.5) 0.13 
Weight (kg; mean, SD)  58.1(11.9) 55.6(11.0) 58.3(11.8) 61.9(12.5) <0.001 
Height (cm; mean, SD) 153.6(7.2) 153.8(7.1) 153.0(7.1) 154.0(7.4) 0.08 
BMI (kg/m2; mean, SD) 24.6(4.5) 23.5(4.1) 24.8(4.5) 26.0(4.5) <0.001 
Hip circumference (cm; 93.2(10.0) 91.0(9.7) 94.1(10.0) 95.8(9.7) <0.001 
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mean, SD) 
Waist circumference 
(cm; mean, SD) 
81.2(11.8) 77.4(10.8) 82.3(11.7) 86.5(11.2) 0.12 
Waist-hip ratio (mean, 
SD) 
0.87(0.07) 0.85(0.06) 0.87(0.06) 0.90(0.06) <0.001 
Hb concentration 
(mg/dl; mean, SD) 
122.7(17.8) 122(18) 123(18) 125(18) 0.04 
Helminth infections 
Any infection 513(33.6) 224(36.8) 189(33.2) 100(28.7) 0.04 
Any trematode 
infection 
473(31.0) 211(34.6) 175(30.7) 87(24.9) 0.03 
Opisthorchis viverrini 466(30.5) 207(34.0)       169(29.6)      90(25.8) 0.03 
Minute intestinal flukes 96(6.3) 37(6.1) 41(7.2) 18(5.2) 0.62 
Paragonimus spp. 4(0.3) 1(0.2) 2(0.3) 1(0.3) 0.82 
Any nematode 
infection 
117(7.7) 51(8.4) 49(8.4) 17(4.9) 0.16 
Hookworm 73(4.8) 34(5.6) 25(4.4) 14(4.0) 0.23 
Strongyloides 
stercoralis 
40(2.6) 13(2.1) 21(3.7) 6(1.7) 0.15 
Ascaris lumbricoides 4(0.3) 2(0.3) 2(0.3) 0(0.0) 0.56 
Trichuris trichiura 7(0.5) 4(0.7) 3(0.5) 0(0.0) 0.34 
Cestodes/Taenia spp. 34(2.2) 10(1.6) 11(1.9) 13(3.7) 0.08 
* P-value comparing the distribution of the respective factor between DM categories 
1
 categorization based on a positive self-report of DM diagnosis and otherwise based on the HbA1c 
concentrations 
DM: Diabetes mellitus 
Table 4 shows the independent associations of infection groups and single infections 
with HbA1c in the study population after exclusion of subjects with physician-diagnosed and 
treated DM. Results are presented with and without adjustment for BMI and physical 
inactivity, which may in part be mediators of the association between helminth infections and 
HbA1c. Positive associations between Taenia spp. infections and HbA1c were observed, in 
both, models containing infection groups of single infections and models with and without 
adjustment for BMI and physical activity (largest effect estimate in model of infections 
groups and adjusting for BMI and physical activity: β = 0.117; 95% CI: 0.042‒0.200). 
Interestingly, this positive association seems to be driven by an association with HbA1c in the 
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diabetic  range. In healthy subjects without pre-DM or DM, we found an inverse relationship 
between Taenia spp. and HbA1c measurements (β = -0.049; 95% CI: -0.075‒0.022) 
(Additional file 1). No association of HbA1c with any other infection or infection group was 
observed.  
Table 4: Independent association of single infections and infection groups with HbA1c in 
all participants 
 
Infections 
Adjusted for other infections, 
study site, age, sex, SES status, 
education status, smoking status, 
alcohol consumption and 
haemoglobin level 
Additionally adjusted for BMI 
and physical inactivity 
β 95% CI β 95% CI 
Grouped infections2 (N = 1474) 
Nematodes -0.040 -0.081‒0.002 -0.035 -0.076‒0.006 
Trematodes -0.003 -0.027‒0.021 -0.0003 -0.023‒0.024 
Cestodes 
Taenia spp. 
0.112 0.037‒0.188 0.117 0.042‒0.200 
Single infection3 (N = 1466) 4 
Hookworm -0.030 -0.083‒0.021 -0.025 -0.076‒0.027 
Opisthorchis 
viverrini 
-0.009 -0.035‒0.017 -0.002 -0.025‒0.022 
Minute intestinal 
flukes 
0.021 -0.028‒0.069 0.011 -0.034‒0.056 
Strongyloides 
stercoralis 
-0.043 -0.128‒0.014 -0.046 -0.116‒0.024 
Trichuris trichiura -0.043     -0.202‒0.115 -0.063 -0.220‒0.094 
Taenia spp. 0.114 0.039‒0.190 0.116 0.042‒0.192 
1Participants excluding participants self-reporting a physician-diagnosis of DM and intake of DM medication   
2Model including infection groups nematodes (yes vs no), trematode infection (yes vs. no), and cestodes (yes vs 
no) 
3Model including single infections hookworm (yes vs no), O. viverrini (yes vs no), minute intestinal flukes (yes 
vs no),  Strongyloides stercoralis (yes vs no), Trichuris trichiura (yes vs no) and Taenia spp./cestodes (yes vs 
no) 
 
4Subjects with other rare types of infections were excluded from this analysis. 
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CI: Confidence interval 
 
Table 5 shows the independent associations of single helminth infections with DM compared 
to non-DM after excluding subjects with a self-reported physician diagnosis of  DM and 
intake of DM medication, and leaving the pre-DM category out. Results are again presented 
with and without adjustment for BMI and physical inactivity. Consistent with our findings on 
the infection-HbA1c associations, we found that having a Cestode infection, but not any other 
infections was associated with an increased risk of DM (Adjusted OR = 2.98, 95% CI: 1.10–
8.05). The independent association of other factors with DM risk in the expected directions 
validate the assessment of DM and HbA1c: age (OR = 1.05, 95% CI: 1.04–1.08), being male 
(OR = 1.42, 95% CI: 0.89–2.00), highest socio-economic status (OR = 1.70, 95% CI: 1.08–
2.67),  ever smoker (OR = 1.89, 95% CI: 1.22–2.92), and exhibiting high Hb concentration 
(OR = 1.02, 95% CI: 1.15–1.25), and high BMI (OR = 1.20, 95% CI: 1.15–1.25). 
Interestingly, self-reported alcohol consumption (OR = 0.54, 95% CI: 0.38–0.76) was 
inversely associated with DM risk. These results did not substantially change when pre-DM 
and DM were jointly compared to the pre-DM or DM group (Additional file 2).  
 
  
Table 5: Independent association of single infections with DM compared to non-DM, with and without adjustment for BMI and  
physical inactivity in all participants (N = 8921) 
DM status compared to Normal2 OR3 95% CI P-value  OR4 95% CI P-value 
Hookworm 0.79 0.36‒1.72 0.56 0.94 0.42-2.10 0.88 
Opisthorchis viverrini 0.76 0.52‒1.10 0.15 0.87 0.58‒1.28 0.46 
Minute intestinal flukes 1.38 0.68‒2.78 0.37 1.20 0.57‒2.52 0.63 
Strongyloides stercoralis 0.65 0.19‒2.30 0.51 0.65 0.15‒2.72 0.55 
Trichuris trichiura 1.00  Omitted  1.00 Omitted  
Taenia spp. 2.59 0.98‒6.87 0.06 2.98 1.10‒8.05 0.03 
Study sites(Vientiane as reference) 
Lung Prabang 0.75 0.47‒1.20 0.24 0.80 0.48‒1.31 0.37 
Saravane 0.74 0.47‒1.28 0.32 0.89 0.52‒1.51 0.66 
Champasack 0.76 0.48‒1.20 0.24 0.85 0.52‒1.39 0.53 
Socio-economic status(Poorest as reference) 
Second least poorest 1.51 1.00‒2.27 0.04 1.30 0.84‒1.99 0.24 
Least poorest 2.16 1.42‒3.31 <0.001 1.70 1.08‒2.67 0.02 
Age 1.05 1.04‒1.07 <0.001 1.05 1.04‒1.08 <0.001 
Gender (Male) 1.64 1.05‒2.56 0.03 1.42 0.89‒2.27 0.14 
Education(Illiterate as reference)  
Primary 0.92 0.57‒1.47 0.72 0.71 0.43‒1.18 0.19 
Secondary 0.85 0.49‒1.45 0.55 0.69 0.39‒1.21 0.20 
Ever smokers 1.53 1.01‒2.32 0.04 1.89 1.22‒2.92 0.004 
Ever alcohol drinkers 0.54 0.38‒0.76 <0.001 0.48 0.33‒1.03 <0.001 
Hb concentration 1.02 1.01‒1.03 <0.001 1.02 1.01‒1.03 0.002 
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+ BMI - - - 1.20 1.15‒1.25 <0.001 
+ Physical activity - - - 1.19 0.76‒1.87 0.45 
1
 Subjects with pre-DM and participants self-reporting a physician diagnosis of DM and intake of DM medication and with other rare types 
 of infections were excluded from this analysis 
2
 Categorization based on a positive self-report of DM diagnosis and otherwise based on the HbA1c concentrations  
3
 Mutually adjusted for variables listed 
4
 Additionally adjusted for BMI and physical inactivity 
CI: Confidence interval; OR: Odd ratio; BMI: Body mass index; DM: Diabetes mellitus 
 
  
6.5 Discussion 
We found alarmingly high rates of DM and pre-DM in this adult study population in 
Lao PDR. Local population-based HbA1c findings for comparison are not available in Lao 
PDR, however, the prevalence found in this study is consistent and comparable to that of the 
province of Guangdong, an economically well-developed and urbanized area in Southern 
China, in which the prevalence is 22% (14). The study in China estimated the diabetes 
prevalence based on a combination of self-reported DM, HbA1c measured in capillary finger-
prick blood as well as venous blood fasting glucose and glucose tolerance testing. This 
suggests that the observed DM prevalence in Lao PDR, may even be higher than reported here 
as adding glucose to the DM screening tests results in the identification of additional cases 
(14, 15). The high pre-DM and DM rates with a tendency for earlier onset in Asian 
populations remain partly unexplained (16). According to the results of this current study 
common helminth infections in Lao PDR may not explain the high DM and pre-DM 
prevalences.  
The current findings on the prevalence and distribution of helminth infections are 
consistent with previous studies in Lao PDR. Multiple helminth infections of different 
trematode, nematodes and cestode species were also common as documented in previous 
literature (17-20). The high prevalence rates of the trematode infection, particularly with O. 
viverrini, is consistent with previous studies (21). Minute intestinal flukes and hookworm 
were also very frequently diagnosed. These helminths are generally more common in Lao 
PDR and the Mekong sub-region (19, 22). In our study we found 2.2% participants infected 
with Taenia spp., which is in general a rather high rate but comparable to previous 
observations from our team (23). The national deworming program from the Ministry of 
Health implements biannual treatment of soil-transmitted helminths in school-children in 
collaboration with the ministry of education. In recent years, several rounds of mass-treatment 
were conducted with praziquantel in selected districts of Southern Lao PDR. While these 
control measures have had a considerable impact on the infection rates of soil-transmitted 
helminths, the prevalence of liver fluke infections were not reduced.  
We have previously reported highly prevalent liver pathologies in rural Lao PDR, as 
documented by an ultrasound-based study in Saravane province, one of the current study areas 
(24). We associated severe liver morbidity with O. viverrini (21), known to be a main risk 
factor for cholangiocarcinoma (25, 26). The absence of an association between O. viverrini 
infection and DM risk, suggests that O. viverrini related liver pathology may not contribute to 
DM development and the high rate of hyperglycaemia. In contrast, fatty liver disease, 
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especially non-alcoholic fatty liver disease, is viewed as hepatic manifestation of the 
metabolic syndrome, is associated with insulin resistance, and was previously found to be an 
independent predictor of incident type 2 DM (27), due to chronic inflammation of the liver or  
hepatokine secretion. Fatty liver disease and O. viverrini associated liver pathology are 
different entities, which can in principle be differentiated by ultrasound, but the histological 
examination of liver biopsies remains the diagnostic gold standard. The independent and 
combined effects of O. viverrini infections, associated liver pathologies and fatty liver disease 
on incident DM need further investigation as the interactions are likely complex and possible 
in opposite directions. Future studies should also consider O. viverrini related modifications 
of the gut microbiome given the strong evidence for its relation to type 2 DM (28, 29). 
Both HbA1c and DM status were positively associated with Taenia spp. infection. 
Taeniasis is an intestinal parasitic infection and is acquired by the consumption of raw or 
undercooked meat (pork or beef) (30). It is common in developing countries of Latin 
America, Asia, and Africa, and associated with poor hygienic and sanitary conditions 
(inadequate use of latrines or open-air defecation, traditional pig farming, lack of regulation 
on meat inspection and inadequate water supply) (30). Taenia spp. infection is listed as one of 
the 17 neglected zoonotic diseases by WHO, which can be preventable and treatable. 
Individuals with intestinal Taenia infection are usually asymptomatic. T. solium is the cause 
of cysticercosis if parasite eggs are faecal-orally acquired. Cysticercosis may lead to a severe 
disease, particularly if the central neural system (neuro-cysticercosis) is affected (31). There 
was no diagnosis of cysticercosisin our study sample. . All taeniasis patients in our study had 
a history of raw meat consumption (92% beef and 32% pork). People infected came mostly 
from rural areas of Vientiane and Saravane provinces. Co-infections with other helminths 
were also detected in half of Taenia sp. infected individuals, mostly with O. viverrini and/or 
minute intestinal flukes, hookworm and S. stercoralis. One study examining the effect of 
immune modulation induced by Taenia crassiceps infection on the outcome of multiple low 
dose of Streptozotocin-induced diabetes (MLDS) reported that T. crassiceps infection might 
protect against MLDS, irrespective of the host’s genetic background. To the best of our 
knowledge, this is the first study to report an association between Taenia sp. infection and 
DM as well as HbA1c.  
A limited number of studies have started to explore the interrelation between helminth 
infections and diabetes. Endemic helminth infections are thought and in part shown to affect 
insulin sensitivity and resistance through immune-modulating properties and by reducing 
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energy intake and altering energy balance (32). Yet, epidemiological evidence remains poor, 
and inconsistent, and points to infection-specific associations with DM. Some previous 
studies have reported a negative association between soil-transmitted helminth infections and 
insulin resistance (33), between filarial infection and type 1 and type 2 DM (34), and between 
Schistosoma japonicum infections and  type 2 DM (35). An infection with S. stercoralis was 
found positively associated with severe DM (36). We reported a positive association of H. 
pylori infections with HbA1c in school children from poor neighbourhoods in South Africa, 
but neither a cross-sectional association with other common helminth infections nor a change 
in HbA1c as a result of anti-helminthic treatment (37). It has been shown that socioeconomic, 
environmental and behavioural factors influence the prevalence and intensity of helminth 
infections and could therefore, in part, be confounders as well as mediators of any association 
with diabetes (18, 38). It is thus, important to consider the recently published results from the 
first randomized placebo-controlled SUGARSPIN trial, investigating the effect of 
anthelmintic treatment on whole-body insulin sensitivity in a large Indonesian population 
sample (39). Albendazole treatment had no effect among participants without any or only a 
single species helminth infection measured (hookworm [Ancylostoma duodenale, Necator 
americanus]; A. lumbricoides; T. trichiura; Strongyloides stercoralis), but resulted in high 
homeostatic model of insulin resistance, a measure of insulin resistance, in the presence of 
multiple species infection at baseline. No effect on HbA1c was observed, though.  
Our study has a number of strengths. First, this is the only study to date assessing DM 
prevalence in Lao PDR, based on Hba1c measurements. Participants from the rural and urban 
area of the provinces located in the middle and southern part of the country were included; 
therefore, the findings reflect the prevalence of helminths and DM status of different 
populations from different geographical settings. Access to curative health services is very 
low in rural settings. Therefore, our results underline the needs for peripheral curative health 
services for DM diagnosis and management. Second, no previous study investigated the dual 
burden of diseases of DM and helminth infections in adults in Lao PDR. In fact, this is the 
first time the association of O. viverrini infection with DM was investigated. Third, we used 
an internationally certified HbA1c test, which was able to capture most of the previously 
diagnosed DM cases. The HbA1c point-of-care method applied was validated for use in hot 
and remote low-income settings in the context of our previous study in South Africa (37). The 
validity of our HbA1c findings is further supported by their positive association with 
validated DM risk factors such as age, BMI and smoking. Finally, to achieve a satisfactory 
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sensitivity for the helminth diagnosis, we examined two stool samples per person, which is 
known to increase the sensitivity (40). 
There are however, some limitations in our study. It is known that T. solium, T. 
saginata and T. asiatica are endemic in Asia (41). In our study, we did not distinguish the 
Taenia species, and hence could not study the species specific associations with HbA1c in the 
blood. Moreover, due to the cross-sectional nature of our study, we were not able to identify 
the time-course relationship between infections and DM development. Reverse causation is a 
concern as DM patients have an increased susceptibility to infections due to their immune 
dysfunction (42). The observed association between Taenia spp. and HbA1c could therefore 
be real, a chance finding, explained by confounding or due to reverse causation. Finally, we 
could not rule out other associated infectious or non-infectious conditions of study 
participants, which might influence the blood glucose levels and confound, modify or mediate 
the observed infection-DM associations. Multi-parasitism is very common in different 
provinces in Lao PDR and a significant association has been observed between S. 
mekongi and hookworm in Southern Lao PDR (23), as well as between S. mansoni and 
hookworm in Côte d'Ivoire (43). Since each parasite has a different effect on blood sugar, 
energy balance, and immunity, co-infections status may play an important role in studying 
dual disease burden. 
6.6 Conclusions 
Our study found an alarmingly high level of uncontrolled hyperglycaemia in both, 
urban and rural Lao PDR. These results are not consistent, with a strong role of common 
infections, such as O. viverrini, explaining the high diabetes burden observed. Larger and 
longitudinal studies including biomarkers and liver ultrasounds are warranted to further 
study the causes of DM in Lao PDR. The Lao PDR health system must work on 
strengthening its healthcare services in the domain of DM screening and treatment.  
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#categorization based on a positive self-report of DM diagnosis and otherwise based on the HbA1c 
concentrations 
*subjects self-reporting a physician diagnosis and taking DM medication were excluded from multivariable 
regression models on the association between infections and HbA1c or DM 
DM: Diabetes mellitus 
Fig 1: Flow chart of the study sample and distribution of pre-diabetes and diabetes 
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7.1 Abstract 
Background: Low- and middle-income countries are facing a dual disease burden with 
infectious diseases (e.g., gastrointestinal tract infections) and non-communicable diseases 
(e.g., diabetes) being common. For instance, chronic parasite infections lead to altered 
immune regulatory networks, anemia, malnutrition, and diarrhea with an associated shift in 
the gut microbiome. These can all be pathways of potential relevance for insulin resistance 
and diabetes. The aim of this study was to investigate the association between common 
gastrointestinal tract infections and glycemia in children from non-fee paying schools in 
South Africa. 
Methodology: We conducted a cross-sectional survey among 9- to 14-year-old school 
children in Port Elizabeth. Stool and urine samples were collected to assess infection status 
with parasitic worms (e.g., Ascaris lumbricoides, Enterobius vermicularis, and Trichuris 
trichiura), intestinal protozoa (e.g., Cryptosporidium parvum and Giardia intestinalis), and 
the bacterium Helicobacter pylori. Glycated hemoglobin (HbA1c) was measured in finger 
prick derived capillary blood. All children at schools with a high prevalence of helminth 
infections and only infected children at the schools with low infection rates were treated with 
albendazole. The association of anthelmintic treatment with changes in HbA1c 6 months after 
the drug intervention was also investigated. 
Findings: A high prevalence of 71.8% of prediabetes was measured in this group of children, 
with only 27.8% having HbA1c in the normal range. Helicobacter pylori was the predominant 
infectious agent and showed an independent positive association with HbA1c in a 
multivariable regression analysis (β=0.040, 95% confidence interval (CI) 0.006-0.073, 
p<0.05). No association of HbA1c with either any other infectious agent or albendazole 
administration was found.  
Conclusion: The role of H. pylori in diabetes needs confirmation in the context of 
longitudinal treatment interventions. The specific effect of other gastrointestinal tract 
infections on glycemia remains unclear. Future studies should integrate the measurement of 
biomarkers, including immunological parameters, to shed light on the potential mediating 
mechanisms between parasite infections and diabetes. 
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7.2 Author summary 
Parasitic worms (e.g., pinworm, roundworm, and whipworm), intestinal protozoa (e.g., 
Cryptosporidium parvum and Giardia intestinalis), and the bacterium Helicobacter pylori 
persist at high rates in the gastrointestinal tract of people from low- and middle-income 
countries. These infectious agents are increasingly paralleled by high rates of non-
communicable diseases (NCDs), such as diabetes. We studied the association of glycemia, 
measured as HbA1c with common gastrointestinal tract infections among school children 
aged 9-14 years from disadvantaged neighborhoods in Port Elizabeth, South Africa. Our goal 
was to deepen the understanding of whether specific gastrointestinal tract infections might be 
early life determinants of elevated HbA1c levels that might lead to diabetes. We found that 
the bacterium H. pylori was very common among our group of children with a positive 
association with hyperglycemia. None of the other infectious agents showed such an 
association. Additional, longitudinal studies are needed to determine whether there is 
causality for the observed association between H. pylori and hyperglycemia. The integration 
of biomarkers will allow studying mediating mechanisms.  
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7.3 Introduction 
In low- and middle-income countries (LMICs), the dual disease burden stemming 
from infectious diseases (IDs) and non-communicable diseases (NCDs) poses a challenge to 
population health and the health systems. Soil-transmitted helminths and schistosomes are 
estimated to infect over a billion individuals in LMICs [1, 2] and cause abdominal pain, 
diarrhea, poor cognitive development, malnutrition, and anemia. As a consequence of such 
symptoms, school and work performance is affected and physical activity levels compromised 
[3]. Helminthiases are often chronic, a result of both under-treatment and re-infection. Soil-
transmitted helminthiasis, schistosomiasis, and intestinal protozoa infection are intimately 
connected with poverty, partially explained by lack of clean water, sanitation, and hygiene 
[4]. 
NCDs are gaining importance, also in LMICs [5]. For example, the frequency of diabetes 
mellitus (DM) is rising worldwide, and South Africa is among the top five countries in Africa 
with an estimated DM prevalence of 9.2% [6]. This can be attributed primarily to aging, 
population growth, increasing rates of unhealthy dietary habits, a sedentary lifestyle, and 
obesity. While NCDs and DM particularly affect older people, it is generally accepted that 
early life exposures contribute to the accumulation of molecular damage and a higher disease 
risk later in adulthood [7]. 
Little is known about how common parasite infections affect glucose homeostasis and 
DM etiology, particularly at young age. It is conceivable that parasite infections influence the 
DM risk through different pathways and in opposite directions [8]. On the one hand, parasite-
induced alterations of immune regulatory networks, which have evolved to prolong survival 
in the human intestines, may stimulate anti-inflammatory pathways and decrease the risk of 
obesity-induced insulin resistance. Malnutrition, diarrhea and, as a result, low body weight 
related to chronic helminth infections may additionally decrease DM risk. On the other hand, 
a sedentary lifestyle and anemia have the potential to increase DM risk. Additionally, the 
mediating role of helminth-induced shifts in the gut microbiome composition remains to be 
determined [9]. 
A limited number of recently reviewed epidemiologic studies with inconsistent results 
investigated the cross-sectional association of different IDs, including lymphatic filariasis [10, 
11], schistosomiasis [12], strongyloidiasis [13, 14], and soil-transmitted helminthiasis [15, 16] 
with DM or insulin sensitivity. In the present study, we followed up on these observations by 
studying the association of gastrointestinal tract infections due to helminths, intestinal 
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protozoa, and the bacterium Helicobacter pylori with glycated hemoglobin (HbA1c) 
concentration in school children in the frame of the “Disease, Activity and Schoolchildren’s 
Health” (DASH) study in Port Elizabeth, South Africa [3, 17]. The study provided detailed 
information on physical activity, fitness, and socioeconomic status (SES) to consider as 
confounding factors on gastrointestinal tract infection status, and intensity of helminth 
infections to study a possible dose-response relationship; and on the longitudinal course of 
HbA1c upon selective anthelmintic treatment. 
7.4 Methods 
Ethics statement 
Ethics approval was obtained from ethics committees in both Switzerland (EKNZ; 
reference no. 2014–179, approval date: 17 June 2014), and South Africa (study number H14-
HEA-HMS002, approval date: 4 July 2014). Written informed consent from the 
parents/guardians of participating children as well as oral assent from the children were 
obtained prior to data collection. 
Study setting and design 
A total of 1,009 grade 4 children aged 9-14 years from eight non-fee paying primary 
schools were recruited in various parts of Port Elizabeth in the south-eastern part of South 
Africa, as described before [3, 17]. The study was part of the 2-year longitudinal DASH study 
that consisted of three cross-sectional surveys. In each of the cross-sectional surveys, 
children’s gastrointestinal infections and other health parameters were assessed, including 
HbA1c, anthropometry, levels of physical fitness, cognitive performance, and psychosocial 
health. After each survey, helminth-infected children were treated with a single 400 mg oral 
dose of albendazole. In schools were the prevalence of helminth infection was 20% or above, 
all children were treated regardless of infection status according to guidelines put forth by the 
World Health Organization (WHO) [18]. Children with other infections (Cryptosporidium 
spp. and/or Giardia intestinalis) in combination with severe symptoms (e.g., bloody stool, 
diarrhea, abdominal pain, and any abnormal lung sounds) were referred to the nearest local 
health clinic for individual management. 
The baseline cross-sectional survey took place in March 2015. The current study 
considers data from this baseline survey and the anthelmintic treatment follow-up 
examination in September/October 2015. 
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Inclusion and exclusion criteria 
Grade-4 primary school children of the selected schools were included in the study. Children 
with severe clinical signs and symptoms (e.g., severe fever, severe headache, dizziness, 
nausea, skin rashes, seizures, and diarrhea) or reported serious health problems, such as 
Crohn’s disease, liver or kidney diseases, or who participated in any other study were 
excluded. 
Procedures 
Questionnaires and interviews. Standardized questionnaires available in both English and 
local languages (Afrikaans and Xhosa) were used to determine the SES of the children and 
their families. Volunteers fluent in relevant languages were trained to conduct these in-person 
interviews. 
Clinical and anthropometric assessment. Experienced nurses obtained a detailed medical 
history through physical examination of the whole body and evaluation of symptoms to assess 
current infections, anemia, jaundice, as well as signs and symptoms of protein energy 
malnutrition, general respiratory and gastrointestinal problems, allergies, and skin infections. 
Body temperature was measured using an infrared digital ear thermometer (TS7, Hi-Care 
International; Cape Town, South Africa). Blood pressure was measured once after the child 
had been seated for 5 min using validated oscillometric Omron® digital blood pressure 
monitor (Omron® M6 AC model; Hoofdoorp, Netherlands). 
For the anthropometric measurements, shoes and sweaters were removed before 
standing on a digital weighting scale (Micro T7E electronic platform scale, Optima 
Electronics; George, South Africa). Body weight was measured once to the nearest 0.1 kg. 
Children’s height was assessed with a Seca stadiometer (Surgical SA; Johannesburg, South 
Africa), whereby the child was standing with the back erect, heals touching the wall, and 
shoulders relaxed. Body height was taken to the nearest 0.1 cm. 
Stool and urine sampling for assessment of gastrointestinal tract infection. A sample of at 
least 15 g of early morning stool from every participant was collected in a container and 
transferred to a laboratory of the Nelson Mandela University (NMU) in Port Elizabeth for 
diagnostic work-up. Stool samples were visually examined for Taenia spp. proglottids, signs 
of blood, mucus, and diarrhea. Duplicate 41.7 mg Kato-Katz thick smears were prepared from 
each stool sample [19] and examined under a microscope by two experienced laboratory 
technicians. The number of helminth eggs was counted and recorded for each species 
separately. Helminth egg counts were multiplied by a factor of 24 to obtain a proxy for 
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infection intensity, expressed as the number of eggs per gram of stool (EPG), which was then 
categorized into light, moderate, and heavy infections using readily available cut-offs offered 
by WHO [20]. For the detection of intestinal protozoa C. parvum and G. intestinalis, a 
Crypto-Giardia Duo-Strip® rapid diagnostic test (RDT) was performed on the stool sample 
[21]. For the discovery of the bacterium H. pylori, a Pylori-Strip® RDT was applied [22] 
(both tests are from CORIS, BioConcept; Gembloux, Belgium). 
Children were also asked to provide a urine sample, which was transferred to the 
laboratory and analyzed on the same day. Visual inspection for macrohematuria was followed 
by testing for blood in urine using Hemastix® strips (Siemens Healthcare Diagnostics GmbH; 
Eschborn, Germany), as a proxy for Schistosoma haematobium infection. A point-of-care 
circulating cathodic antigen (POC-CCA) urine cassette test (Rapid Medical Diagnostics; Cape 
Town, South Africa) was used for the diagnosis of Schistosoma mansoni infection [23]. 
The infectious agents under the same taxonomy were grouped as trematodes 
(S. mansoni and S. haematobium), nematodes (Ascaris lumbricoides, Enterobius vermicularis, 
and Trichuris trichiura), intestinal protozoa (G. intestinalis and C. parvum), and bacteria 
(H. pylori) in the statistical analyses. 
HbA1c measurement. HbA1c reflects plasma glucose concentrations over an 8- to 12-week 
period. It is used as a convenient diagnostic indicator for DM, as no fasting is required to 
measure it. HbA1c concentrations were obtained by using the POC instrument Afinion (Alere 
Inc. Waltham; Waltham, MA, USA), which is based on boronate affinity separation and the 
use of fluorescence quenching, with results available after 3 min. This method meets the 
generally accepted performance criteria for HbA1c, as defined by the U.S. National 
Glycohemoglobin Standardization Program (NGSP), with no interference from HbC, HbS, 
HbE, and HbD traits results. All test cartridges for the Afinion test belonged to the specific lot 
number. Test cartridges were stored at 4°C during the study and were removed from the 
refrigerator a maximum of 120 min before the test. The tests were run when the temperature 
of the cartridges were in their optimal range (15-25°C). Ambient room temperature was 
measured on each test day to assure absence of temperature effects on HbA1c test results as a 
means of quality control. Patients with HbA1c ≥6.5%, the recommended cut-off for 
diagnosing DM [24], were referred to DM care centers for confirmation and specific 
management. 
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Hemoglobin (Hb) measurement. Hb concentration was measured with the HemoCue® Hb 
301 system (HemoCue®AB; Ängelholm, Sweden) and the results were considered to the 
nearest 0.1 g/l. 
Covariates information 
The SES was derived from housing characteristics and household assets (S1 Table). 
The SES score of the households was categorized as poorest, poor, and least poor using the 
scale by Filmer and Pritchett to disaggregate the distribution of the scores [25]. 
The age of individuals was grouped into five categories (8-9, 10, 11, 12 and >12 
years), according to the age distribution of the population in the study. The body mass index 
(BMI) was calculated as kg/m2 based on the measured height and weight. For physical 
activity, we used questionnaires on the frequency and duration of certain activities (how many 
days in a week the children were physically active for a total of at least 60 min, the traveling 
time from home to school, and numbers of exercising days and intensity of exercise in 
children’s free time). The scores were summed up and equally categorized into tertiles: active, 
fair, and poor physical activity level according to the distribution of scores. 
Cardiorespiratory fitness (VO2 max) is the maximum rate of oxygen consumption, as 
measured during incremental exercise. We estimated the individual VO2 max from the 20 m 
shuttle run test, which is the most widely used field test for determining cardiorespiratory 
fitness in children [26]. 
Statistical analysis 
A complete case analysis was applied. Forty out of 882 participants at baseline moved 
or changed schools within the 6-month anthelmintic treatment follow-up, and hence, did not 
participate in the latter cross-sectional survey. Statistical analyses were performed with 
STATA version 14.1 (StataCorp; College Station, TX, USA). Statistical significance was 
defined as a two-sided p-value<0.05.  
Descriptive statistics include counts, percentages for categorical variables and, means, 
and standard deviations (SD) for continuous variables. The categorization of DM status by 
sex is described according to the American Diabetes Association cutoffs for HbA1c. The 
baseline prevalence of the different gastrointestinal tract infections is presented for the 
different schools separately. The characteristics of covariates at baseline are presented 
stratified for infected and non-infected children. To assess the independent association 
between gastrointestinal tract infections and HbA1c measurement (treated as continuous 
numerical data) at baseline, linear mixed regressions models with random intercepts for 
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schools were computed. Models were a priori adjusted for factors previously shown to be 
associated with infections and glycemia or diabetes, and therefore with a potential role as 
confounders: age, sex, SES, Hb, height, weight, BMI, systolic and diastolic blood pressure, 
physical activity, VO2 max, and body temperature. As a sensitivity analysis, we also omitted 
weight, BMI, physical activity, VO2 max, anemia and blood pressure from the models as they 
are potential mediators of infection effects on glycemia or correlates of glycemia. All models 
were run (i) by adding each infection separately without excluding children with other 
infections; (ii) by adding each infection separately and excluding children with other 
infections; (iii) by adding all infection variables simultaneously and; and (iv) by adding 
groups of infections. We also assessed dose-response effects on HbA1c for infectious agents, 
especially A. lumbricoides infection, where data on intensity of infection was available. To 
assess the independent effect of anthelmintic treatment on changes in HbA1c level between 
baseline and the 6-month anthelmintic treatment follow-up among children from schools 
without lifestyle intervention and who were infected at baseline, linear mixed regression 
models with random intercepts for schools were built. Models were a priori adjusted for age, 
sex, SES, Hb, height, weight, BMI, diastolic and systolic blood pressure, physical activity, 
VO2 max, and body temperature, considering information from both time points, as 
appropriate. Longitudinal models were re-run among subjects infected at baseline but not at 
follow-up, to differentiate between the effect of the anthelmintic treatment itself and the effect 
of resolved infection on change in HbA1c. Models were also run for children infected with 
nematodes and for children with any gastrointestinal tract infection separately. 
7.5 Results 
Complete data records including the baseline and 6-month anthelmintic treatment 
follow-up surveys were available from 842 children (Fig 1). Fig 2 shows the distribution of 
HbA1c at baseline and at the 6-month follow-up for the total study sample of 842 children 
irrespective of the intervention that they obtained. There was a small shift towards lower 
HbA1c levels at follow-up (p<0.001), reflecting the lifestyle intervention in some schools. 
The results of quality control tests underline the validity of the HbA1c data. First, HbA1c 
results did not depend on the day of examination (p=0.222), body temperature (p=0.327), or 
ambient temperature (p=0.217) (Fig S1a-c). Second, results from the weekly calibration with 
identical control 1 and control 2 are presented in S2 Table. At baseline, the overall mean 
HbA1c level of participants was 5.79% with SD of 0.25. The prevalence of prediabetes and 
diabetes according to baseline is presented in S3 Table. A high prevalence of preDM was 
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observed with 605 (71%) of children having preDM HbA1c levels. Three children (0.4%) 
exhibited HbA1c results ≥6.5% at baseline and were offered diagnostic follow-up for DM. 
The characteristics of the study population and its univariate association with HbA1c are 
presented in S4 Table. 
 
Fig 1. Children retained in the study sample for complete case analysis 
 
Fig 2. Distribution of HbA1c measured at baseline and 6 month follow-up in the total study 
sample, irrespective of the intervention obtained(N=842) 
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Table 1 shows the prevalence of gastrointestinal tract infections in the study schools at 
baseline. H. pylori was the predominant infection (416 children with a positive RDT result, 
49.4%). At the unit of the school, the prevalence of H. pylori ranged from 27% to 62%. 
The second most common infections were the soil-transmitted helminths A. lumbricoides 
and T. trichiura. Two out of eight schools showed very high prevalence of A. lumbricoides 
infection (62.5% and 74.1%), there was a moderate infection prevalence in a third school 
(25.9%), while the prevalence in the five remaining schools were below 5%. High prevalence 
of T. trichiura infection was observed in the same two schools where the prevalence of 
A. lumbricoides prevalence was high (66.7% and 67.9%, respectively), while the prevalence 
of T. trichiura was below 3% in the remaining six schools. 
In all schools, infection rates were low to very low or even undetectable for intestinal 
protozoa (Cryptosporidium spp. 1-5%; G. intestinalis 6-17%), the nematode E. vermicularis 
(1-5%), and the trematodes S. mansoni (1-3%; detected by POC-CCA urine cassette test) and 
S. haematobium (0%). 
Table 1. Baseline prevalence (%)2 of gastrointestinal tract infections, stratified by 
schools 
Schools and 
infection status 
School 
1 
N=89 
School 
2 
N=168 
School 
31 
N=81 
School 
41 
N=102 
School 
5 
N=82 
School 
6 
N=84 
School 
71 
N=143 
School 
81 
N=93 
Total 
N=842 
100.0 
Nematodes 
n=1 
1.1 
n=133 
79.2 
n=67 
82.7 
n=4 
3.9 
n=1 
1.2 
n=4 
4.8 
n=42 
29.4 
n=9 
9.7 
n=261       
31.0 
Ascaris 
lumbricoides 
1.1 62.5 74.1 1.0 0 3.6 25.9 4.3 
n=211       
25.1 
Trichuris 
 trichiura 
0 66.7 67.9 0 1.2 0 2.1 2.2 
n=137       
16.3 
Enterobius 
vermicularis 
0 1.2 3.7 2.0 1.2 2.4 2.8 4.3 
n=18        
2.1 
Trematodes 
n=8 
9.0 
n=11 
6.6 
n=1 
1.2 
n=1 
1.0 
n=6 
7.3 
n=5 
6.0 
n=9 
6.3 
n=5 
5.4 
n=46        
5.5 
Schistosoma 
mansoni 
0 3.0 0 1.0 1.2 0 0.7 0 
n=8 
1.0 
Schistosoma 
haematobium* 
9.0 3.6 1.2 0 6.1 6.0 5.6 5.4 
n=38        
4.5 
Intestinal 
protozoa 
n=13 
14.6 
n=30 
17.9 
n=11 
13.6 
n=7 
6.9 
n=11 
13.4 
n=9 
10.7 
n=24 
16.8 
n=9 
9.7 
n=114       
13.5 
Cryptosporidium 3.4 1.8 1.2 1.0 4.9 4.8 4.2 2.2 n=21        
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parvum 2.4 
Giardia  
intestinalis 
11.2 16.1 12.4 5.9 9.8 9.5 14.0 7.5 
n=96       
11.4 
Helicobacter  
pylori 
n=62 
69.7 
n=111 
66.1 
n=50 
61.7 
n=53 
52.0 
n=35 
42.7 
n=23 
27.4 
n=42 
29.4 
n=40 
43.0 
n=416       
49.4 
1 Schools without intervention related to health education, nutrition, and physical activity 
2 A detailed description of infections in the 8 schools is presented in our previous paper [27] 
N Number of children in each school 
n Number of infected children in each school and parasite group 
*S. haematobium infections only detected with Hemastix® strips 
Table 2 simply compares the characteristics of participants with and without a specific 
gastrointestinal tract infection. Except for H. pylori, the proportion of children with low SES 
was higher among infected children compared to their non-infected counterparts. Infections 
with nematodes and G. intestinalis were more common in males, whereas C. parvum infection 
was more common in females. Infected children were, on average, older than their non-
infected peers. Nevertheless, children with an A. lumbricoides, T. trichiura, and 
E. vermicularis infection had lower height, weight, and BMI compared to non-infected 
children. However, children infected with A. lumbricoides, T. trichiura, and H. pylori 
reported higher physical activity, but did not differ with regard to cardiorespiratory fitness. 
Concerning anemia and HbA1c, no clear pattern of association was evident from the 
univariate analysis. 
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Table 2. Distribution of characteristics of participants at baseline, by presence or absence of specific gastrointestinal tract infections 
Covariates 
A. lumbricoides T. trichiura E. vermicularis S. mansoni S. haematobium C. parvum G. intestinalis H. pylori 
No Yes No Yes No Yes No Yes No Yes No Yes No Yes No Yes 
Low SES, N, % 
189, 
30.0 
147, 
70.0 
218, 
32.6 
118, 
68.2 
326, 
39.6 
10, 
55.6 
332, 
39.8 
4, 
50.0 
316, 
39.3 
20, 
52.6 
329, 
40.0 
7, 
33.3 
291, 
39.0 
45, 
46.9 
172, 
40.4 
164, 
39.4 
Female, N, % 
322, 
51.4 
94,  
45.5 
342, 
51.4 
74,  
42.7 
409, 
50.1 
7, 
38.9 
412, 
49.9 
4, 
50.0 
392, 
48.8 
24, 
63.1 
401, 
48.8 
15, 
71.4 
374, 
50.1 
42, 
43.8 
205, 
48.4 
211, 
51.4 
Age, years 
N, mean,SD 
631, 
10.7, 
0.972 
211,  
11.2, 
0.865 
669, 
10.7, 
0.987 
173, 
11.2, 
0.789 
824,  
10.8 
0.969 
18, 
10.9, 
1.017 
834, 
10.8, 
0.970 
8, 
11.6, 
0.721 
804, 
10.8, 
0.953 
38, 
11.2,  
1.239 
821, 
10.8, 
0.972 
 
21, 
10.8, 
0.905  
746, 
10.8, 
0.964 
96, 
11.1, 
0.994 
426, 
10.8, 
1.012 
416, 
10.9, 
0.926 
Height, cm,  
N, mean, SD 
631, 
133.8 
7.083 
211 
131.5, 
6.830  
669, 
133.8, 
6.933 
173, 
130.8, 
7.164 
824,  
133.3, 
7.063 
18, 
130.0 
7.547 
834, 
133.2, 
7.064 
8, 
139.4,  
6.931 
804, 
133.1, 
7.034 
38, 
134.7, 
8.045 
821, 
133.1, 
7.039 
21, 
134.8, 
8.756 
746, 
133.2, 
7.067 
96, 
133.3, 
7.257 
426, 
133.7, 
7.214 
416, 
132.8, 
6.929 
Weight, kg,  
N, mean, SD 
631, 
31.3, 
8.048 
211 
28.1, 
5.580 
669, 
31.3, 
7.901 
173, 
27.4, 
5.463 
824,  
30.6, 
7.660 
18, 
26.9, 
4.662 
834, 
30.4, 
7.634 
8, 
34.1, 
5.944 
804, 
30.5, 
7.668 
38, 
30.9, 
6.747 
821, 
30.4, 
7.596 
21, 
32.7, 
8.615 
746, 
30.5, 
7.628 
96, 
30.5, 
7.650 
426, 
30.0, 
7.938 
416, 
30.9,  
7.276 
BMI, kg/m2,  
N, mean, SD 
631, 
17.3, 
3.254 
211 
16.1, 
2.102 
669, 
17.3, 
3.213 
173, 
15.9, 
1.930 
824,  
17.0, 
3.066 
18, 
15.8, 
1.626 
834, 
17.0, 
3.048 
8, 
17.6, 
3.108 
804, 
17.0, 
3.084 
38, 
16.9, 
2.168 
821, 
17.0, 
3.057 
21, 
17.7, 
2.602 
746, 
17.0, 
3.054 
96, 
17.0,  
3.010 
426, 
3.2, 
 3.186 
 
416, 
2.9, 
2.898 
VO2 max, 
ml/kg/min, 
N,mean, SD 
631, 
45.9, 
5.080 
211 
45.5, 
5.098 
669, 
45.8, 
5.099 
173, 
45.8, 
5.055 
824,  
45.8, 
5.048 
18, 
46.6, 
6.729 
834, 
45.8, 
5.073 
8, 
46.4, 
6.805 
804, 
45.9, 
5.081 
38, 
44.3, 
5.210 
821, 
45.9, 
5.081 
21, 
43.8, 
5.050 
746, 
46.1 
5.027 
96, 
45.5, 
5.562 
426, 
46.0, 
5.375 
 
416, 
45.9, 
4.781 
Low physical 
activity, N,% 
250, 
39.6 
56, 
26.5 
271, 
40.5 
35, 
20.2 
297, 
36.0 
9, 
50.0 
302, 
36.2 
4, 
50.0 
292, 
36.3 
14, 
36.8 
298,3
6.3 
8, 
38.1 
274, 
36.7 
32, 
33.3 
176, 
41.3 
130, 
31.3 
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Hb, g/l 
N, mean, SD 
631, 
12.3, 
9.482 
211 
11.9, 
9.158 
669, 
12.3, 
9.629 
173, 
11.9, 
8.367 
824,  
12.2, 
9.475 
18, 
12.1, 
10.820 
834, 
12.2, 
9.491 
8, 
12.3, 
11.179 
804, 
12.2, 
9.474 
38, 
12.5, 
9.887 
821, 
12.2, 
9.460 
21, 
12.3, 
11.24
0 
746, 
12.2, 
9.635 
96, 
12.3, 
8.417 
426, 
12.3, 
9.594 
416, 
12.2, 
9.389 
HbA1c %, 
 N, mean, SD 
631, 
5.8, 
0.245 
211 
5.7,  
0.255 
669, 
5.8, 
0.243 
173,  
5.7,  
0.270 
824,  
5.8, 
0.249 
18, 
5.7, 
0.266 
834, 
5.8, 
0.250 
 
8, 
5.9, 
0.225 
 
804, 
5.8, 
0.250 
38, 
5.8, 
0.229 
821, 
5.8, 
0.249 
 
21, 
5.8, 
0.264 
 
746, 
5.8, 
0.245 
96, 
5.8, 
0.284 
426, 
5.8, 
0.246 
416, 
5.8, 
0.253 
N Number of children 
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The results from the multivariable linear regression models of the cross-sectional association of 
single or grouped infections with HbA1c are presented in Table 3. We observed a positive 
association between H. pylori infection and HbA1c, irrespective of adjustments for other infections 
(β=0.040; 95% confidence interval (CI) 0.006 - 0.074). No significant association of HbA1c with 
any other infectious agent or infection group was observed. Omitting covariates from the 
multivariable regression models that are potential mediators of infection effects on glycemia 
(physical activity; physical fitness; weight, BMI, anemia) or correlated outcomes (blood pressure) 
did not materially alter the results presented for the fully adjusted models (S5 Table). Excluding 
children with diabetes at baseline or at the 6-month anthelmintic treatment follow-up did not 
materially alter the findings (S6 Table). In addition, we were not able to show a statistically 
significant dose-response relationship between intensity of A. lumbricoides and T. trichiura infection 
and HbA1c levels, albeit adjusted HbA1c levels were highest in children with most intense infections 
(S7 Table). 
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Table 3. Adjusted associations of infection with HbA1c at baseline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3a: 
Single Infections 
and infection 
Groups 
All with respective infection1 Only respective infection2 
Mutually adjusted for other 
infections or groups3 
N β* 95% CI N  β * 95% CI N β* 95% CI 
Nematodes 842 -0.018 -0.069 – 0.032 343 -0.039 -0.115 – 0.037 842 -0.027 -0.079 – 0.024 
A. lumbricoides 842 -0.021 -0.070 – 0.029 307 -0.039 -0.133 – 0.055 842 -0.029 -0.080 – 0.023 
T. trichiura 842 0.000 -0.060 – 0.060 280 0.061 -0.208 – 0.330 842 0.002 -0.061 – 0.066 
E. vermicularis 842 -0.053 -0.164 – 0.058 284 -0.079 -0.251 – 0.093 842 -0.057 -0.168 – 0.054 
Trematodes 842 0.013 -0.058 – 0.084 296 0.012 -0.097 – 0.120 842 0.012 -0.059 – 0.083 
S. mansoni 842 0.033 -0.132 – 0.199 278 0.069 -0.387 – 0.525 842 0.029 -0.137 – 0.195 
S. haematobium 842 0.008 -0.070 – 0.086 295 0.011 -0.102 – 0.123 842 0.006 -0.072 – 0.084 
Protozoa 842 -0.006 -0.052 – 0.041 283 -0.126 -0.314 – 0.062 842 -0.005 -0.052 – 0.042 
C. parvum 842 -0.020 -0.122 – 0.083 283 -0.121 -0.310 – 0.067 842 -0.030 -0.133 – 0.074 
G. intestinalis 842 0.005 -0.045 – 0.055 305 0.001 -0.093 – 0.095 842 0.006 -0.045 – 0.057 
H. pylori 842 0.040 0.006 – 0.074 488 0.041 -0.003 – 0.085 842 0.041 0.007 – 0.075 
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Table 3b: Nematode infections 
All with respective infection1 
N β 95% CI 
Only nematodes 842 -0.057 -0.124 – 0.011 
Nematodes and other infections 842 0.013 -0.046 – 0.070 
Only other infections 842 0.016 -0.024 – 0.055 
 
* Beta coefficients reflect the adjusted mean difference HbA1c (%) between children with and without the respective infection. Differences that are statistically significantly 
different (p<0.05) are marked in bold. 
1Single and group infection models as well as nematode infection models are adjusted schools, for age, sex, socioeconomic status (SES), hemoglobin (Hb) level, height, 
weight, BMI, systolic and diastolic blood pressure, physical activity, physical fitness, body temperature on the day of the HbA1c test 
2children with other infections are excluded from this analysis 
3Mutually adjusted models include either all single infections or all infection groups; H. pylori is included in single infection and infection group models 
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Results pertaining to the association between albendazole treatment and change in HbA1c 
level at the 6-month treatment follow-up are presented in Table 4. The analysis is restricted to 
children from schools not subjected to lifestyle interventions given the observed slight 
decrease in HbA1c in the total study sample. Furthermore, only children with any infection or 
with nematode infection at baseline, respectively, were included. The regression analyses 
point to statistically non-significant increases in HbA1c concentrations at the 6-month 
treatment follow-up. The findings from multivariable regression model excluding covariates 
that could be potential mediators of infection effects on glycemia or correlated outcomes 
(weight, BMI, anemia, physical activity, physical fitness, blood pressure) point to generally 
weaker and still statistically non-significant results but in the subjects with a nematode infection 
at baseline, but without any infection at follow-up showing decreased estimate average change in 
HbA1c (S8 Table). 
Table 4. Adjusted1 estimate of average change in HbA1c (follow-up minus baseline) 
among children infected at baseline and visiting schools without lifestyle intervention 
Infections exposures N 
Estimate average 
change in HbA1c (%) 95% CI 
Nematode infections 
All subjects with a nematode 
infection at baseline, adjusted for the 
presence of infection of any type at 
baseline and follow-up 
414 
 
0.049 
 
 
-0.018 – 0.117 
 
Subjects with a nematode infection at 
baseline, but without any infection at 
follow-up 
217 
 
0.025 
 
 
-0.008 – 0.108 
 
Any infection 
All subjects with any infection at 
baseline, adjusted for the presence of 
infection at follow-up 
260 0.070 -0.008 – 0.148 
Subjects with any infection at 
baseline, but  without any infection at 
follow-up 
103 0.054 -0.055 – 0.164 
1All models were adjusted for schools, age, sex, socioeconomic status (SES), hemoglobin (Hb) level, weight, 
height BMI, physical activity, VO2 max, and body temperature, systolic and diastolic blood pressure at baseline 
and follow-up 
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7.6 Discussion 
To our knowledge this is the first investigation examining the cross-sectional association 
of a broad spectrum of gastrointestinal tract infections with glycemia in school-aged children 
and assessing the impact of anthelmintic treatment on the change in HbA1c values. We 
observed a positive association between H. pylori infection and HbA1c, while no statistically 
significant relationship was observed with any other type of infection. 
Some animal experiments [28] and human epidemiologic studies [10, 11, 13, 15] have 
shown helminth infections to lower the blood sugar level and inhibit the development of type 
1 DM as well as type 2 DM. An inverse relationship between lymphatic filariasis and both 
type 1 and type 2 DM was reported from India [10, 11]. Having a previous schistosome 
infection exhibited a strong protective effect against DM in the People’s Republic of China 
[12]. Strongyloides stercoralis infection seemed to be associated with a reduced risk of type 2 
DM in adult Australians [13]. Soil-transmitted helminth infections were linked with an 
improvement of insulin sensitivity in Indonesia [15]. Diabetic patients in Turkey were found 
to have a lower prevalence of parasitic disease than their healthy counterparts [16]. In 
contrast, a positive association was found between S. stercoralis infection and DM in Brazil, 
where it was also found that such infections were associated with a high mortality risk among 
poorly controlled DM patients [14]. A study conducted by Hakim and colleagues reported a 
high rate of G. intestinalis infection among DM patients [29]. For trematode infections, 
positive association with HbA1c concentrations were reported from several studies [12, 30, 
31]. The cross-sectional nature of these studies precludes casual inference. 
H. pylori is one of the most common human pathogens causing gastrointestinal 
inflammation. Potential underlying mechanisms linking H. pylori infection and HbA1c levels 
and DM may include a disturbance of glucose and lipid absorption by the inflamed 
gastrointestinal tissue. H. pylori infections may also alter host metabolic homeostasis by 
affecting appetite regulation and energy expenditure through altered balance of ghrelin and 
leptin secretion, leading to over-eating and metabolic syndrome pathogenesis. The mediating 
role of gut microbiota alterations remains unknown [32]. The reported associations between 
H. pylori infection and DM remain inconsistent. The positive association reported among 
school children in the present study corroborates findings from two large cross-sectional 
national surveys conducted by Chen and Blaser in American population samples (one aged 
≥18 years and one aged ≥3 years) and a Taiwanese study in adults, which all found that 
H. pylori infections were associated with higher mean HbA1c levels [33, 34]. Several smaller 
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outpatient clinic or hospital based studies in Turkey, Pakistan, and Qatar among adults aged 
18 years and above showed a higher prevalence of H. pylori infection in diabetic patients than 
non-DM control groups [35-37]. Other studies failed to find a positive association between 
H. pylori and HbA1c or DM [38-40].  
In fact, DM patients were found to have higher rates of H. pylori eradication therapy 
according to national health insurance data from Taiwan. H. pylori eradication treatment 
success was found to be lower in DM compared to non-DM patients [41, 42]. Future 
intervention studies for the treatment of H. pylori should systematically consider changes in 
glycemia to shed light on the potential etiologic role of H. pylori in DM development. Some 
studies indicated an improvement of mean HbA1c and insulin resistance in patients with type 
2 DM after H. pylori treatment [43, 44].  
We did not observe a statistically significant increase in HbA1c after anthelmintic 
treatment with albendazole in children harboring nematode infections at baseline, possibly as 
a result of sample size limitations. The observed direction of the effect is in line with the 
reported shift towards a Th2 response in helminth-infected individuals. A number of clinical 
trials with helminth or helminth antigen therapy have reported promising results in 
inflammatory bowel diseases [45, 46], multiple sclerosis [47], rheumatoid arthritis [48]. After 
deworming, which triggers several hyper-inflammatory processes and shifts immune 
responses from Th2 to Th1, groups of children treated with either albendazole or 
mebendazole (against soil-transmitted helminthiasis) or praziquantel (against schistosomiasis) 
had a higher positive response to the skin-prick test and allergy related symptoms [49, 50]. 
Nevertheless, other studies emphasized that anthelmintic treatment did not have an effect on 
clinical eczema and asthmatic severity scores [51, 52].  
Given that in our study the highest increase in HbA1c after albendazole treatment was 
observed in children with non-nematode parasite infection, additional research is needed to 
understand the effect of the anthelmintic drugs on human glucose metabolism. Yet, our results 
are aligned with the first publication from a randomized placebo-controlled trial in Indonesia, 
which showed no effect of albendazole treatment on insulin resistance [53]. 
Our study has several strengths. First, the study population exhibited sufficient 
prevalence range for at least some of the infectious agents investigated to allow for efficient 
interrogation of the study objective. Second, the detailed characterization of children allowed 
us to assess independent associations of parasite infections with glycemia and limiting 
residual confounding. To analyze the SES of study participants, we chose multiple 
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correspondence analysis (MCA) based on household characteristics and assets ownership over 
more traditional methods thereby minimized measurement error related to the different 
calculation methods of income and consumption, recall bias, and seasonal variation of income 
and expenditure. Third, we used internationally certified HbA1c testing (Alere Technologies), 
regularly calibrated with standard control procedure. Ehehalt et al. showed that the 
measurement of HbA1c was a reliable criterion for children and adolescents to diagnose the 
onset of childhood type 1 DM [54]. In addition, the POC HbA1c test is an accepted screening 
instrument for pre-DM and type 2 DM [55, 56]. We carefully evaluated potential 
measurement error in HbA1c in the light of the observed high prevalence of pre-DM. We 
demonstrated the absence of correlations with external temperature, body temperature, and 
examination date. In addition, all models were adjusted for the concentration of Hb, a 
potentially important confounder, which was assessed with the widely used HemoCue Hb 301 
system. 
We also acknowledge some limitations of our study. Reverse causation remains a 
problem related to the cross-sectional nature of our main analysis. The low prevalence for 
some infections limited statistical power for the analyses. The association between H. pylori 
infection and HbA1c is no longer statistically significant if the p-values are adjusted for the 
number of infections investigated (n=8). Additionally, the co-infections [27] may in part mask 
opposite effects of different parasites on HbA1c. Examining only one stool sample has a low 
diagnostic accuracy due to the day-to-day and intra-specimen variation in helminth egg 
output. To partially remedy this shortcoming, test specificity was increased by preparing 
duplicate Kato-Katz thick smears from each stool sample. We observed a very high rate of 
prediabetes in the children studied, which may limit the generalizability of the observed 
associations. Despite the fact that the Alere HbA1c testing is minimally affected by 
hemoglobinopathies, we cannot assess any influence in the absence of genotyping results. 
Selection bias related to the complete case analysis approach cannot be excluded but the very 
high participation rate at baseline and the 6-month anthelmintic treatment follow-up (5% 
drop-out rate), and the relatively low rate of children not providing stools (15%) are unlikely 
to have substantially altered the results. 
In conclusion, the positive cross-sectional association of H. pylori infections with 
glycemia is consistent with a potential role of this highly prevalent bacterium in DM in 
LMICs. The direction and causality of the association warrants further scientific inquiry in the 
context of longitudinal studies and biobanks that focus on specific parasites and integrate 
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immunity as well as other biomarkers to improve mechanistic understanding of parasite-
glycemia associations and the potential impact of deworming programs on DM prevalence. 
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Chapter 8 
Discussion 
 
8.1 Overview of discussion  
This PhD thesis pertains to dual burden of diseases, i.e. chronic diseases with 
communicable diseases between DM and NTDs, particularly on dengue viral infections and 
helminth infections. To have a true understanding of epidemiological association and associated 
risk factors between these particular diseases, we performed a systematic literature review (and 
meta-analyses) with the data from published articles. The findings from the review have been 
verified by epidemiological field studies. 
The justifications of this thesis are as follows: DM prevalence is a growing epidemic in 
both developed and developing world. Dengue is currently one of the most re-emerging tropical 
diseases and dengue outbreak increased in recent years. Dengue, nowadays not only affects to 
children but also adults. However, there is very little knowledge on the association between DM 
and dengue viral infections. Our systematic literature highlighted the importance of 
comorbidities of DM in the development of severe dengue. The current information of relevance 
on these diseases associations was also updated and we identified the needs for the further 
research and comorbid patient care.  
A number of epidemiological studies and clinical trials reported that helminthes were 
protective against autoimmune diseases. Animal studies also confirmed that experiment with 
helminth eggs in mice slowed down the onset of developing type 1 DM, but the studies in human 
setting and type 2 DM is still lacking and the methodology of previously conducted studies did 
not adequately explain the underlying mechanism. The helminth-DM literature review 
summarized the current evidence of the effects of each helminth on different types of DM with 
their comorbid associations and set the stage for additional studies. This understanding was 
applied in our field studies in Laos PDR and South Africa. Studying comorbidity of NCD and 
NTDs is novel in both children and adults population. Our studies also gave novel results on 
comorbid relationships and gave a new insight into the single and dual disease burden in both 
countries from DM perspective. Moreover, we also assessed the regional differences in 
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prevalence of different helminth infections (and parasite infections in the South African study) as 
well as the DM status and DM risks of population. We also observed in more of a pilot setting 
the possible linkage between helminth infections and the blood sugar status after anthelmintic 
treatment. This will also provide significant impact in terms of developing potential novel 
therapeutic strategies (either a vaccine or a drug using helminth related compound or a 
substitute) aimed at preventing and/or delaying the disease onset and/or decreasing the severity 
of DM. In addition, the studies conducted in Lao PDR and South Africa created a reasonable 
awareness related to dual disease burden to health policy makers in helminth endemic countries, 
which are currently implementing the nationwide mass deworming program for continuation or 
discontinuation of deworming program.  
 
8.2 Discussion of the main findings 
8.2.1 Association between diabetes mellitus and dengue viral infections 
Dengue is currently concerned as the most emerging mosquito-transmitted tropical 
disease in every geographical region of the world, particularly in South Asia, South East Asia 
and Latin America (Brazil and Mexico) (Bhatt et al., 2013, Murray et al., 2013). It is linked with 
the dynamics of globalization (Gubler, 2011), international traveling and trading (Russell et al., 
2009), global population growth and rapid urbanization, socio-economic constraints on control 
measures (Gubler et al., 2001, Astrom et al., 2012, Brunkard et al., 2008), climate change 
(Astrom et al., 2012), and the evolution of viral virulence (Jarman et al., 2008, Rico-Hesse, 
2003). At the same time, many of the tropical countries begin to encounter the epidemiological 
transition, adding burden of NCDs such as DM, cardiovascular diseases, cancer, chronic 
obstructive pulmonary disease to the overall mortality rate along with ageing of the population 
(Porta MS., 2008). The co-morbidities of dengue with NCDs in these regions are expected to be 
increasing and the understanding of the relevance of DM in the development of severe dengue is 
fundamental in order to improve the clinical monitoring and interventions. 
Associated risk factors 
The findings of our DM-dengue study showed that patients with dengue fever and DM 
comorbidities seem to be at higher risk of developing complications and/or severe dengue 
compared to those without comorbid conditions although this result was based on very limited 
data. Some studies have postulated that in adults, non-communicable comorbidities and other 
Chapter 8: Discussion 
151 
 
underlying medical conditions such as cardiovascular diseases, endocrine diseases, allergies, 
hematological diseases, chronic hepatopathy, recipients of solid organ transplant, chronic renal 
insufficiency, autoimmune disorders, respiratory diseases, stroke and also the condition of being 
old age may have a role in predisposing individuals to the severe forms of dengue (Lye et al., 
2010, Toledo et al., 2016). The data of Cuban epidemic dengue outbreaks also expressed that co-
presentation between dengue and DM and having diabetes mellitus was a risk factor contributing 
to the development of dengue haemorrhagic fever (Guzman, 2012). A number of studies 
revealed that the effects of nutritional status on dengue disease outcome have been controversial. 
Some studies found that patients with excessive body weight or obesity have increased risk for 
severe dengue fever (Pichainarong et al., 2006, Junia et al., 2007) as the physiological reaction of 
a person with a high body mass are intrinsically more likely to leak the fluid from blood vessels 
to surrounding tissues and organs. Other studies mentioned that malnutrition is a protective 
factor due to suppressed immune activation in malnourished children (Nguyen et al., 2005, 
Thisyakorn and Nimmannitya, 1993). Among different serotypes of dengue viral infection, 
infection with one serotype gives lifelong immunity to that type, but only short term immunity to 
the other serotypes. Due to seasonal variation, therefore, subsequent infection with a different 
type increases the risk for severe disease and complications (Rodenhuis-Zybert et al., 2010). A 
Pakistani study conducted in the Lahore also showed a significant association between dengue 
and diabetes particularly among middle to elderly participants (Aamir et al., 2015). 
Clinical management of dengue in DM patient  
Due to no specific treatment for dengue viral infection (Simmons et al., 2012, Halstead, 
2007, WHO, 2009) and the pathophysiological mechanism of increasing vascular permeability 
and severe bleeding, the standard therapy of clinical management of severe cases of dengue is 
fluid replacement, both orally and intravenously (Rosenberger et al., 2016) with intensive 
monitoring of plasma leakage and supportive care. However, excessive fluid replacement might 
lead to hypervolemia, pulmonary edema and respiratory distress. This clinical aspect is very 
important in elderly patients, due to their respiratory-cardiovascular and renal compliance 
(WHO, 2009, Mandell GL, 2005). In addition, according to Hasanat and colleagues study, 
glucose intolerance is frequently associated with dengue fever in its early course of dengue 
infection (Hasanat et al., 2010) and therefore, clinicians should be aware using of dextrose 
contained infusions as fluid replacement in dengue fever.  
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Dengue vaccine  
In late 2015, the first dengue vaccine, Dengvaxia (CYD-TDV), a live recombinant 
tetravalent vaccine with a 3 series of doses scheduled on a 0,6,12 month aiming to provide the 
long term immunity to all serotypes, was introduced by Sanofi Pasteur pharmaceutical company 
in five Latin American countries (Villar  et al., 2015). With scientifically evidenced efficacy of 
the vaccine with fewer hospitalization among virologically confirmed dengue cases, WHO 
considers dengue vaccines to be an integrated part of the Global dengue prevention and control 
strategy (2012-2020) (WHO, 2012) and recommends the dengue endemic countries to consider 
introducing the dengue vaccine for individuals aged between 9 and 45 years in order to reduce 
the burden of dengue. Other additional potential vaccines are now under evaluation in clinical 
trials (Thisyakorn and Thisyakorn, 2014). The WHO Initiative for Vaccine Research (IVR), in 
collaboration with a wide range of partners, aims to facilitate the development and future 
introduction of safe, effective and affordable dengue vaccines in epidemiologically burden 
dengue area.  
Limitations of our study 
Our findings from the systematic literature review and meta-analyses have limitations. 
Some retrieved studies did not mainly focus on DM and dengue as the exposures and outcomes 
and most of the clinical data information relevant comorbidities were usually underreported in 
the articles which made it difficult to retrieve these information from the data provided from the 
studies and to summarize and conclude the results. Additionally, the studies in our review were 
mostly case-control and retrospective in nature and thus, there is likely to be a selection bias of 
research participants either in-patients or out-patients, who lived nearby the health facilities or 
hospitals. The retrieved studies did not also represent or recruit non-severe dengue cases that 
were treated at the general practitioners. This also raised the variability of studies and 
generalizability of study population.  
 
8.2.2 Association between DM and helminth infections 
In the previous sections (chapter 5, chapter 6 and chapter 7), the discussion of each 
research study findings and outcome has been provided. In this chapter, a global relevant 
perspective on results of the association between DM and heminth or parasite infections is given  
Effects of helminthes, parasites, bacterial and viral infections on DM status 
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In our studies, we found the different prevalence of helminth infections in the study area 
(different provinces in LADUBU study and different schools in South African study). In 
LADUBU study, the food-borne trematodes were prevalent across all provinces. In South Africa, 
STHs were more common and the rate of infections varies from schools to schools. We found a 
significant positive association between Taenia infection and DM status measured by HbA1c 
blood concentration in Lao PDR study. T. solium infection has been widely found in China, 
Nepal, India, Philippines, Indonesia, Thailand, Cambodia, Vietnam and Lao PDR (Conlan et al., 
2008, Willingham Iii et al., 2010). T. saginata has only been reported in southern Laos 
(Sayasone et al., 2009) and T. solium and T. saginata have been common in northern Laos (Eom 
et al., 2009). The prevalence of Taenia was more frequent in pigs than human. Even taeniasis 
itself or cysticercosis caused by T. solium is a major NTD and substantial work for elimination 
programs in various geographical regions around the world exists, the parasites still remains. In 
taeniasis, the main risk factor of infection is insufficiently cooked meat consumption (either pork 
or beef). Among Taenia spp, T. solium infection can mainly cause major health problems and 
elimination programs of T. solium have been ineffective in endemic countries, due to insufficient 
integrated surveillance in both human and animals (Willingham Iii et al., 2010). Our findings of 
Taenia infection being positively associated with the blood sugar levels is confirmed in 
additional studies that integrate biomarkers to improve mechanistic understanding, screening and 
elimination of taenia infection in DM patients and vice versa. DM control in persons with taenia 
infection becomes clinically relevant.  
Our South African study revealed a positive association between Helicobactor pylori 
infection and HbA1c measurements. H. pylori infection is widespread in South Africa and is 
present in 70% of gastric ulcer and 90% of duodenal ulcer and carcinoma of stomach in 
advanced stage (Figueiredo et al., 2005). Multidrug resistance is also identified as a major cause 
of treatment failure in South Africa (Tanih et al., 2010). Growing research evidence describes 
that H. pylori infection is associated with DM via H. pylori induced gastritis that affects gastric 
related hormones and inflammatory cytokines, leading to insulin resistance; however, the 
relationship remains debatable due to complicated autoimmune inflammatory mechanism 
behind. It was shown that H. pylori treatment or eradication in DM patients resulted in decreased 
mean HbA1c (Zojaji et al., 2013) or fasting insulin HOMA-IR levels (Gen et al., 2010) , while 
other studies showed no effect (Wada et al., 2013, Vafaeimanesh et al., 2013). However, Zojaji 
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and colleagues suggested that it could be beneficial to inspect the H. pylori infection among the 
individuals at high risk of DM (Zojaji et al., 2013). 
The factors that influence the dual disease relationship include helminth or parasite 
species, host genetics, timing, burden and chronicity of helminth infections (Cooper, 2009). 
Some studies suggested that the parasite related protective immune effects could be the most 
effective in early life to combat the autoimmune diseases (Ndibazza et al., 2012, Pelosi et al., 
2005).  
Other infectious agents such as bacteria or viruses are also associated with both type 1 or 
type 2 DM as either an increased or a decreased risk. Studies found a significant association 
between enterovirus infection (Yeung et al., 2011), Cytomegalovirus (Yoneda et al., 2017) and 
both type 1 and related autoantibodies. The German population study also reported that recurrent 
viral respiratory tract infections in the first 6 months of life were associated with an increased 
chances of having type 1 DM by their age of 8 (Beyerlein et al., 2016). Other reports presented a 
weak association between mumps and type 1 DM (Saad et al., 2016) but other studies outlined 
no evidence of viral infections with type 1 DM development (Cinek et al., 2014, Lee et al., 
2013). In animal studies, a link has been found between H1N1 as well as Coxsackie B virus and 
type 1 DM (Qi et al., 2017). Moreover, it is known that hepatitis C (Antonelli et al., 2014, 
Desbois and Cacoub, 2017), Herpes virus (Pompei, 2016), endotoxins (Min and Min, 2015) 
could be associated with type 2 DM. Again, some bacterial infections also have a relationship 
with DM. Staphylococcal infections, Streptococcal infections, and Klebsiella pneumoniae are 
common infections among DM patients. Uncontrolled DM is also associated with increased risk 
of TB (Leung et al., 2008) but not in other study (Leegaard et al., 2011). A study in Tanzania 
remarked that transient hyperglycemia is frequent during clinical course of tuberculosis, and 
further DM confirmation and diagnosis is essential after tuberculosis treatment (Boillat-Blanco et 
al., 2016). Finally, a bacterial infection called melioidosis has been strongly associated with DM. 
Therefore, knowledge of melioidosis and DM association is quite important for endemic 
countries such as Southeast Asia and Northern Australia (Cheng and Currie, 2005, Currie, 2015) 
. 
Co-infections and multiparasitism 
Multiparasitism or co-infections were also very common in both of our studies. 
Multiparasitism, also known as polyparasitism, can be defined as the concurrent infestation with 
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two or more parasite species in high frequencies and mostly intestinal forms (Steinmann et al., 
2010). Though it is an important public health concern in tropical and subtropical countries, it is 
often being neglected. The assessment of multiparasitism is always a challenging issue due to the 
necessity of sensitive broad-spectrum diagnostic approaches and collecting multiple biological 
samples for each and specific helminth. Besides, the effects of multiple species infections on 
disease outcome in hosts are usually multiplex due to a potential synergistic or antagonistic 
effect between parasites. The co-infections can also alter the host susceptibility, transmission 
risks, and clinical symptoms. Additionally, the effects of associations are further affected by a 
diversity of potential risk factors such as the status of socioeconomic demography, 
environmental exposure and immunological reactions. 
Typically after treatment, reinfection rate especially STH is high and occur rapidly if the 
exposure is not changed. E.g. the reinfection rate 3 months after the anthelminthic treatment was 
26% for A. lumbricoides, 36% for T. trichiura and 30% for hookworm (Jia et al., 2012). The 
reinfection rates were T. trichiura (37.2%), for A. lumbricoides (34.6 %) and for hookworms 
(25.0%) after 18 weeks post-treatment in Tanzania (Speich et al., 2016). Re-infection rate of S. 
stercoralis was found among one third of ivermectin treated schoolchildren (Khieu et al., 2014). 
In Thailand, re-infection rate of O. viverrini after one year with Praziquental treatment was 
between 54.8% and 94.0% (Sithithaworn and Haswell-Elkins, 2003). The main reasons were due 
to the high frequency of raw and insufficiently cooked fish consumption and inadequate 
sanitation facilities the transmission. In our longitudinal South African study, we also found that 
the 2 schools which had a higher infection rate were still infected and the re-infection rate at 
follow up was almost as similar as baseline, 6 months after deworming with Albendazole.  
Gut microbiome, obesity and metabolic dysfunction 
The role of gut microbiome is crucial in controlling human metabolic metabolism by 
regulating the host genes (Tilg and Kaser, 2011). In murine studies, the microbiome affect the 
host energy expenditure, immune and inflammatory mechanisms via several pathways such as 
fasting induced adipose factor in central regulation of energy metabolism (Kim et al., 2010), 
affecting skeletal muscle fatty acid oxidation that control cellular energy status (Backhed et al., 
2007), synthesizing hydrolases which influences host energy storage (Backhed et al., 2005). 
However, other experiments report that obesity can influence the composition of gut microbiota 
(Ridaura et al., 2013). Since there is an increased risk of developing type 2 DM in obesity, the 
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microbiome might also influence type 2 DM through increased acetate and decreased butyrate 
production which cause insulin resistance leading to low grade inflammation in the gut, as shown 
in human studies (Forslund et al., 2015). A study with more than 7,000 children also showed the 
link of probiotics usage during the first month of life to a lower risk of islet autoantibodies, 
suggesting that the gut microbiome may also play a role in type 1 diabetes mellitus (Uusitalo et 
al., 2016). The human microbiomes contain exponentially more genes than human genes, and 
those microbial genes produce molecules that affect human physiology when they are 
disordered. Modulation of microbiota through diet, pre- and probiotics, antibiotics, surgery, and 
fecal transplantation has a major impact the obesity epidemic (John and Mullin, 2016). A proper 
understanding of environmental influences on the microbiota and the consequences on 
metabolic-inflammatory diseases become a key aspect. 
Helminthes and metabolic syndrome/parameters 
Metabolic syndrome (MetS) has reached epidemic proportions across the globe and place 
huge burdens on the health systems of both economically developed and developing societies 
(Misra and Khurana, 2008). MetS is defined as a co-occurrence of medical disorders  consists of  
elevated blood pressure, elevated fasting sugar level, high serum lipid profiles and abdominal 
obesity (excess body fat around the waist) (Alberti and Zimmet, 1998, Zimmet et al., 2005). The 
effects of helminthes on type 1 and type 2 have rigorously been discussed in previous chapters. 
Intestinal helminths absorb lipids either from their host’s gut or blood stream, which could 
reduce their host’s circulating lipids and thereby minimize accumulation of plaques in 
vasculature (Hall et al., 2008). A study conducted by Wiria and colleagues describe that the 
interplay between helminth infection and carotid intima media thickness which is a marker for 
subclinical atherosclerosis was negatively associated (Wiria et al., 2013). This finding is 
supported by another study that Opistorchis felineus infection describing lower serum total 
cholesterol level and being a negative predictor of aortic atherosclerosis development (Magen et 
al., 2013). O. felineus is a close relation of O. viverrini which was the most frequent parasite in 
the Laos study. 
Obesity is usually associated with chronic low-grade inflammation and alterations of 
immune cells composition in metabolic organs, especially in adipose tissues. Chronic low-grade 
inflammation associated with obesity contributes to insulin resistance and type 2 DM by 
inducing pro-inflammatory cytokines, chemokines, insulin resistance-associated adipokines and 
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acute inflammtory reactants are central to the MetS development (Wu et al., 2011). Helminth 
parasites are the strongest natural inducers of type 2 immune responses and counterbalance 
sterile metabolic inflammation and insulin resistance by re-shifting the balance from Th1 to Th2 
and inhibiting of Treg cells and macrophage activation resulting in the protective alternative state 
from the maladaptive classical response (Odegaard and Chawla, 2011). Hussaarts and colleagues 
demonstrated in a study that chronic helminth infection reduced body weight gain by 62%, fat 
mass gain and adipocyte size by 89%, lowered whole-body insulin resistance by 23%, glucose 
intolerance by 16%; and improved peripheral glucose uptake by insulin sensitivity by 25% 
(Hussaarts et al., 2015). In spite of that, several modifiable risk factors such as advancing age 
with loss of muscle mass, physical inactivity, endocrine dysfunction, and genetic factors are also 
involved in the expression of syndrome. A number of circumferences such as endothelial 
activation and damage leading to changes in vascular tone, vascular reactivity, and coagulation 
and fibrinolysis pathways are contributing to pathophysiological mechanism of hypertension 
(Beevers et al., 2001). Insulin resistance causes endothelial dysfunction by decreasing Akt kinase 
activity, resulting in declined endothelium NOS phosphorylation activity (Muniyappa and 
Sowers, 2013). Visceral adiposity also fosters endothelia dysfunction through the effects of 
resistin, IL 6 and TNFα on endothelium NOS phosphorylation (Zhu et al., 2005). These 
interrelated factors share the common pathways to hypertension. However, the scientific linkage 
between helminth effect and hypertension is still undiscovered.  
Deworming and helminthic therapy 
The deworming removes the helminth infections and reduces the immune suppression of 
Th1, Th2 and Th17 and Tregs responses leading to the several inflammatory reactions. 
Therefore, administration of helminth related substance or therapy could restore the immune 
regulation mechanism of T cells and Treg cells which proves to have similar roles in chronic 
helminthic infections (Wammes et al., 2014). Helminthic therapy is currently being studied as a 
promising treatment for several autoimmune diseases including Crohn's disease (Hunter and 
McKay, 2004), asthma (Falcone and Pritchard, 2005) and ulcerative colitis (Saunders et al., 
2007)  using Trichuris suis ova. 72% of patients improved symptoms with no adverse reaction 
(Hunter and McKay, 2004). However, T. suis ova therapy showed no effect in allergic rhinitis, 
even though it induced a substantial clinical and immunologic response (Bager et al., 2012). Two 
previous studies reported that infection with hookworm (N. americanus) larvae was strongly 
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associated with protection against asthma symptoms (Scrivener S, 2001 ). It also led to a slight 
improvement in disease symptoms with Crohn’s disease patients (Croese et al., 2006).While 
hookworms have some pathogenic potential effect (Hotez et al., 2004) they are likely to be safe 
at low infection intensities (Pritchard et al., 1999). However, no long-termed follow up has been 
assessed for clinical, parasitological and immunological consequences. Helminth derived 
molecules or products have also been used against allergic diseases, colitis and rheumatoid 
arthritis (Wammes et al., 2014). However, overall effects of deworming on autoimmune and 
inflammatory diseases in human studies have been inconsistent. In our study, we did not find any 
significant association of change in HbA1c level after deworming. This could be explained by 
the fact that significant clinical effects of deworming might take some time to establish. We 
could not follow up these clinical effects and we could not keep the participants free of 
reinfection during our study period.  
Helminthic control strategy/Deworming program in South Africa and Laos PDR 
Since recurrent helminth infections are very prevalent in the different provinces of Laos 
according to the existing helminth studies (Rim et al., 2003, Phommasack et al., 2008, Sayasone 
et al., 2011), the Ministry of Health and Ministry of Education collaborate on school deworming 
programs with health education, which takes place two times a year targeting schoolchildren. In 
addition, the Lao government has made considerable efforts to control STHs in women at 
reproductive age (Phommasack et al., 2008).  
In South Africa, STH infection is most prevalent amongst socioeconomically 
disadvantaged children who live in densely populated and under serviced areas such as informal 
settlements. Studies reported infection rates from 20 to 90% among young learners. High levels 
of infection have been documented amongst children in all provinces, including KwaZulu-Natal, 
the Eastern Cape, Mpumalanga, the Western Cape and Gauteng (Ajoge et al., 2014). School-
based deworming is universally accepted as a safe, simple and cost-effective measure. Even 
though the South African healthcare experts agreed that deworming is an important component 
of school health programme, the implementation of deworming programs in schools varies 
between regions. The departments of basic education and health have endorsed the regular 
deworming of learners in late 2015, and at a first stage, the government of South Africa’s new 
national deworming program intended to deworm 7 million primary school children in 2016 to 
improve children's health. The goal is to reach a minimum target of regular administration of 
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deworming medication to at least 75% of school-age children in general and up to 100% of those 
at risk. 
Deworming becomes a key element to fight the helminthiasis from a global perspective. 
Mass drug administration (MDA) programs in endemic countries usually involve cooperation 
between ministry of health, and pharmaceutical companies, or international 
donors/organizations. MDA programs are mainly targeted at preschool- and school-aged 
children. Therefore, children who do not attend school are missed (Barry et al., 2013). The major 
barriers to cost-effective helminth control are the lack of research evidence on the geographical 
distribution of infection and the occurrence of co-infections or re-infection (Prichard et al., 
2012). The success of MDA also depends on drug coverage as well as compliance of the 
community. It is also important that the community in endemic countries would need to have the 
knowledge about the nature of helminthes, their modes of transmission, the helminth associated 
diseases, the consequences of helminthiasis and the benefits of MDA. A mixed method survey 
conducted by Phongluxa and colleges revealed that the concept and practice of MDA was well 
accepted in affected Laos communities and the main reason was to avoid severe complication of 
schistosomiasis (Phongluxa et al., 2015). However, a systematic review revealed that deworming 
is unlikely to improve overall public health. In addition, global deworming program could not 
kill a variety of different helminth infections as different helminthes infections require different 
treatment regimes, therefore, global drug coverage for different helminth infections could fall 
below target levels and infection levels remain the same or even high (Allen and Parker, 2016).  
 
Diabetes mellitus or chronic diseases prevention program in Laos PDR and South Africa 
Starting from 2014, the Laotian government engaged the DM related activities and 
projects to improve the diabetic health care in the country. Since there is no DM national policy, 
the ministry of Health and international non-governmental organizations have collaborated and 
developed 3 years project plan (2017-2020) which is funded by International Diabetes 
Federation, to tackle DM issues and its related co-morbidities. The project includes training the 
health care providers in targeted tertiary hospitals in four provinces (Vientiane Capital, 
Champasak, Luang Prabang and Savannakhet) to provide a standardized care and managmenet 
of DM as well as hypertension. Currently, more than 12,000 DM patients are receiving a proper 
treatment in the hospitals (WDF, 2017).     
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Type 2 DM ranks fourth in South African ambulatory primary care setting with 65% of 
the adult population are affected. However, recent studies reported it could be as high as 33% in 
some communities of Cape Town (Mash et al., 2015). According to our HbA1c assessments in 
South African study, most of the children fell into preDM group, which means a high risk of 
having DM in near future. The IDF & International Society for Pediatric and Adolescent 
Diabetes has developed the guideline for Diabetes in Childhood and Adolescence to assist health 
providers and caregivers in managing diabetic children and adolescents in a standardized way. 
The Kids and Diabetes in Schools (KiDS) project is designed to support the rights of children 
with diabetes, for happy school days in increasing the awareness of the needs of diabetic children 
(IDF, 2015). To minimize the burden of NCDs in South Africa, the department of health set out a 
detailed plan in the 2011 South African Summit on prevention and Control of NCDs with 
objectives, indicators, activities and time frames. Increasing the percentage of persons controlled 
for hypertension, DM and asthma by 30% are among 10 goals with specific targets is missioned 
to be achieved by 2020. Other target programs are  in reducing the relative premature mortality 
by at least 25%; reducing tobacco use by 20%; reducing the per capita consumption of alcohol 
by 20%; reducing mean population intake of salt <5 grams per day; reducing the prevalence of 
people with raised blood pressure by 20%; increasing the prevalence of physical activity (defined 
as 150 minutes of moderate-intensity physical activity per week, or equivalent) by 10%; reducing 
the prevalence of cervical cancer and every woman with STDs to be screened every 5 years; and 
increasing the number of people screened and treated for mental disorder by 30%. More 
investment in innovation, scientific enquiry, health systems reforms and legislative interventions 
are required to combat NCDs. A healthy lifestyle is an obvious key to the prevention of 
approximately 80% of NCDs. To improve health systems to attain higher levels to control for 
hypertension, DM and asthma, integrated chronic care model with training of community health 
workers in adherence of counseling, monitoring, diagnoses of high CVD risk people and 
referring people suffering from NCDs has been implemented in 3 sub districts of South Africa in 
2013. This chronic care model has been expanding into 10 full districts in 2015 and the model 
will then be evaluated in terms of the feasibility and integration for further application. 
Limitations of our studies 
Re-infections, co-infections and multiparatism have been major limitations in our studies. 
Moreover, we did not include any immunological measures in our studies; therefore. Therefore, 
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we were not able to further explore the exact patho-physiological mechanism associated with the 
dual diseases burden. We expect that different parasitic species could have different 
immunological reactions in the host and they lead to remarkable impact in HbA1c levels (e.g 
hookworm used to act in a different way compared to other STH). In LADUBU study, a causal 
link could not be identified as the study was cross-sectional in nature. In South African study, we 
have seen the HbA1c level has been increased after deworming. However, we could not assume 
the causation as the association is not statistically significant. We believe that there were a 
number of factors influencing the disease interaction between infections and HbA1c levels. 
Some medical diseases related to abnormal haemoglobinopathies such as thalassemia, sickle cell 
anemia might have impact on the HbA1c assessment and other blood test of haemoglobinopathy 
for the medical related diseases, however, the assessment of anemia with the HemoCue Hb 301 
system was considered in our study.  
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Chapter 9 
Conclusion and recommendations 
 
9.1 Conclusion and recommendation for DBD 
In this PhD thesis, we looked into ways how different diseases interact with each other, 
particularly on the association of DM with NTD. DM is well known for its link to altered 
immune responses and immunological complications and the drastic rise of DM in LMIC places 
it as a central contributor to the DBD in a large part of the world. Dengue viral infection and 
helminthic infections represent an important example of the overlap between NTDs and NCDs, 
especially among the poor society. However, it is also urgently required to have a better 
understanding of co-morbid pathogenesis and to identify other NCDs interactions among the 
NTDs or other NTDs interactions with DM. The findings of the study act as an eye opener for 
health policy makers and also draw an attention from the health researchers as there are 
relatively few literatures about this relationship. A key factor is the development of dengue 
vaccines or helminthic therapy, which could be prioritized for individuals with underlying DM, 
depending though on the direction of the association between specific infections and DM. The 
adoption of the strategy addressing both diseases which is a crucial first step should be followed 
by the implementation at the country level. A policy with multi-sectorial approach involving all 
stakeholders; public health decision makers, healthcare providers, non-governmental 
organizations, research institutions, community and individuals should be necessitated.   
9.2 Conclusion and recommendation for DM and Dengue viral infections association 
9.2.1 Conclusion 
The literature review and epidemiological studies looking into the dual burden of DM and 
dengue viral infections are still scarce due to low political interest to prioritize the research 
attention and also lack of coordinated efforts between endemic countries, despite the burden of 
these diseases being enormous from social and economic point of view. Large dengue outbreaks 
have been occurred worldwide in recent years. The objectives of the global strategy in reducing 
the burden of dengue by WHO  are to reduce dengue mortality by at least 50% by 2020 and to 
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reduce dengue morbidity by at least 25% by 2020. By addressing the following recommendation, 
the goal of global strategy could be achievable in near future and the DM patients with dengue 
infection would also have a better prevention and treatment.  
9.2.2 Recommendations 
 
• Timely dengue case diagnosis and appropriate clinical management can prevent the 
dengue related mortality. Additional clinical studies to develop a standardized clinical 
guideline and treatment protocol for the dengue infected DM patients to prevent a severe 
dengue are suggested.  
• As most of the previously conducted studies were case-control studies, prospective 
studies in high endemic area of dengue viral infection which explain the relevance of any 
NCDs comorbidity with dengue infections are needed.  
• Glycemic assessment in patients with suspicion of dengue viral infections or assessment 
of dengue viral infection along with other arbovirus differential diagnosis such as Virus 
Zika or Chikungunya should be performed among DM patients to prevent a severe form 
of these infections.  
• Future studies in different countries settings should be conducted with similar 
epidemiological methods and outcome measures, to improve the comparability of the 
research in the context of DM and dengue viral infection.  
• Studies focusing on detailed immunological and pathophysiological mechanism on 
association between DM and dengue viral infection are also pivotal in better 
understanding of comorbidity.  
• Effective vector control measures are critical to achieving and sustaining reduction of 
dengue morbidity. Therefore, it should also remain as a pillar for dengue prevention and 
control.  
• Risk assessment, integrated epidemiological and entomological surveillance and 
improved reporting of dengue cases at various levels of health care management are also 
critical component in dengue control and measures. It also relates to in preventing of 
severe dengue cases among normal individuals as well as DM patients.  
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• More accurate data on diseases burden of dengue and DM data are recommended for 
research prioritization, health policy, and resources management toward reducing this 
poorly controlled disease.  
• Additionally, clinical trials with dengue vaccination should be considered for all age 
groups and the current dengue vaccination implementation should be expanded to all 
endemic countries and also including DM patients and patients with other NCDs.  
 
To translate these recommendations into action, advocacy and resource mobilization, 
partnership, coordination and collaboration, capacity building, monitoring and evaluation are 
essential for effective implementation as the global strategy. 
 
9.3 Conclusion and recommendation for DM and parasite infections association 
9.3.1 Conclusion 
The research on co-morbid conditions and their influence on the progression of another 
disease are very insightful and useful in clinical setting of disease management. Reducing case 
morbidity or mortality through management of associated risk factors can definitely improve 
clinical outcomes. Through actual understanding of the complex interactions between or parasite 
infections on co-morbid DM condition, we will be able to determine in prioritizing target 
populations for prevention, interventions and effective resources allocation for treatment and 
care of comorbid patients. Our findings contribute to the steps in developing potential novel 
therapeutic strategies (either a vaccine or a drug) aimed at preventing and/or delaying the disease 
onset and/or decreasing the severity of DM. A series of evidence based recommendations are 
also available to health authorities especially in helminth and parasite endemic countries. 
Furthermore, the findings from this study provide a basis to conduct other comprehensive 
studies, investigating the impact of antihelminth treatment on the immune system and on insulin 
resistance. Such studies need to take different helminth species into consideration, given the 
potentially different effects.  
9.3.2 Recommendations 
• As taeniasis is the immediate source of cysticercosis in pigs and humans, addressing 
taeniasis issue with estimating of the prevalence or incidence requires large-scale 
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collection and screening of stool samples and it could be a challenge in a taeniasis 
elimination program.  
• It is evident that future Taenia research in endemic countries still needs the use of more 
robust and reliable diagnostic protocols for the animal and human studies.   
• The valid epidemiological data of taeniasis in human as well as affected animals is still 
inadequate; therefore a basic research and appropriate surveillance system of taenia 
infection in endemic regions should be addressed to identify high risk population and to 
focus prevention and control measures in those areas. 
• If there is evidence of taeniasis infection, infected individuals and animals should be 
properly treated and health awareness of community to undercooked meat should be 
promoted to avoid reinfections. 
• Longitudinal and mechanistic studies need to evaluate how Taenia infections and DM 
influence each other in order to determine if that relationship has clinical relevance. 
• According to our study findings, further interventional studies are urgently needed to 
evaluate the long-term benefit of H. pylori eradication for prevention and progression of 
DM.  
• Due to the evidence of H. pylori role on blood sugar concentration, preventive measures, 
such as increased hygienic conditions and treatments using combination of antibiotics 
and proton pump inhibitor, should be targeted to high risk communities.  
• As a couple of studies including our study have remarked that the causal link of these 
relationships have never been clearly identified, well-designed household cluster 
randomized control trial to assess the effect of anthelminthic treatment on glucose 
metabolism with clean and undetectable worm status will be needed to avoid the 
reinfection of treated individuals. 
• However, reinfection must also be addressed with some basic helminthiasis research 
initiatives in affected society.  
• Given evidence of antibiotic resistance to H. pylori infection, choosing the right drugs 
(antibiotics) for DM or high risk population becomes a necessity to eradicate the 
infection. 
• Like other infectious diseases, as an alternative treatment to deworming or antibiotics, 
developing a potential vaccine therapy which doesn’t currently exist for taeniasis or H. 
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pylori infections, could be an interesting and cost-effective strategy for sustained control 
and treatment of infections. 
• More accurate epidemiological and surveillance data will be needed to prioritize this dual 
burden of diseases in healthcare planning of resource allocation, and investing of new 
diagnostic techniques, development of new therapeutic helminthic or parasitic related 
compound or vaccine which are expected to treat also DM patients in coming decades.  
• In the context of assumed protective effect of some helminthes on DM, well-designed 
clinical trials with large scale deworming would be needed to assess the advantages and 
disadvantages of deworming in the population.  
• In regards to potential helminthic therapy for DM, proper trials with adequate sample 
size, dose of helminthic therapy used, and longer follow up period to monitor and 
evaluate the clinical, parasitological and immunological features of the participants 
should be considered. 
 
 
 
